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 Subtilin and nisin belong to a unique class of antibiotics called lantibiotics that 
contain unusual dehydro and lanthionine amino acid residues. The gene-encoded 
antimicrobial peptides subtilin and nisin exhibit bactericidal effects against several Gram-
positive bacteria and also inhibit bacterial spore outgrowth.  
Subtilin and nisin are structural analogs and possess similar mechanisms of 
antimicrobial action. Although nisin is very stable, subtilin previously isolated was highly 
unstable with loss of biological activity observed during storage. Subtilin isolated in this 
work using hydrophobic interaction chromatography was very stable, with biological 
activity retained for at least a few months after isolation.  
The possibility that specificity of subtilin and nisin towards sensitive Gram-
positive bacteria is due to interaction of these lantibiotics with specific target proteins in 
susceptible bacteria was explored in this work. Phage display experiments performed to 
detect peptides interacting with subtilin identified a 12-mer peptide with a KTTLL motif 
found in ATP binding proteins such as ABC transporters and protein synthesis initiation 
  
factor IF-2 (~78 kDa). Binding of subtilin to specific ABC transporters in bacterial cell 
membrane would contribute to its specificity. Binding of subtilin to IF-2 would result in 
inhibition of protein synthesis suggesting an alternative mechanism of action for subtilin.  
Experiments performed to determine the nature of interaction of subtilin and nisin 
with bacterial cellular proteins detected both covalent and non-covalent interactions. The 
covalent interactions between bacterial proteins and subtilin or nisin were stable on 
boiling in SDS and analyzing by SDS-PAGE. These stable covalent adducts indicated 
that the electrophilic dehydro residues of subtilin and nisin were probably involved in 
covalent attachment with specific nucleophilic groups in bacterial protein targets. 
Covalent attachment of an antibiotic to its bacterial target has been previously observed 
with only a few antibiotics.  
Sites of nisin attachment to bacterial spores as visualized by electron microscopy 
showed nisin binds to highly localized regions on spore surfaces. Attempts to identify 
bacterial protein targets of subtilin and nisin using monomeric avidin and anti-FITC 
columns, respectively, resulted in isolation of proteins in ~70-80 kDa range. Further 
characterization of these proteins should help in understanding the specificity and 
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Part I.  Antibiotics and the problem of bacterial resistance. 
Antibiotics are chemical compounds synthesized by microorganisms that can 
inhibit the growth of or kill other microorganisms (74). Antibiotics can be classified as 
non-peptide antibiotics like tetracycline or peptide antibiotics like gramicidin S (32), 
(83). Peptide antibiotics can be synthesized by multienzyme complexes (penicillin) or by 
ribosomal mechanisms as seen in lantibiotics (83). Modes of action of antibiotics include 
interference with DNA replication, transcription, translation, cell wall biosynthesis and 
cell membrane integrity (53) by forming pores or ion channels in membrane bilayers and 
inhibiting enzyme reactions (29). 
Antibiotics are the primary agents used to treat microbial infections. 
Unfortunately, bacterial resistance to the antibiotics in use has been steadily increasing. 
Measures taken to combat this problem have involved improving the currently available 
antibiotics, discovering new antibiotics or inventing new antibiotics. However, 
modification of existing antibiotics like penicillin has not been able to ward off bacterial 
infections for long and has led to the evolution of bacteria resistant to the modified 
penicillins (34). In addition, designing variants of enzyme-synthesized antibiotics like 
penicillin involves organic synthesis, which limits the number of structural variants that 
can be synthesized and tested. 
Also, screening of microorganisms for new antibiotics over the past several years 
has not been very successful as it involves screening a multitude of microorganisms. The 
few new substances that could be found are likely to belong to an already known 
antibiotic class which would therefore not be very effective for long (82). It is easier to 
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alter the reactivity and specificity of already known and effective antibiotics that are 
gene-encoded in order to invent new antibiotics. The advantage that gene-encoded 
antibiotics have over conventional enzyme-synthesized antibiotics is that it is possible to 
make a great variety of mutants by site-directed mutagenesis to generate analogs that 
exhibit enhanced antimicrobial activity.  
 
Part II.  Lantibiotics: unusual peptide antibiotics. 
Lantibiotics produced by Gram-positive bacteria form an example of             
gene-encoded peptide antibiotics (52). Lantibiotics are so named because of the presence 
of lanthionine rings (Fig. 1). Lanthionine formation is a result of posttranslational 
modification and involves the reaction of a dehydrated serine or threonine with cysteine 
residues through thioether linkages (Fig. 2) resulting in the formation of lanthionine (Ala-
S-Ala) or β-methyl lanthionine (Aba-S-Ala), respectively (24), (83). The presence of 
these unusual residues, their influence on structure and activity of the peptides and their 
unique biosynthetic pathways have caused them to be targets of research (62). 
Lantibiotics can be classified into types A, B and C according to their structural features 
(Fig. 3). Type A lantibiotics are linear, cationic peptides which include nisin, subtilin and 
sublancin. Type B such as cinnamycin are less cationic or neutral, while type C 
lantibiotics like mersacidin are small and neutral (24). 
Part III.  Type A lantibiotics – nisin and subtilin. 
Two well-studied type A lantibiotics are nisin and subtilin produced by 








































Figure 1. Structures of dehydro residues and lanthionine residues.
The unusual dehydro residues and lanthionine residues observed in lantibiotics
are formed as a result of post-translational modifications of naturally occurring
amino acids (Sahl, ., 1995).et al
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Figure 2. Formation of dehydro and lanthionine residues.
Enzyme-catalyzed dehydration of serines and threonines during
posttranslational modifications results in the formation of
dehydroalanine (Dha) and dehydrobutyrine (Dhb), respectively.
Nucleophilic addition of the sulfhydryl group of cysteine to Dha and
Dhb leads to the formation of lanthionine and -methyl lanthionine,
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Figure 3. Structures of few type A, type B and type C lantibiotics.
Lantibiotics are classified into type A, type B and type C based on their structural
features. Nisin, subtilin and sublancin belong to type A (nisin-like) lantibiotics.
Cinnamycin is a type B (duramycin-like) lantibiotic, and mersacidin is a type C
lantibiotic (Hansen, J.N., 1997).
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and subtilin are structural analogs exhibiting 60% identity in their amino acid residues 
(22). Nisin is a peptide of 34 amino acids while subtilin has 32 amino acids. Both 
peptides possess three dehydro residues - two Dha and one Dhb, and five lanthionine 
rings (31), (42). The lanthionine rings are named alphabetically with ring A at the amino 
terminus. Another type A lantibiotic is sublancin with 37 amino acid residues, including a 
Dha residue and a lanthionine ring. Sublancin differs from other lantibiotics in exhibiting 
the presence of disulfide bridges, instead of the thioether linkages seen in other 
lantibiotics (57).  
Subtilin and nisin are synthesized as precursor peptides with leader peptides at the 
N terminus comprising 24 and 23 amino acid residues, respectively, that must be cleaved 
to give the mature lantibiotic. Biosynthesis of subtilin involves multiple genes arranged 
in a cluster on the B. subtilis ATCC 6633 chromosome, comprising the spaBTCSIFGRK 
gene cluster. The subtilin structural gene, spaS, is located in the middle of the gene 
cluster. Enzyme SpaB is responsible for dehydration of serines and threonines whereas 
SpaC is involved in lanthionine ring formation. The SpaT protein exhibits characteristics 
of ATP-binding cassette (ABC) transporters and participates in transport of subtilin. 
SpaIFG proteins appear to participate in immunity against secreted subtilin. SpaK and 
SpaR are involved in the regulation of subtilin synthesis (2), (28). In contrast to the 
subtilin gene cluster, the nisin genes are located on a conjugative transposon comprising 
the nisABTCIPRKFEG gene cluster (69). Nisin is synthesized as a prepropeptide from the 
nisA gene and then modified posttranslationally by a membrane localized enzyme 
complex consisting of the NisB and NisC proteins. The modified prepeptide is then 
transported through the cellular membrane by the NisT protein. The mature peptide is 
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then released into the extracellular medium after being proteolytically cleaved by NisP 
(Fig. 4). Immunity to the mature nisin molecule is possibly provided by the NisI 
lipoprotein, which could interact with the extracellular nisin and prevent it from binding 
to the cell membrane (65). Alternatively, the ABC transporter system comprising of 
proteins NisE, NisF and NisG may participate in the active transport of mature nisin into 
the cell which is subsequently degraded to protect the cell from mature nisin (13), (16). 
 
Part IV.  Applications of lantibiotics. 
Nisin has found application as a food preservative after being granted GRAS 
(generally recognized as safe) status in 1988 (23). Nisin is the only antibiotic approved 
by the FDA for use as a food preservative. Nisin has also been approved as a food 
preservative in 50 countries worldwide. Specifically, nisin is used to increase the shelf-
life of dairy products such as cheese and ice cream as it inhibits not only bacterial spore 
outgrowth but also vegetative bacterial cells. Nisin is also used in meat products, and is 
being considered as an alternative to the potentially carcinogenic nitrite used as a food 
preservative. Use of nisin in beer and wine is another growing application (24).  
Lantibiotics exhibit a broad spectrum of action against Gram-positive bacteria. 
With the exception of Neisseria gonorrhoeae (49), lantibiotics are generally not active 
against Gram-negative bacteria unless the lipopolysaccharide layer has been treated with  
chelating agents such as EDTA (71). Nisin has been shown to inhibit several Gram-
positive bacteria such as Enterococcus faecalis ssp. liquefaciens ATCC 27959, 
Staphylococcus aureus ATCC 29740, Staphylococcus epidermidis ATCC 14990, several 
species of Streptococcus and Bacillus, and a few species of Clostridium (23). Nisin also 
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Figure 4. Model for nisin biosynthesis.
Activation of the sensor histidine kinase NisK protein by a signal leads to the
activation of the response regulator NisR protein. NisR then activates the nisin gene
to produce the nisin prepropeptide which undergoes specific dehydrations and
thioether modifications. The modified prepeptide is then transported through the
cell membrane by the NisT protein. The leader peptide is cleaved by NisP to release
the mature nisin peptide. NisI and NisGEF provide immunity to mature nisin















inhibits Bacillus cereus spores as well as vegetative B. cereus cells. Bacillus cereus is an 
opportunistic human pathogen causing contamination problems in dairy products leading 
to food poisoning. The genomes of Bacillus cereus and Bacillus anthracis exhibit a close 
similarity, suggesting that they could be considered as belonging to the same species, 
with the functional differences arising as a result of genes carried on different plasmids in 
the two organisms (25). The spore-forming B. anthracis causes the lethal disease anthrax 
and is therefore of concern as a possible agent in biological warfare. Bacillus cereus and 
B. anthracis are genetically very closely related, and therefore, nisin could potentially be 
used to combat B. anthracis. Coughlin et al. showed that formulations containing nisin, 
chelator, detergent, and alcohol inhibited growth of spores and vegetative cells of a test 
strain of B. anthracis (11).
Other lantibiotics that have been studied include epidermin and mersacidin. 
Epidermin, a type A lantibiotic, has been used in the treatment of skin diseases such as 
acne (30). Mersacidin, a type C lantibiotic, was shown to be effective in treating systemic 
staphylococcal infections by affecting a target that is not attacked by the current drugs 
(5). This offers hope in developing new antimicrobial substances that are active against 
methicillin-resistant staphylococci or vancomycin-resistant enterococci. An example of a 
modified antibiotic with increased antimicrobial activity is E4I subtilin, which exhibited 
enhanced biological activity and stability when Glu4, a residue adjacent to Dha5, was 
altered to Ile4. The mutant E4I subtilin exhibited a three-fold increase in antimicrobial 
activity and a 60-fold increase in chemical stability mainly on account of changing the 
amino acid environment around Dha5 (44). 
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Lantibiotics therefore form interesting objects of study on account of the unique 
amino acid residues and the high amount of amino acid modifications. The lanthionine 
rings confer local rigidity, protease stability and increased temperature insensitivity while 
the dehydro residues are important in antimicrobial activity (30). Deciphering the 
structure-function relationship of these residues could aid in the development of newer 
antibiotics targeted against resistance-developing pathogens.  
 
Part V.  Antimicrobial mechanism of type A lantibiotics subtilin and nisin. 
This points to the importance of understanding the mechanism of the 
antimicrobial effect of these lantibiotics. Two modes of bacterial growth inhibition have 
been suggested for type A lantibiotics, one which involves the pore-forming ability of the 
lantibiotics in vegetative bacterial cells and another in which the dehydro residue plays an 
important role in inhibition of spore outgrowth. Type B lantibiotics affect enzyme 
function while type C lantibiotics inhibit cell wall biosynthesis in susceptible bacteria 
(29), (62).  
 
Part V-1.  Pore forming mechanism in bacterial vegetative cells. 
The mechanism of pore formation by type A lantibiotics has been thoroughly 
studied, mainly using nisin as a model. Pore formation involves diffusion of nisin through 
the cell wall, association of nisin with the cell membrane surface, followed by insertion 
of nisin aggregates into the membrane in the presence of a sufficiently high transnegative 
membrane potential (62) or a transmembrane pH gradient (inside alkaline) resulting in 
pores. Experiments involving the activity of nisin on bacterial cells artificially energized 
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by valinomycin speculated a range of –50 mV to -80 mV as the threshold potential 
(∆Ψ) required for nisin to form pores (63). In the absence of ∆Ψ, nisin can form pores 
when the pH gradient is alkaline inside the cell (19), (48).  
Nisin forms pores with a diameter of approximately 1 nm while subtilin pores are 
approximately 2 nm in diameter (62), (67). Nisin and subtilin exhibit subtle differences in 
the mechanism of pore formation. Subtilin forms more stable pores which are larger in 
size compared to nisin (67), (33). This has been explained to be due to the absence of 
charged amino acids in the central domain of subtilin (residues 5-28), which increase the 
hydrophobicity of subtilin that could facilitate membrane insertion and therefore, lead to 
the formation of more stable pores. The affinity of nisin is strongly dependent on the 
presence of negatively charged phospholipids and based primarily on electrostatic 
interactions, while subtilin may partially penetrate into membranes with its hydrophobic 
central domain (33).  
Nisin and subtilin are thought to consist of two domains connected by a flexible 
hinge. Lanthionine rings A, B and C in the N-terminus form one domain while rings D 
and E in the C-terminus form the other domain with the hinge region composed of amino 
acids 20-22 (62). Intact rings A and C have been shown to be essential for antibacterial 
activity of nisin (8). This evidence supports the wedge model (Fig. 5) proposed by Moll 
et al. for the formation of pores by nisin in the bacterial membrane which postulates that 
the N-terminal part of nisin, comprising rings A and C, is responsible for binding of nisin 
to the membrane and/or its oligomerization, while the more cationic C-terminal part of 
the molecule plays a significant role in pore formation. The flexible hinge region is 










Figure 5. Wedge model of pore formation by nisin.
In the wedge model, pore formation by nisin involves three steps -
binding of nisin to the cell membrane, followed by insertion of nisin into
the cell membrane which subsequently results in wedge-like pore
formation. Binding of nisin leads to perturbation of the bilayer surface.
A transnegative membrane potential or a pH gradient (inside alkaline)
can induce the insertion of nisin into the cell membrane. Coinsertion of
bound phospholipids together with the C-terminus of nisin results in




like pore. Nisin is considered to be amphipathic in the pores and oriented with its 
hydrophobic side towards the membrane and with its hydrophilic side towards the water-
filled channel (76). The adhesion of the amphiphilic molecules to the surface of the cell 
membrane causes destabilization of the bilayer structure by disturbing the lipid dynamics 
near the phospholipid polar headgroup-water interface (14). The presence of a 
transnegative membrane potential above a threshold or transmembrane pH gradient 
(inside alkaline) may change the orientation of nisin in the membrane relative to the plane 
of the membrane and drive the membrane insertion of the phospholipid surface-bound 
molecules (14), (48). The carboxyl terminal residues carrying a net positive charge, 
together with the bound lipids, are then drawn across the membrane forming a wedge to 
form a water-filled pore. Pore formation leads to an efflux of ions, amino acids and ATP 
resulting in cell death. Nisin exhibits no selectivity for charge and size of the efflux, as 
the efflux velocity remains unchanged for small ions like Rb+ and for larger positively or 
negatively charged amino acids. This suggests that nisin causes a generalized membrane 
perturbation rather than a channel with finite size (61). Transient, multi-state pores are 
formed by nisin and subtilin, which require the aggregation of several peptide molecules 
in a transmembrane orientation (33).  
The wedge model proved to be a good model to illustrate the effect of nisin on 
model membranes. However, the wedge model failed to explain the observation that 
micromolar concentrations of nisin were required for pore formation in model 
membranes, whereas nanomolar concentrations of nisin were sufficient to inhibit living 
bacterial cells (79). This effect was explained by proposing a model involving the role of 
lipid II as a docking molecule for nisin (Fig. 6). The lipid II-mediated nisin pore  
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Figure 6.
The lipid II-mediated model of pore formation by nisin proposes that lipid II, a
peptidoglycan precursor acts as a docking molecule for nisin. Nisin first binds to the
carbohydrate moiety of lipid II through its N-terminal segment. The C-terminal part of
nisin then translocates across the cell membrane. Interaction of nisin with lipid II may
stabilize the transmembrane orientation of nisin. Several nisin-lipid II complexes
assemble together to form a functional pore resulting in the efflux of metabolites and
cell lysis (Wiedemann, ., 2001).et al
Lipid II-mediated model of pore formation by nisin.
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formation model proposed that nisin uses lipid II as a docking molecule for subsequent 
pore formation. Lipid II is a precursor of peptidoglycan, which comprises the bacterial 
cell wall. The model proposed that nisin first binds to the carbohydrate moiety of lipid II 
in a 1:1 stoichiometry through its N-terminal segment. The C-terminal part of nisin then 
translocates across the cell membrane. Interaction of nisin with lipid II may stabilize the 
transmembrane orientation of the nisin molecule. Several such nisin-lipid II complexes 
assemble to form a functional pore resulting in the efflux of metabolites from the cell and 
eventual cell lysis (79).  
 
Part V-2.  Mechanism of inhibition of bacterial spore outgrowth. 
The second mechanism of antimicrobial action of nisin and subtilin involves their 
ability to inhibit bacterial spore outgrowth probably by covalent modification. The 
electrophilic dehydro residues are speculated to react with nucleophilic sulfhydryl groups 
on the surface of germinating spores. This was supported by experiments which showed 
that covalent modification of a nucleophilic sulfhydryl group in germinating spores by 
iodoacetate resulted in inhibition of B. cereus spore outgrowth (50). Further, nisin was 
shown to compete with iodoacetate, which modifies membrane sulfhydryl groups, for 
binding to germinated spores (51). The spore inhibiting activity has been critically linked 
to Dha5 in ring A. Mutation of Dha5 to Ala in subtilin (44) and nisin (8) resulted in loss 
of inhibition of spore outgrowth but had no effect on the ability to cause cell lysis of 
vegetative cells. Thus, it can be summarized that the antimicrobial action of nisin and 
subtilin on vegetative cells and germinated spores occurs by two different mechanisms 
(45). 
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Part VI.  Research objectives. 
The wedge model of pore formation by type A lantibiotics in bacterial vegetative 
cells has postulated that the pore forming ability of type A lantibiotics does not require 
specific receptors in the cell membrane since they act on artificial phospholipid bilayers 
although the overall charge of the bilayer may assist in attracting and accumulating the 
peptides at the membrane surface (47). However, the lipid II-mediated model of nisin 
pore formation requires binding of nisin to lipid II which acts as a docking molecule and 
thereby enhances the antimicrobial effect of nisin. Both the wedge model and the lipid II 
model do not satisfactorily explain the high specificity of nisin towards certain Gram-
positive bacteria. The phospholipid composition of the bacterial cell membrane is fairly 
similar amongst a wide spectrum of Gram-positive bacteria, with the differences arising 
mainly from the presence of different cell membrane proteins. Also, lipid II is a precursor 
of peptidoglycan that forms the bacterial cell wall. All Gram-positive and Gram-negative 
bacteria possess a bacterial cell wall formed from peptidoglycan. Therefore, although 
lipid II might function as a docking molecule to enable nisin binding, the possibility that 
the specificity of nisin towards susceptible Gram-positive bacteria is due to the result of 
its interaction with specific, and as yet, unidentified protein targets in the bacterial cell 
membrane cannot be ruled out.  
Also, the two models that were proposed to explain type A lantibiotic pore 
formation contrast with the mechanism of action of a number of other antibacterial 
peptides, such as lactococcin A, a bacteriocin produced by Lactococcus lactis (75), and 
carnocin UI49, a type A lantibiotic produced by Carnobacterium piscicola UI49 (73), 
which are thought to interact with specific membrane-bound receptor proteins that 
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mediate the specificity of these antibacterial peptides. Carnocin UI49 shows bactericidal 
activity against many lactic acid bacteria (LAB) including the nisin-producing L. lactis 
subsp. lactis, which are 10-fold more sensitive to carnocin UI49 than other LAB. 
Experiments involving testing several transformed L. lactis subsp. lactis strains carrying 
a fragment of the nisin gene cluster for their sensitivity to carnocin UI49 suggested that 
NisP, one of the membrane associated proteins involved in the production of active nisin 
by cleaving off the leader peptide, acts as a receptor for carnocin UI49. NisP may 
facilitate the binding and/or insertion of carnocin UI49 into the cytoplasmic membrane 
thus increasing the efficiency of its bactericidal activity (72).  
Since protein-protein interactions are highly specific, this work explored the 
possibility that specificity of subtilin and nisin is conferred by their initial recognition and 
binding to specific protein targets in the bacterial cell membrane and not merely due to 
their interaction with membrane lipids. The phage display technique was therefore 
employed to identify potential peptide targets of subtilin by allowing subtilin to select for 
specific peptide structural motifs from random peptide libraries displayed on the surface 
of M13 bacteriophage. This research also attempted to isolate and identify bacterial 
protein targets of subtilin and nisin in susceptible bacterial vegetative cells to correlate 
the results obtained from phage display with the biological targets of subtilin and nisin. 
Isolation and identification of bacterial protein targets of subtilin and nisin will not only 
help in understanding the specificity of subtilin and nisin but also provide an insight into 





Further, a research goal in this lab has been to determine whether covalent 
attachment of nisin and subtilin with their biological targets can occur. Previous 
experiments involving E4I/Dha5A subtilin, in which Glu4 was changed to Ile and 
dehydroalanine5 (Dha5) was changed to Ala, revealed that E4I/Dha5A subtilin lost its 
ability to inhibit spore outgrowth in B. cereus spores. However, E4I/Dha5A subtilin was 
capable of inducing cell lysis in vegetative B. cereus cells (45). A similar result was seen 
with Dha5A nisin (8), indicating that both subtilin and nisin exert their antimicrobial 
effects against bacterial spores and vegetative cells by different mechanisms. It is 
possible that the mechanism of bacterial spore outgrowth by subtilin and nisin involves 
covalent modification of nucleophilic sulfhydryl groups on the surface of germinating 
spores by the electrophilic dehydro residues since an intact Dha5 is required to inhibit 
spore outgrowth. Experiments were therefore performed to determine the nature of 
interaction of subtilin and nisin with bacterial protein targets in bacterial vegetative cells 
to examine whether subtilin and nisin could interact covalently with specific bacterial 
protein targets in bacterial vegetative cells. Detection of a covalent linkage would 
indicate that the electrophilic dehydro residues are involved in bond formation with 
specific nucleophilic groups in the protein target. Detection of covalent attachment of 
subtilin and nisin to protein targets in bacterial vegetative cells would also pave the way 
towards understanding alternative mechanisms of action of subtilin and nisin in bacterial 
vegetative cells, in addition to pore formation. This knowledge will aid in the design of 
structural variants of antibiotics by introducing reactive groups such as dehydro residues 
(35) to create newer antibiotics more effectively targeted against bacterial pathogens. 
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Materials and Methods 
Part I.  Material sources 
Part I-1.  Reagents and chemicals 
Acetic Acid, Glacial    Baker Inc., Phillipsburg, NJ 
Acetonitrile, HPLC grade   Fisher Scientific Co., Fair Lawn, NJ 
Acrylamide     Bio-Rad Laboratories, Hercules, CA 
Agarose     Gibco BRL, Gaithersburg, MD 
Amino acids     Sigma Chemical Company, St. Louis, MO 
Ammonium hydroxide (30%)   Baker Inc., Phillipsburg, NJ 
Ammonium persulfate   Baker Inc., Phillipsburg, NJ 
Ammonium phosphate, dibasic  Sigma Chemical Company, St. Louis, MO 
[α-35S]-dATP     New England Nuclides, Boston, MA 
BCIP      Gibco BRL, Gaithersburg, MD 
Biotin disulfide NHS ester   Sigma Chemical Company, St. Louis, MO 
Bisacrylamide     Bio-Rad Laboratories, Hercules, CA 
Bovine serum albumin   Sigma Chemical Company, St. Louis, MO 
Bromophenol blue    Sigma Chemical Company, St. Louis, MO 
Calcium chloride    Fisher Scientific Co., Fair Lawn, NJ 
Cellulose, non ionic powder   Bio-Rad Laboratories, Hercules, CA  
Citric acid monohydrate   Fisher Scientific Co., Fair Lawn, NJ 
α-Cyano-4-hydroxycinnamic acid  Sigma Chemical Company, St. Louis, MO 
N, N, - dimethylformamide   Fisher Scientific Co., Fair Lawn, NJ 
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Dithiothreitol     Sigma Chemical Company, St. Louis, MO 
Ethanol     Aaper Chemical Co., Shelbyville, KY 
Ethidium bromide    Gibco BRL, Gaithersburg, MD 
Ferric chloride    Acros Organics, NJ 
Glycerol     Fisher Scientific Co., Fair Lawn, NJ 
Glycine     Fisher Scientific Co., Fair Lawn, NJ 
Guanidine hydrochloride   Sigma Chemical Company, St. Louis, MO 
Hydrochloric acid (38%)   Baker Inc., Phillipsburg, NJ 
N-hydroxy succinimide fluorescein  Pierce Biotechnology Inc., Rockford, IL 
IPTG      Gibco BRL, Gaithersburg, MD 
Isobutanol     Baker Chemical, Phillipsburg, NJ 
Isopropanol     Fisher Scientific Co., Fair Lawn, NJ 
Manganous chloride tetrahydrate  Baker Inc., Phillipsburg, NJ 
Magnesium chloride hexahydrate  Fisher Scientific Co., Fair Lawn, NJ 
Magnesium sulfate    Baker Inc., Phillipsburg, NJ 
2-mercaptoethanol    Baker Inc., Phillipsburg, NJ 
Methanol     Fisher Scientific Co., Fair Lawn, NJ 
NBT      Gibco BRL, Gaithersburg, MD 
Phosphoric acid    Fisher Scientific Co., Fair Lawn, NJ 
Polyethylene glycol-8000   Fisher Scientific Co., Fair Lawn, NJ 
Potassium chloride    Baker Inc., Phillipsburg, NJ 
Potassium phosphate, monobasic  Fisher Scientific Co., Fair Lawn, NJ 
Potassium phosphate, dibasic   Fisher Scientific Co., Fair Lawn, NJ 
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1-StepTM NBT/BCIP      Pierce Biotechnology Inc., Rockford, IL 
Sinapinic acid     Sigma Chemical Company, St. Louis, MO 
Sodium bicarbonate    Fisher Scientific Co., Fair Lawn, NJ 
Sodium chloride    Fisher Scientific Co., Fair Lawn, NJ 
Sodium dodecyl sulfate   Fisher Scientific Co., Fair Lawn, NJ 
Sodium hydroxide    Fisher Scientific Co., Fair Lawn, NJ 
Sodium iodide     Baker Inc., Phillipsburg, NJ 
Sodium phosphate, monobasic  Baker Inc., Phillipsburg, NJ 
Sodium phosphate, dibasic   Baker Inc., Phillipsburg, NJ 
Sodium sulfate    Fisher Scientific Co., Fair Lawn, NJ 
Sucrose     Fisher Scientific Co., Fair Lawn, NJ 
TEMED     Sigma Chemical Company, St. Louis, MO 
Thiamine     Sigma Chemical Company, St. Louis, MO 
Toyopearl™ Butyl-650M HIC resin  Tosohaas, Montgomeryville, PA 
Tricine      Sigma Chemical Company, St. Louis, MO 
Trifluoroacetic acid    Acros Organics, NJ 
Tris base     Fisher Scientific Co., Fair Lawn, NJ 
Tween-20     Sigma Chemical Company, St. Louis, MO 
Urea      Fisher Scientific Co., Fair Lawn, NJ 
X-Gal      Gibco BRL, Gaithersburg, MD 




Part I-2.  Antibodies, enzymes and kits 
Goat Anti-rabbit IgG-alkaline phosphatase  Pierce Biotechnology Inc., Rockford, IL 
Ph.D.-7 Phage Display Peptide Library Kit New England Biolabs, Boston, MA 
Ph.D.-12 Phage Display Peptide Library Kit New England Biolabs, Boston, MA 
PlusOneTM Silver Staining Kit  Pharmacia Biotech, Uppsala, Sweden 
Immobilized Monomeric Avidin Kit  Pierce Biotechnology Inc., Rockford, IL 
ImmunoPure Protein A IgG Orientation Kit Pierce Biotechnology Inc., Rockford, IL 
Rabbit anti-FITC antibody   Biodesign International, Saco, ME 
Rabbit anti-subtilin antibody   Research Genetics, Huntsville, AL 
Seize Classic (A) Immunoprecipitation Kit Pierce Biotechnology Inc., Rockford, IL 
Seize X Protein A Immunoprecipitation Kit Pierce Biotechnology Inc., Rockford, IL 
Sequenase version 2.0 DNA sequencing kit U. S. Biochemicals, Cleveland, OH 
Streptavidin-alkaline phosphatase   Gibco BRL, Grand Island, NY 
Trypsin     Sigma Chemical Company, St. Louis, MO 
 
 
Part I-3.  Media and antibiotics 
Bacto agar     Difco, Detroit, MI 
Bacto tryptone    Difco, Detroit, MI 
 
Chloramphenicol    Sigma Chemical Company, St. Louis, MO 
 
Penassay broth (PAB) antibiotic medium 3 Difco, Detroit, MI 
 
Nisin       Aplin Barrett, Trowbridge, Wilts UK (?) 
 





Part I-4.  Apparatus 
 
Air and water incubating shakers  New Brunswick Scientific, New Brunswick 
Centrifuge, Avanti J25-I   Beckman Instruments Inc., Palo Alto, CA 
Centrifuge bottles    VWR Scientific, Baltimore, MD 
Corex glass centrifuge tubes, 30 ml  VWR Scientific, Baltimore, MD 
Digital photo documentation system  Eastman Kodak Company, Rochester, NY 
DNA sequencing apparatus   American Bionuclear, Emeryville, CA 
DNA sequencing glass plates and spacers VWR Scientific, Baltimore, MD 
ESI-Mass Spectrometer (LCQ)  Finnigan, San Jose, CA 
HIC chromatography Econo-Columns Bio-Rad Laboratories, Hercules, CA 
HIC peristaltic pump    Gilson Medical Electronics, WI 
HPLC column, Microsorb   Rainin Instrument Co. Inc., Woburn, MA 
HPLC      Hewlett-Packard Company, Avondale, PA 
Eppendorf microcentrifuge tubes  VWR Scientific, Baltimore MD 
French pressure cell    Aminco Inc., Silver Spring, MD 
French pressure cell power supply  Enerpac, Butler, WI 
Gel dryer, Model 583    Bio-Rad, Hercules, CA 
Gel electrophoresis vertical units  Bio-Rad Laboratories, Hercules, CA 
Gel electrophoresis vertical unit glass plates Bio-Rad Laboratories, Hercules, CA 
ImmobilonTM-NC nitrocellulose membrane Millipore Inc., Bedford, MA 
Kapak pouches    VWR Scientific, Baltimore, MD 
Kapak pouch sealer    Kapak Corporation, Minneapolis, MN 
MALDI-TOF MS    Bruker Instruments, Manning Park, MA 
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MALDI-TOF MS sample stages  Bruker Instruments, Manning Park, MA 
Microscope     Nikon, Japan 
Petri dishes     VWR Scientific, Baltimore, MD 
pH meter, Accumet AB15   Fisher Scientific Co., Fair Lawn, NJ 
Pipetman, P20, P200, P1000   Rainin Instruments Co. Inc., Woburn, MA 
Power supply, Model 494   ISCO, Lincoln, NE 
Power supply, Model EC105   E-C Apparatus, St. Petersburg, FL 
Snakeskin pleated dialysis tubing   Pierce Biotechnology Inc., Rockford, IL 
SpeedVac concentrator   Savant Instruments Inc., Farmingdale, NY 
Spore spray unit    Sigma Chemical Company, St. Louis, MO 
Storm 860 Imager     Amersham Biosciences, Piscataway, NJ 
Syringes, 60 ml    VWR Scientific, Baltimore, MD 
Syringe filters, 0.2 µm, 0.45 µm  Pall Corporation, Ann Arbor, MI 
Syringe needles, 18G1½   VWR Scientific, Baltimore, MD 
UV transilluminator    Fotodyne Inc., New Berlin, WI 
UV-VIS Spectrophotometer   Hewlett-Packard Company, Avondale, PA 
X-Omat XAR-5 X-ray films   VWR Scientific, Baltimore, MD 
Water bath     Precision Scientific, Chicago, IL 
Whatman 3MM filter paper    VWR Scientific, Baltimore, MD 




Part II.  Methods 
Part II-1.  Stock solutions, buffers and growth media 
1-1.  Stock Solutions 
 
Acrylamide/bis-acrylamide:  Several acrylamide:bis-acrylamide stock solutions 
were prepared for use in SDS-PAGE of proteins and DNA sequencing. For tricine-SDS-
PAGE of peptides, two stock solutions of varying acrylamide:bis concentrations were 
prepared (66). The first stock solution of acrylamide and bis (49.5%T, 3%C) was 
prepared by dissolving 48 g of acrylamide and 1.5 g of bis-acrylamide in 70 ml of 
ddH2O, and then adjusting the volume to 100 ml with ddH2O. The second stock solution 
of acrylamide and bis (49.5%T, 6%C) was prepared by dissolving 46.5 g of acrylamide 
and 3 g of bis-acrylamide in 70 ml of ddH2O. The volume was then adjusted to 100 ml 
with ddH2O. Both solutions were filtered through a 0.45 µm filter and stored at 4°C in 
lightproof bottles. 
A stock solution of acrylamide:bis (29:1) for Laemmli SDS-PAGE of proteins 
was prepared by dissolving 29 g of acrylamide and 1 g of bis-acrylamide in 70 ml of 
ddH2O. After adjusting the volume to 100 ml with ddH2O, the solution was filtered 
through a 0.45 µm filter and stored at 4°C in a lightproof bottle.  
For DNA sequencing, a 40% acrylamide:bis (19:1) solution was prepared by 
dissolving 38 g of acrylamide and 2 g of bis-acrylamide in 70 ml of ddH2O. The volume 
was adjusted to 100 ml with ddH2O and the solution filtered through a 0.45 µm filter. The 
solution was stored at 4°C in a lightproof bottle. 
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Ammonium persulfate (APS):  A 10% stock solution of APS was prepared by 
dissolving 0.5 g of APS in 5 ml of ddH2O. The solution was stored at 4ºC for upto a 
month. 
Chloramphenicol:  A 10 mg/ml stock solution was prepared by dissolving 10 mg 
of chloramphenicol in 1 ml of 95% ethanol. The stock solution was stored at -20ºC for 
upto a month. 
 Dithiothreitol (DTT):  A 1 M stock solution of DTT was prepared by dissolving 
1.54 g of DTT in 10 ml of 10 mM sodium acetate, pH 5.2. The solution was filter 
sterilized through a 0.2 µm filter and stored in 1 ml aliquots at –20°C.  
EDTA:  A 0.5 M stock of EDTA was prepared by adding 9.3 g of 
Na2EDTA·2H2O to 40 ml of ddH2O. The pH was adjusted to 8.0 with 1 N NaOH to 
dissolve all of the EDTA. The volume was adjusted to 50 ml with ddH2O and the solution 
stored at RT. 
Isopropylthio-β-galactoside (IPTG):  A 0.1 M stock solution was prepared by 
dissolving 0.25 g of IPTG in 10.5 ml of ddH2O. The solution was filter sterilized using a 
0.2 µm filter and stored at –20°C in 0.5 ml aliquots. 
Nisin:  A stock solution of 10 mg/ml was prepared by dissolving 10 mg in 1 ml of  
0.05% TFA. The solution was stored at -20ºC for upto 3 months. 
Sodium acetate:  A 1 M stock solution of NaOAc, pH 4.0 was prepared by adding 
28.6 ml of glacial acetic acid to 400 ml of ddH2O. The pH was increased to 4.0 with 10 N 
NaOH and the volume adjusted to 500 ml with ddH2O. The solution was autoclaved at 
121°C for 20 min and stored at 4°C. 
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Sodium chloride (NaCl):  A 5 M solution of NaCl was prepared by dissolving 
146.1 g of NaCl in 400 ml of ddH2O and then adjusting the volume to 500 ml with 
ddH2O. The solution was stored at 4°C. 
Sodium dodecyl sulfate (SDS):  A 10% stock solution was prepared by dissolving 
1 g of SDS in 10 ml of ddH2O by gentle inversion. The solution was stored at RT. 
Tris-HCl:  A 1 M stock solution of Tris-HCl was prepared by dissolving 121.11 g 
of Tris base in 800 ml of ddH2O. The pH was adjusted to the desired pH using 
concentrated HCl and the volume increased to 1 L with ddH2O. A 1.5 M stock of Tris-
HCl was also prepared by dissolving 18.16 g of Tris base in 80 ml of ddH2O, adjusting to 
the desired pH with concentrated HCl, and the volume increased to 100 ml with ddH2O. 
Stock solutions were autoclaved at 121°C for 20 min and stored at RT. The stock 
solutions were diluted to the desired working concentrations as specified in the 
appropriate methods. 
5-bromo-4-chloro-3-indolyl-β-galactoside (X-Gal):  A 20 mg/ml stock solution 
was prepared by dissolving 200 mg of X-gal in 10 ml of dimethyl formamide. The 
solution was stored in the dark at –20°C in 0.5 ml aliquots. 
1-2.  Solutions for peptide purification. 
 
HIC equilibration/wash buffer:  The HIC equilibration buffer consisted of 0.05 M 
NaOAc, pH 4.0 and 1 M NaCl. A 1 L buffer solution was prepared by adding 50 ml of    
1 M NaOAc, pH 4.0 and 200 ml of 5 M NaCl to 750 ml of ddH2O. 
HIC elution buffer:  The HIC elution buffer used to elute subtilin from the HIC 
column consisted of 50% CH3CN in 0.05% TFA. 50 ml of elution buffer was prepared by 
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adding 500 µl of 5% TFA to 24.5 ml of ddH2O and adjusting the volume to 50 ml with 
CH3CN. 
Solvent A for RP-HPLC:  500 ml of solvent A was prepared by adding 25 ml of 
CH3CN, 500 µl of acetic acid and 50 µl of 100% TFA to ddH2O and adjusting the 
volume to 500 ml with ddH2O. 
Solvent B for RP-HPLC:  500 ml of solvent B was prepared by adding 25 ml of 
ddH2O, 500 µl of acetic acid and 50 µl of 100% TFA to CH3CN and adjusting the 
volume to 500 ml with CH3CN. 
 Solvent C for SEC-HPLC:  500 ml of solvent C (0.05 M KH2PO4, 0.1 M NaCl, 
pH 6.8) was prepared by dissolving 3.4 g of KH2PO4 and 2.92 g of NaCl in 400 ml of 
HPLC-grade water. The pH was adjusted to 6.8 using 1 N NaOH and the volume 
adjusted to 500 ml with water.  
1-3.  Solutions for SDS-PAGE. 
 
 16.5% T, 6% C separating gel with 6 M urea:  The separating gel for Tricine-
SDS-PAGE was prepared by dissolving 3.6 g of urea in 3.33 ml of gel buffer (3 M Tris, 
0.3% SDS), 2 ml of ddH2O, and 3.33 ml of 49.5% T, 6% C acrylamide/bisacrylamide 
solution. The volume was adjusted to 10 ml with ddH2O (66).  
 10% T, 3% C spacer gel:  The spacer gel for Tricine-SDS-PAGE was prepared by 
adding 1 ml of 49.5% T, 3% C acrylamide/bis solution to 1.66 ml of gel buffer (3 M Tris, 
0.3% SDS) and adjusting the volume to 5 ml with ddH2O. 
 4% T, 3% C stacking gel:  The stacking gel for Tricine-SDS-PAGE was prepared 
by adding 0.33 ml of 49.5% T, 3% C acrylamide/bis solution to 1 ml of gel buffer (3 M 
Tris, 0.3% SDS) and adjusting the volume to 4.2 ml with ddH2O. 
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 12% resolving gel for Laemmli SDS-PAGE:  The resolving gel was prepared by 
adding 16 ml of 30% acrylamide/bis (29:1) solution, 10 ml of 1.5 M Tris at pH 8.8,      
0.4 ml of 10% SDS and 13.2 ml of ddH2O.  
 5% stacking gel for Laemmli SDS-PAGE:  The stacking gel was prepared by 
adding 1.7 ml of 30% acrylamide/bis (29:1) solution, 1.25 ml of 1 M Tris at pH 6.8,     
0.1 ml of 10% SDS and 6.8 ml of ddH2O.  
Anode buffer:  A 5X anode buffer for Tricine-SDS-PAGE (1 M Tris) was 
prepared by dissolving 121.11 g of Tris base in 800 ml of ddH2O. After adjusting the pH 
to 8.9 with concentrated HCl, the volume was adjusted to 1 L with ddH2O. 
Cathode buffer:  A 5X cathode buffer for Tricine-SDS-PAGE (0.5 M Tris, 0.5 M 
Tricine, 0.5% SDS) was prepared by dissolving 60.55 g of Tris base, 89.6 g of Tricine 
and 5 g of SDS in a total volume of 1 L of ddH2O. The pH of this solution was around 
8.25 and therefore, pH adjustment was not necessary. Both the cathode and the anode 
buffers were stored at RT. 
Gel buffer:  A 3 M Tris, 0.3% SDS gel buffer for Tricine-SDS-PAGE was 
prepared by dissolving 36.33 g of Tris base and 0.3 g of SDS in 70 ml of ddH2O. The pH 
was adjusted to 8.45 with concentrated HCl and the volume increased to 100 ml with 
ddH2O.  
A 5X stock of Tris-glycine electrophoresis buffer (125 mM Tris, 1.25 M glycine, 
0.5% SDS) for Laemmli SDS-PAGE was prepared by dissolving 7.55 g of Tris base, 47 g 
of glycine and 2.5 g of SDS in 400 ml of ddH2O. The pH of this solution was not 
adjusted since the pH of this solution was around 8.3. The volume was adjusted to 500 ml 
with ddH2O (64). 
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Gel-loading buffer:  5X gel-loading buffer (250 mM Tris-HCl at pH 6.8, 10% 
SDS, 50% glycerol and 0.5% bromophenol blue) was prepared by dissolving 2.5 ml of    
1 M Tris-HCl at pH 6.8, 1 g of SDS, 5 ml of glycerol and 0.05 g of bromophenol blue in 
a total volume of 10 ml using ddH2O.  
1-4.  Solutions for Western blot transfer and blot development. 
 
Alkaline phosphatase developing buffer:  A 1 L solution of 100 mM Tris-HCl at 
pH 9.5, 100 mM NaCl and 50 mM MgCl2 was prepared by dissolving 12.11 g of Tris 
base, 5.84 g of NaCl, and 10.15 g of MgCl2•6H2O in 950 ml of ddH2O. The pH was 
adjusted to 9.5 with concentrated HCl and the volume adjusted to 1 L with ddH2O.  
Blocking buffer:  Blocking buffer of 1% BSA in TBST was prepared by 
dissolving 0.5 g of BSA in 50 ml of TBST.  
5-bromo-4-chloro-3-indolyl phosphate (BCIP):  A 15 mg/ml stock solution was 
prepared by dissolving 15 mg of BCIP in 1 ml of DMF. The stock solution was stored at 
–20°C for upto three months. 
Nitro blue tetrazolium chloride (NBT):  A 30 mg/ml stock solution was prepared 
by dissolving 30 mg of NBT in 1 ml of 70% DMF. 1 ml of 70% DMF was prepared by 
adding 0.3 ml of ddH2O to 0.7 ml of DMF. The NBT stock solution was stored at –20°C 
for upto three months. 
TBST (Tris buffered saline - 0.05% Tween-20):  1 L of 10 mM Tris-HCl at pH 8 
and 150 mM NaCl was prepared by dissolving 1.21 g of Tris and 8.76 g of NaCl in      
950 ml of ddH2O. The pH was adjusted to 8.0 with concentrated HCl. 500 µl of Tween-
20 was added to get a final concentration of 0.05% and the volume adjusted to 1 L with 
ddH2O. 
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Transfer buffer:  For transfer of a Tricine-SDS-PAGE gel, a 3 L transfer buffer 
was prepared by dissolving 9.1 g of Tris and 43.2 g of glycine in 2 L of ddH2O. 600 ml of 
methanol was added and the volume adjusted to 3 L with ddH2O.  
For transfer of a Laemmli gel, a 3 L transfer buffer was prepared by dissolving 
17.4 g of Tris, 8.7 g of glycine and 1.11 g of SDS in 2 L of ddH2O. 600 ml of methanol 
was added and the volume adjusted to 3 L with ddH2O (64). 
1-5.  Solutions for Phage Display. 
 
 Blocking buffer:  100 ml of blocking buffer (0.1 M NaHCO3 at pH 8.6, 5 mg/ml 
BSA, 0.02% NaN3) was prepared by dissolving 0.5 g of BSA in 80 ml of 0.1 M NaHCO3. 
1 ml of 2% NaN3 was added to obtain a final concentration of 0.02%, and the volume 
adjusted to 100 ml with NaHCO3. The solution was filter sterilized using 0.2 µm filter 
and stored at 4°C for upto a week. 
Coating buffer:  500 ml of coating buffer (0.1 M NaHCO3, pH 8.6) was prepared 
by dissolving 4.2 g of NaHCO3 in 450 ml of ddH2O. The pH was adjusted to 8.6 with 1 N 
NaOH and the volume increased to 500 ml with ddH2O. The solution was autoclaved and 
stored at RT. 
Dithiothreitol (DTT) elution buffer:  10 ml of 20 mM DTT was prepared by 
adding 0.2 ml of 1 M DTT stock solution to 9.8 ml of 10 mM sodium acetate, pH 5.2. 
 Glycine-HCl elution buffer:  50 ml of 0.2 M Glycine-HCl at pH 2.2, 1 mg/ml 
BSA was prepared by dissolving 0.75 g of glycine in 40 ml of ddH2O. The pH was 
adjusted to 2.2 with concentrated HCl and 0.05 g of BSA added. The volume was 
increased to 50 ml with ddH2O and the solution stored at 4°C. 
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 Iodide buffer:  50 ml of iodide buffer (10 mM Tris-HCl at pH 8, 1 mM EDTA,     
4 M NaI) was prepared by dissolving 29.96 g of NaI in 25 ml of ddH2O. 0.5 ml of 1 M 
Tris-HCl stock at pH 8 and 0.1 ml of 0.5 M EDTA stock were added and the volume 
increased to 50 ml with ddH2O. The solution was stored at RT. 
PEG/NaCl:  100 ml of PEG/NaCl (20% w/v polyethylene glycol-8000, 2.5 M 
NaCl) was prepared by dissolving 14.6 g of NaCl and 20 g of PEG-8000 in 80 ml of 
ddH2O, and adjusting the volume to 100 ml with ddH2O. This was autoclaved and stored 
at RT. 
 Streptavidin stock solution:  1 ml of streptavidin stock solution was prepared by 
dissolving 1.5 mg of lyophilized streptavidin in 1 ml of 10 mM sodium phosphate at     
pH 7.2, 100 mM NaCl, 0.02% NaN3. The solution was stored at –20°C for upto 6 
months.  
TBS buffer:  A 1 L solution of TBS (50 mM Tris-HCl at pH 7.5, 150 mM NaCl) 
was prepared by dissolving 6.05 g of Tris and 8.76 g of NaCl in 950 ml of ddH2O. The 
pH was adjusted to 7.5 with concentrated HCl and the volume adjusted to 1 L with 
ddH2O. The solution was autoclaved and stored at RT. Tween-20 was added according to 
the required strength. 
 TBE buffer:  A 10X stock of TBE buffer (1 M Tris, 0.83 M boric acid, 10 mM 
EDTA) was prepared by dissolving 121.11 g of Tris, 51.4 g of boric acid, and 3.72 g of 
Na2EDTA in 800 ml of ddH2O. The pH was checked to be ~8.3 and the volume adjusted 
to 1 L with ddH2O. The autoclaved solution was stored at RT. The working buffer of 
0.5X TBE was prepared by diluting the 10X stock 1:19 with ddH2O. 
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TE buffer:  10 ml of TE buffer (10 mM Tris-HCl at pH 8, 1 mM EDTA) was 
prepared from stocks of 1 M Tris-HCl, pH 8.0 and 0.5 M EDTA, pH 8.0 by adding 0.1 ml 
of 1 M Tris-HCl, pH 8 and 0.02 ml of 0.5 M EDTA, pH 8 to a final volume of 10 ml of 
ddH2O. 
1-6.  Growth Media. 
 
Agarose Top:  500 ml of agarose top was prepared by dissolving 5 g of bacto 
tryptone, 2.5 g of yeast extract, 2.5 g of NaCl and 0.5 g of MgCl2 in 400 ml of ddH2O.  
3.5 g of agarose was added and the volume adjusted to 500 ml with ddH2O. The media 
was autoclaved at 121°C for 20 min and stored solid in 50 ml aliquots in sterile bottles at 
room temperature. The media was melted in a microwave as needed. 
 LB (Luria Bertani) media and plates:  LB media was prepared by dissolving 10 g 
of bacto tryptone, 5 g of yeast extract, and 5 g of NaCl in 800 ml of ddH2O. The volume 
was adjusted to 1 L with ddH2O and then autoclaved at 121°C for 20 min. The media was 
stored in a sterile bottle at room temperature. To make plates, the LB media was 
supplemented with 15 g of bacto agar and then autoclaved. For plates requiring IPTG and 
X-Gal, 20 µl of 0.1 M IPTG and 40 µl of 20 mg/ml X-Gal were added to the autoclaved 
media just before pouring onto the plates. The media was poured onto sterile 100 mm 
petri dishes (~15 ml/dish) in a sterile hood. Plates were allowed to solidify at room 
temperature and kept overnight for evaporation of excess moisture. Plates were then 
stored inverted at 4°C in the dark for upto one month without loss of IPTG/X-gal activity. 
Medium A media and plates:  Medium A was prepared from four stock solutions. 
Solution I was prepared by dissolving 20 g of sucrose and 2 g of PAB medium in 780 ml 
of ddH2O. To prepare solution II (5X), 11.7 g of citric acid, 4.2 g of (NH4)2HPO4, 4 g of 
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Na2SO4, and 5 g of yeast extract were dissolved in 150 ml of ddH2O. The pH was 
adjusted to 6.9 with 30% NH4OH and the volume increased to 200 ml with ddH2O. 
Solution III was prepared as a 100X stock by dissolving 7.62 g of KCl, 4.18 g of 
MgCl2·6H2O, 0.543 g of MnCl2·4H2O and 0.11 g of ZnCl2, and the volume adjusted to 
100 ml with ddH2O. The autoclaved solutions I, II and III were stored at 4°C. Solution IV 
(100X) was prepared by dissolving 0.25 g of FeCl3 in 100 ml of ddH2O. This was 
sterilized by filtering through 0.2 µm and stored at 4°C. 1 L of medium A was prepared 
by adding 200 ml of solution II and 10 ml of solutions III and IV to 780 ml of autoclaved 
solution I just before inoculation with the Bacillus subtilis strain. The bacterial strain was 
cultured in 500 ml of medium A transferred to a 2 L baffled flask. To make plates, 1 L of 
medium A was supplemented with 15 g of bacto agar and then autoclaved. 
Minimal plates:  500 ml of media for minimal plates was prepared by dissolving  
3 g of Na2HPO4, 1.5 g of KH2PO4, 0.25 g of NaCl, 0.5 g of NH4Cl, 1 ml of 1 M MgSO4 
and 50 µl of 1 M CaCl2 in 400 ml of ddH2O. 7.5 g of agar was added and the volume 
adjusted to 490 ml with ddH2O. The solution was autoclaved and cooled to <50°C before 
adding 10 ml of filter sterilized 20% glucose and 0.5 ml of filter sterilized 10 mg/ml 
thiamine. The plates were stored at 4°C for upto a month. 
Penassay Broth (PAB) media and plates:  PAB media was prepared by dissolving 
17.5 g of dehydrated antibiotic medium 3 (PAB) in 800 ml of ddH2O, and the volume 
adjusted to 1 L. For plates, 15 g of bacto agar was added to the solution. Autoclaving and 
storage of PAB media and plates were performed in the same manner as with LB. To 
make plates with chloramphenicol, 1 ml of 10 mg/ml chloramphenicol was added to the 
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autoclaved media and the media poured onto the petri dishes. The PAB/cm10 plates were 
stored at 4°C in the dark and retained antibiotic activity for upto a month. 
Part II-2.  Maintenance and growth of bacterial strains. 
 
Bacillus subtilis LH45:  Frozen stocks of B. subtilis LH45 were maintained in 
PAB medium containing 15% of sterilized glycerol at –80°C, and working stocks were 
maintained on PAB/cm10 plates at RT. For long-term storage, the LH45 strain was grown 
on a PAB/cm10 plate at 37°C overnight to form a dense lawn. The bacterial lawn was 
suspended in 3 ml of PAB medium and 15% sterile glycerol. 1 ml of this solution was 
pipetted into each labeled cryotube. The cryotubes were flash frozen in an ethanol/dry ice 
bath and stored frozen at –80°C. To grow cells from the frozen archives, they were 
quickly streaked onto a PAB/cm10 plate using a sterile inoculation needle. The working 
stock was then restreaked onto a fresh PAB/cm10 plate every 3-4 weeks. 
Escherichia coli ER2537:  A frozen stock of E. coli ER2537 in glycerol culture 
was maintained at –80°C. The ER2537 strain was supplied with the Phage Display kit to 
be used for M13 bacteriophage amplification. The ER2537 strain was streaked onto a 
minimal plate using sterile techniques. The plate was inverted and incubated at 37°C for 
1-2 days. The plate was wrapped with parafilm and stored at 4°C for a maximum of one 
month. To culture ER2537 for M13 propagation, LB medium was inoculated with a 








Part II-3.  Isolation of subtilin from bacterial culture. 
  
Subtilin was isolated from Bacillus subtilis LH45, a strain of B. subtilis 168 that 
was engineered to produce subtilin (43). The natural producer of subtilin is B. subtilis 
ATCC 6633 from which the chromosomal fragment (~40 kb) carrying the subtilin operon 
was isolated and integrated alongwith the cat gene into the chromosome of B. subtilis 168 
to obtain B. subtilis LH45, a subtilin producing strain. A single colony of LH45 from a 
PAB/cm10 plate was inoculated into 5 ml of PAB/cm10 medium and grown overnight at 
37°C at 250 rpm. The LH45 strain was then grown in 500 ml of medium A (17) by 
inoculating medium A/cm10 with 5 ml of the overnight culture grown in PAB/cm10. The 
medium A culture was grown for 27-30 hours at 37°C at 250 rpm, after which it was 
checked for change in color and pH. Cultures producing subtilin turned reddish-brown 
with pH decreasing from 6.9 to anywhere between 6.0-6.4. These cultures were acidified 
to a pH of 2.5 using 85% phosphoric acid and then centrifuged to pellet the cells. Subtilin 
and sublancin, both being secretory peptides, were present in the supernatant. Isolation of 
subtilin from LH45 also resulted in isolation of sublancin, since B. subtilis 168 is a 
natural producer of sublancin.  
 
Part II-4.  Hydrophobic interaction chromatography (HIC). 
 
The supernatant obtained after centrifugation of the LH45 culture (from Part II-3) 
was either loaded immediately on to a hydrophobic interaction column or stored at -20°C 
until used. A chromatographic Bio-Rad Econo-Column of 15 cm length and 1.5 cm 
diameter was packed with 20 ml of Tosohaas Toyopearl Butyl-650 resin (57). The 
column was equilibrated with 7 volumes of equilibrating/wash buffer comprising of   
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0.05 M sodium acetate, pH 4 and 1 M NaCl (see Part II-1, 1-3). The supernatant was also 
equilibrated with NAOAc (pH 4) and NaCl to a final concentration of 0.05 M and 1 M, 
respectively. The equilibrated supernatant was placed on ice and slowly loaded onto the 
column at a flow rate of 1.5-2 ml/min using a peristaltic pump. The column was then 
washed with 7 volumes of wash buffer. The less hydrophobic molecules were washed off 
the column using 2 volumes of 0.05 M NaOAc, pH 4. Subtilin, a more hydrophobic 
peptide, was eluted with 50% acetonitrile in 0.05% TFA and fractions collected every 
minute in microcentrifuge tubes. The collected fractions were tested for antimicrobial 
activity using halo assays.  
 
Part II-5.  Spore outgrowth inhibition assay (halo assay). 
The antimicrobial activity of the lantibiotics subtilin, sublancin and nisin was 
assessed by their ability to inhibit the outgrowth of B. cereus T spores. The spores were 
prepared for the assay by heat shocking the spores. 250 mg of lyophilized B. cereus 
spores was suspended in 20 ml of sterile ddH2O. The spores were thoroughly dispersed in 
a glass homogenizer. The homogenized spores were then heat shocked for 2 h at 65°C. 
The spore pellet was collected after centrifugation for 10 min at 4,000 rpm. The spores 
were resuspended in 50 ml of 10% ethanol prepared in sterile water and stored in a Sigma 
spray unit at RT. The same protocol of heat shocking B. subtilis 168 spores was followed 
in cases where biotinylated subtilin or biotinylated nisin was tested for antimicrobial 
activity against B. subtilis 168 spores. 
The halo assay was performed on medium A plates pre-warmed at 37°C for 10-15 
min. 10 µl of each fraction to be tested for antimicrobial activity was spotted onto a    
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pre-warmed medium A plate and allowed to air dry. The plate was sprayed either with 
heat shocked Bacillus cereus or B. subtilis 168 spores using a Sigma spray unit and the 
inverted plate was incubated at 37°C overnight for ~12 hours. Fractions with 
antimicrobial activity showed clear halos representing zones of growth inhibition amidst 
a lawn of bacterial cells.  
Part II-6.  Reversed phase high performance liquid chromatography (RP-HPLC). 
 
 Reversed phase high performance liquid chromatography was used to further 
purify the peptides obtained from the HIC purification. Reversed phase HPLC was 
performed on a Hewlett-Packard Ti Series 1050 equipped with a diode array detector 
system. The HPLC was interfaced to a Gateway 2000 computer running the HP 
Chemstation instrument and data acquisition software provided by the manufacturer. 
Fractions collected from the HIC purification (see Part II-4) that exhibited 
antimicrobial activity were lyophilized in a SpeedVac and resuspended in 0.05% TFA. 
The resuspended fractions were pooled in a total volume of 1-2 ml, centrifuged to remove 
any insoluble matter and then purified using a reverse phase C-18 HPLC column. The 
column used was a Rainin Microsorb-MV C-18 column with 5 µm spherical particles and 
300 Å pores, and was of 250 mm length and 4.6 mm internal diameter. Subtilin was 
eluted initially by a linear gradient going from 0-100% of solvent B (0.05% TFA in 
acetonitrile) from solvent A (0.05% TFA in water) over 30 min at a flow rate of            
1.2 ml/min. Later, to optimize conditions for MALDI-TOF analysis of the collected 
fractions, solvent A was modified to 95% ddH2O, 4.89% CH3CN, 0.1% acetic acid and 
0.01% TFA while solvent B consisted of 95% CH3CN, 4.89% ddH2O, 0.1% acetic acid, 
and 0.01% TFA. The column was first equilibrated for 20 min with solvents A and B 
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after which the sample was loaded onto the column. Non-specifically bound proteins 
were washed off the column by a linear gradient going from 0-25% of solvent B from 
solvent A over 5 min. The sample was then subjected to a mobile phase of 100% solvent 
A for 4 min, followed by a linear gradient of 0-100% solvent B for 21 min when 
sublancin eluted first followed by subtilin at a later time. The mobile phase was 
maintained at 100% solvent B for 3 min and then changed back to 100% solvent A over  
2 min with the entire elution run lasting for 30 min. The elution profile was observed at 
254 nm, 214 nm and 280 nm to monitor the absorbances of dehydro residues, peptide 
bond and aromatic residues, respectively. Fractions were collected every min and the 
fractions assayed for activity using halo assays (see Part II-5). Presence of subtilin in the 
active fractions was confirmed by MALDI-TOF mass spectrometry (see Part II-7). The 
active fractions containing subtilin were lyophilized and stored at -20°C.  
RP-HPLC was also used to separate biotinylated subtilin or biotinylated nisin (see 
Part II-8) from the non-biotinylated peptide species. Fluorescein labeled nisin (see Part 
II-17) was also purified from unreacted nisin using RP-HPLC. After first equilibrating 
the column for 20 min with solvents A and B, the biotinylated peptide or fluorescein-
nisin in 2 ml of the reaction solution was loaded onto the column. The labeled peptide 
was eluted over a 30 min elution run by a linear gradient of 0-100% solvent B for 21 min 
and the fractions corresponding to the labeled peptide collected. 
 
Part II-7.  MALDI-TOF mass spectrometry. 
 
 Matrix-assisted laser desorption/ionization-time of flight mass spectrometry 
(MALDI-TOF MS) was employed to detect subtilin and sublancin in the various 
 39
biologically active fractions collected from RP-HPLC purification. CHCA (α-cyano-     
4-hydroxycinnamic acid) matrix was employed for mass spectroscopy analysis of 
peptides less than 10 kDa. The samples for MALDI-TOF MS analysis were crystallized 
on CHCA matrix by the ‘sandwich method’ as described by Kussmann et al. (37). The 
CHCA matrix was prepared by dissolving 0.02 g of CHCA in 1 ml of 0.1% TFA and             
50% CH3CN. Sample crystallization for mass spectrometry analysis was performed on a 
small metal disc about 2 cm in diameter with 10 numbered, etched circles (~2 mm in 
diameter) arrayed on the sample disc in a circular fashion for sample deposition. The 
sample disc was cleaned with 0.1% TFA, followed by methanol and rinsing with ddH2O. 
The sample disc was dried before adding the sample onto the disc. 
For each sample to be analyzed, 0.5 µl of CHCA matrix was pipetted onto a circle 
of the sample disc and allowed to air dry completely in a fume hood. The samples to be 
analyzed were either HPLC purified samples, or were dissolved in a low pH solution 
such as 0.05% TFA to facilitate ionization. 1 µl of each sample was then overlaid on top 
of the dried crystallized matrix and allowed to air dry completely. 0.5 µl of matrix was 
then deposited again on top of the dried sample to create a ‘sandwich’ of the sample to be 
analyzed. Peptides of known molecular mass such as nisin (MW = 3354 Da) were used as 
external standards for calibration during measurements. Samples were analyzed on a 
Bruker Proflex MALDI-TOF mass spectrometer which was interfaced to a Sun Solaris 
workstation. The relative power of the laser and the number of laser shots were adjusted 
to obtain the best possible spectra for each sample. The data was averaged over multiple 
laser shots by the machine. The external standard was always measured first so as to use 
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the mass peak of the standard for calibration. The mass spectra of the samples were then 
taken, which were depicted as the m/z values of the resulting peaks. 
 
Part II-8.  Biotinylation of subtilin and nisin. 
 
Highly purified, lyophilized nisin was obtained from Aplin and Barrett 
(Trowbridge, Wilts UK). A 10 mg/ml stock solution of nisin was prepared by dissolving 
1 mg of nisin in 1 ml of 0.05% TFA. Subtilin concentration was calculated in moles by 
comparing the peak area of subtilin obtained from RP-HPLC at OD254 with that of the 
peak area of a known molar quantity of a nisin standard since subtilin and nisin share the 
same number of Dha (two) and Dhb (one) residues (24). The biologically active fractions 
containing subtilin were pooled and the concentration of subtilin was also determined in a 
uv-vis spectrophotometer at 254 nm using nisin dilutions to plot the standard curve.  
Subtilin or nisin was biotinylated by reacting the peptide with the biotinylating 
agent biotin disulfide N-hydroxy succinimide ester (BDNHSE) in a 1:1 nanomolar ratio. 
Both subtilin and nisin have three lysine residues. A 1:1 ratio was therefore chosen to 
ensure that the peptide was biotinylated at only one of its three lysine residues. A fresh    
1 mg/ml stock solution of BDNHSE was prepared by dissolving 1 mg of BDNHSE in     
1 ml of ddH2O with vigorous vortexing for 15 min. 87 µl of the BDNHSE stock 
corresponding to an equimolar concentration of subtilin (151 µM) was added to 0.5 mg of 
subtilin or nisin and the volume adjusted to 2 ml with 100 mM NaHCO3, pH 8. This was 
incubated on ice for 2 hours. The biotinylated peptide was purified using RP-HPLC as 
described in Part II-6, and fractions corresponding to the biotinylated peptide were 
collected. Halo assay was performed on the fractions to test whether the biotinylated 
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peptide retained antimicrobial activity (see Part II-5). The fractions with biological 
activity were lyophilized in a SpeedVac, pooled together in a 500 µl volume of 0.05% 
TFA and stored at –20°C. The presence of biotin was confirmed by resolving the 
biotinylated peptide on a 16.5% polyacrylamide gel (see Part II-9), followed by western 
blot analysis using streptavidin-conjugated alkaline phosphatase as a probe (see Part      
II-11, 11-1 and 11-2). 
 
Part II-9.  SDS-PAGE analysis of peptides and proteins. 
 
 Analysis of proteins and peptides was performed by electrophoresing on SDS-
PAGE. While larger proteins were resolved on a 12% gel using the Laemmli SDS-PAGE 
method, the Tricine-SDS-PAGE protocol was used for resolution of small peptides in the 
5-20 kDa range (66). All the solutions used for SDS-PAGE are described in Part II-1, 1-1 
and 1-3. 
9-1.  Tricine-SDS-PAGE of biotinylated subtilin. 
 
The biotinylated subtilin fractions purified by HPLC were run on a Tricine-SDS-
PAGE gel. The Tricine-SDS-PAGE gel comprised of a separating gel, a spacer gel and a 
stacking gel. 14 cm x 16 cm gel plates were assembled with spacers of 1 mm thickness, 
and the edges and the bottom of the assembly were sealed with 1% molten agarose (in 
ddH2O). 150 µl of 10% APS and 30 µl of TEMED were added to 10 ml of the separating 
gel solution and this was immediately poured into the plate assembly. The solution was 
overlaid with isobutanol and allowed to polymerize for 45-60 min. After polymerization 
was complete, the overlay was poured off and the top of the gel washed with ddH2O 
several times. The spacer gel was then allowed to polymerize on top of the separating gel. 
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This was followed by polymerization of the stacking gel which occurred with the spacer 
comb in place. The comb and clamps were then removed from the assembly, and the gel 
assembly was placed into the electrophoretic apparatus. 400 ml of 1X cathode buffer   
(0.1 M Tris at pH 8.25, 0.1 M Tricine, 0.1% SDS) was added to the upper chamber of the 
gel apparatus, while the lower reservoir was filled with 400 ml of 1X anode buffer (0.2 M 
Tris, pH 8.9). 10 µl of the sample was diluted with an equal volume of 2X gel loading 
buffer. The samples were boiled for 3 min before being loaded on the gel. The gel was 
electrophoresed at a constant voltage of 100 mV until the bromophenol blue tracking dye 
had just migrated into the separating gel. The gel was then electrophoresed at 15 mV until 
the tracking dye had migrated to the bottom of the gel (~17-19 hr). The gel was stained 
using the silver stain protocol (see Part II-10). Alternatively, proteins resolved on the gel 
were electroblotted onto a nitrocellulose membrane for western blot analysis as described 
in Part II-11.  
9-2.  Laemmli SDS-PAGE of proteins. 
 
 Bacterial proteins bound either to biotinylated subtilin or to fluorescein-nisin were 
analyzed by resolving on a 12% polyacrylamide gel containing 0.1% SDS (38). 16 cm x 
20 cm gel plates were assembled with spacers of 1.5 mm thickness and the glass plate 
sandwich was clamped on either side using two sandwich clamps. The assembled gel 
plate sandwich was then clamped upright in a Bio-Rad Protean II xi casting stand. 400 µl 
of 10% APS and 16 µl of TEMED were added to 40 ml of the separating gel, and this 
was allowed to polymerize for 45-60 min with an overlay of isobutanol. 100 µl of      
10% APS and 10 µl of TEMED were then added to 10 ml of the stacking gel which was 
allowed to polymerize with a 1.5 mm 15-well comb in place. The comb was removed and 
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the gel assembly placed in a Protean II xi electrophoretic apparatus. The upper and lower 
buffer chambers were filled with a total volume of 2.5 L of 1X gel running buffer         
(25 mM Tris, 250 mM glycine, 0.1% SDS). 5% 2-ME and 5X gel buffer (250 mM Tris-
HCl at pH 6.8, 10% SDS, 50% glycerol, 0.5% bromophenol blue) were added to 50-75 µl 
of the samples which were boiled for 3 min before being loaded on the gel. The gel was 
then electrophoresed at 100 V for 5-6 h. The gel was then either silver stained (see Part 
II-10) or transferred onto a nitrocellulose membrane for Western blot analysis (see Part 
II-11).  
For samples analyzed on mini gels, the separating and stacking gels were 
polymerized in between 8 cm x 10 cm gel plates with 1 mm spacers clamped in a Hoefer 
Mini-Gel gel caster and 10-20 µl of the samples electrophoresed on the gel at 100 V for 
90 min in a Hoefer Mini-Gel electrophoresis apparatus.  
 
Part II-10.  Silver staining of proteins resolved by SDS-PAGE. 
 
 Silver staining was used to detect proteins which were less than 100 ng in quantity 
on the gel. Silver staining allowed detection of as little as 0.1-1 ng of protein bands. The 
gel was stained using a Pharmacia Biotech PlusOneTM Silver Staining Kit in accordance 
with manufacturer protocols. 250 ml of solutions were used for the 16 cm x 20 cm gels 
and 100 ml of solutions were used for the mini gels. The gel was fixed for 30 min in  
40% C2H5OH and 10% CH3COOH with gentle agitation. The gel was then sensitized in 
30% C2H5OH, 0.125% glutardialdehyde, 0.2% sodium thiosulfate and 0.83 M sodium 
acetate for 30 min. The gel was washed thrice in ddH2O for 5 min each. The gel was then 
placed in the silver reaction solution comprised of 0.25% AgNO3 and 0.015% HCHO for 
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20 min. The gel was washed twice in ddH2O for 1 min before adding the developing 
solution comprised of 0.24 M Na2CO3 and 0.007% HCHO. Development was continued 
for several min until protein bands of the desired intensity were seen. The developing 
reaction was stopped by the addition of 0.04 M EDTA-Na2 for 10 min. The gel was 
washed thrice in ddH2O for 5 min and placed in a preserving solution of 30% C2H5OH 
and 4% glycerol. Silver stained protein bands were visualized on a fluorescent light box 
and photographed by a Kodak Photo Documentation and Analysis System running the 
Kodak Digital Science 1D LE computer software package. 
 
Part II-11.  Western blot detection of peptides/proteins resolved by SDS-PAGE. 
  
Biotinylated subtilin electrophoresed on Tricine-SDS-PAGE and larger proteins 
resolved on Laemmli SDS-PAGE were detected by Western blot analysis. The proteins 
were first transferred electrophoretically onto a nitrocellulose membrane in the Western 
blot transfer apparatus. The nitrocellulose membrane was then incubated with an 
appropriate probe conjugated to the alkaline phosphatase (AP) enzyme. Addition of AP 
substrates then resulted in the detection of the bound protein. 
11-1.  Transfer of proteins to nitrocellulose membrane. 
  
For transfer of proteins from the gel onto a nitrocellulose (NC) membrane, the NC 
filter and the gel were sandwiched between Whatman 3MM filter paper in the transfer 
apparatus (64). Six sheets of Whatman 3MM filter paper and a single sheet of 
ImmobilonTM-NC nitrocellulose membrane were cut to the exact size of the gel. The NC 
membrane was gently soaked in ddH2O for a few min, while the Whatman sheets and two 
porous pads were soaked in transfer buffer. The gel was rinsed briefly in deionized water. 
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The transfer block was then assembled by successive layering of all of the above 
materials within the transfer block. The porous pad was placed on the anode plate, 
followed by three sheets of Whatman paper, NC membrane, gel, three sheets of Whatman 
paper, another porous pad and finally the cathode plate of the transfer block. Care was 
taken to ensure that there were no air bubbles between the successive layers in the 
stacked assembly by squeezing out any air bubbles using a glass rod at each stage of 
layering. The transfer block was then placed in the transfer cell filled with 3 L of transfer 
buffer (see Part II-1, 1-4). The cell was either electrophoresed at 250 mA for 3-4 h at RT 
with sufficient cooling or at 50 mA at 4°C overnight. After the electrophoretic transfer 
was complete, the NC membrane was rinsed briefly in deionized water and probed with 
the appropriate probe conjugated to alkaline phosphatase.  
11-2.  Detection of biotinylated subtilin using streptavidin-alkaline phosphatase  
conjugate. 
 
 This protocol was used to detect both biotinylated subtilin bound to the NC 
membrane, and also to detect biotinylated subtilin bound to bacterial proteins that had 
been membrane-immobilized. A 1 L solution of TBST (10 mM Tris-HCl at pH 8,        
150 mM NaCl, 0.05% Tween-20) was prepared as described in Part II-1, 1-4. The NC 
membrane with immobilized biotinylated subtilin was first incubated in 50 ml of 
blocking buffer (1% BSA in TBST) for 1 h at RT with gentle agitation. The NC 
membrane was then washed with 2 x 50 ml of TBST for 5 min. The streptavidin-AP 
conjugate was diluted 1:1,000 in 30 ml of TBST and the NC membrane was incubated 
with the streptavidin-AP probe solution for 1 h at RT with gentle agitation. The NC 
membrane was again washed with 2 x 50 ml of TBST for 5 min. The developing solution 
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was then prepared by adding 99 µl of 15 mg/ml of 5-bromo-4-chloro-3’-indolylphosphate 
(BCIP) and 198 µl of 30 mg/ml of nitro-blue tetrazolium chloride (NBT) to 30 ml of the 
AP developing buffer (100 mM Tris-HCl at pH 9.5, 100 mM NaCl, 50 mM MgCl2) just 
before development of the membrane. BCIP and NBT react to form a purple, insoluble 
precipitate after cleavage of the BCIP phosphate group by AP. The NC membrane was 
incubated in the developing solution for several min with agitation until color 
development of the desired intensity was observed. The NC membrane was then rinsed 
with 2 x 50 ml of ddH2O for 5 min and dried between sheets of paper towels. The 
developed NC membrane was then scanned on a computer scanner to obtain a digital 
image of the developed protein bands. 
 
Part II-12.  Screening of peptide targets of subtilin using Phage Display. 
 
 Phage Display was used as a selection technique to identify peptide sequences 
that interact favorably with subtilin. Two libraries, differing in the length of the random 
peptide displayed on M13 bacteriophage were screened against subtilin. Both peptide 
libraries, Ph.D.-12 and Ph.D.-7, were obtained as kits from New England Biolabs. 
Subtilin was screened against these random peptide 12-mers or 7-mers displayed on 
phage by an in vitro selection process called biopanning. The biopanning method used 
here involved incubating the biotinylated subtilin target with the phage-displayed peptide 
library in solution, affinity-capturing the phage-target complex by immobilized 
streptavidin, washing away the unbound phage, and eluting the bound phage. The eluted 
phages were then amplified in E. coli and subjected to three more rounds of biopanning 
and amplification to enrich the phage pool for specifically binding sequences. The 
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individual phages were then subjected to DNA sequencing to identify the binding peptide 
sequences.  
12-1.  Biopanning procedure. 
 
Subtilin was biotinylated as described in Part II-8. Two RP-HPLC fractions of 
biotinylated subtilin exhibiting biological activity were lyophilized and resuspended in 
small measured volumes of 0.05% TFA. For each round of biopanning, 5 nM of 
biotinylated subtilin was reacted with 10 µl of the 12-mer phage library or the 7-mer 
phage library containing 4 X 1010 plaque forming units (pfu) of phage in a final volume 
of 150 µl of TBST (50 mM Tris-HCl at pH 7.5, 150 mM NaCl, 0.1% Tween-20). The 
two biotinylated subtilin fractions were complexed with the phage in duplicates for 1 h at 
RT. Five wells of a 96-well microtiter plate were coated with 100 µg/ml of streptavidin in 
0.1 M NaHCO3, pH 8.6 and incubated at 4ºC overnight in a humidified container. The 
coating solution was poured off and residual solution removed by firmly tapping the plate 
face down on a clean paper towel. To reduce non-specific binding, 400 µl of the blocking 
buffer (5 mg/ml of BSA in 0.1 M NaHCO3 at pH 8.6, 0.02% NaN3) was added to the 
wells and incubated for at least an hour at 4ºC. After discarding the blocking solution, the 
plate was washed rapidly with 6 x 400 µl of TBST. For each wash, 400 µl of TBST was 
added to each well, gently swirled, drained, and the plate was inverted and firmly tapped 
on a clean paper towel. 150 µl of the biotinylated subtilin bound to phage in TBST was 
added to four of the streptavidin-coated wells and incubated for 1 h at RT. Nonbinding 
target was discarded by pouring off the solution and washing the wells 10X with TBST. 
The bound target in two of the wells was eluted with 100 µl of 20 mM DTT in 0.01 M 
 48
sodium acetate at pH 5.2 for 30 min, while the bound target in the other two wells was 
eluted with 100 µl of 0.2 M glycine-HCl at pH 2.2, 1 mg/ml BSA for 10 min. The 
glycine-HCl eluates were neutralized with 15 µl of 1 M Tris-HCl, pH 9.1. In the control 
biopanning experiment, streptavidin was used as the target. The blocking solution 
contained 0.1 µg/µl of streptavidin to complex to any biotin in the BSA. The phage was 
allowed to react directly with streptavidin bound to the microtiter plate and eluted with 
0.1 mM biotin in TBS for 30 min. The control was also subjected to three rounds of 
biopanning.  
12-2.  Phage titering and phage amplification. 
 
A small amount of the eluate was titered while the rest of the eluate was 
amplified. 5 ml of LB was inoculated with a single colony of E. coli ER2537 and 
incubated with shaking until mid-log phase (OD600 ~0.5). 1 µl of the unamplified eluate 
was titered by incubating 200 µl of the E. coli culture at mid-log phase with 10 µl of each 
dilution (101 – 104) of the eluate in LB for 3 min at RT. The infected cells were mixed 
with 3 ml of agarose top warmed to 45°C and poured evenly onto a pre-warmed 
LB/IPTG/Xgal plate. The plate was allowed to cool and then incubated at 37ºC overnight. 
The blue plaques were counted and the number multiplied by the dilution factor to obtain 
the phage titer in pfu per 10 µl.  
The rest of the eluate was amplified in 20 ml of E. coli culture in LB at early-log 
phase for 4.5 hours at 37ºC. The culture was centrifuged at 10,000 rpm for 10 min at 4°C. 
The phage was precipitated from the supernatant in a fresh tube by adding 1/6 volume of 
PEG/NaCl (20% polyethylene glycol-8000, 2.5 M NaCl) and incubating at 4°C 
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overnight. Precipitated phage was recovered as a pellet by centrifuging the PEG 
precipitation at 10,000 rpm for 15 min at 4°C. The pellet was then resuspended in 1 ml of 
TBS. The phage was reprecipitated with 1/6 volume of PEG/NaCl for 1 h on ice. The 
phage was pelleted by spinning for 10 min at 4°C. The pellet was resuspended in 200 µl 
of TBS, 0.02% NaN3 to obtain the amplified eluate. 1 µl of the amplified eluate was 
titered in the dilution range 107–1010 on LB/IPTG/Xgal plates and the blue plaques 
counted to determine the phage titer. This value was used to calculate a volume 
corresponding to 1011 pfu to carry out the second round of biopanning. The second round 
amplified eluate was also titered for the third round of biopanning. The unamplified third 
round eluate was titered and a number of the resulting plaques were amplified in 1 ml of 
E. coli culture in LB at early-log phase for 4.5 hours at 37ºC. The amplified phage was 
then subjected to DNA purification followed by DNA sequencing to identify the peptide 
displayed on the phage surface. 
12-3.  Purification of sequencing templates. 
 
The plaques obtained from the third round of biopanning were amplified in         
E. coli. 500 µl of the amplified phage was precipitated with 200 µl of PEG/NaCl for      
10 min at RT. The pellet obtained after centrifugation at 14,000 rpm for 10 min was 
suspended in 100 µl of iodide buffer (10 mM Tris-HCl at pH 8, 1 mM EDTA, 4 M NaI) 
and 250 µl of ethanol was added. A 10 min short incubation at room temperature 
precipitated single-stranded phage DNA, leaving phage protein in solution. After 
centrifugation for 10 min, the pellet was washed by suspending the pellet in 500 µl of 
70% ethanol, centrifuging for 10 min and discarding the supernatant. The pellet was dried 
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in the SpeedVac for 30 min to remove any traces of ethanol. The dried pellet was 
suspended in 10 µl of TE buffer (10 mM Tris-HCl at pH 8, 1 mM EDTA). The purity of 
the ss-phage DNA was then assessed by running 1 µl of each DNA sample on a 1% 
agarose gel followed by EtBr visualization on a UV transilluminator. 
 
Part II-13.  Dideoxy sequencing of purified single-stranded phage DNA. 
 
 The purified DNA template from Part II-12, 12-3 was subjected to dideoxy 
sequencing with 35S to identify the 12-mer and 7-mer peptide sequences that bound to 
subtilin. Manual dideoxy sequencing of the purified ssDNA was performed using a 
Sequenase version 2.0 DNA sequencing kit. The sequencing reactions were 
electrophoresed on a sequencing gel and an autoradiogram of the gel obtained. Sequences 
were then read from the exposed film. 
13-1.  Dideoxy DNA sequencing reaction. 
 
The sequencing reaction comprised of three steps – annealing, labeling and 
termination. For the annealing reaction, 2 µl of 5X sequenase reaction buffer, 1 µl of       
–96 gIII sequencing primer diluted 1:1 with ddH2O and 2 µl of ddH2O were added to 5 µl 
of the ssDNA in a total volume of 10 µl. The -96 gIII sequencing primer used for the 
annealing reaction was supplied in the Phage Display kit. The annealing mixture was 
heated at 65°C for 2 min in a beaker of water and allowed to cool slowly to <35°C over 
30 min in the beaker of water. The sample was centrifuged for 10 sec and then placed on 
ice. While the annealing mixture was cooling, four microcentrifuge tubes for each of the 
samples to be sequenced were set up for the termination reaction by adding 2.5 µl of each 
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ddNTP termination mix (ddGTP, ddATP, ddTTP, ddCTP) to the appropriately labeled 
tubes. For the labeling reaction, the dNTP labeling mix (dGTP, dTTP and dCTP) was 
diluted 1:5 to working concentration with ddH2O, and the sequenase polymerase was 
diluted 1:8 in ice-cold sequenase enzyme dilution buffer. To 10 µl of the ice-cold 
annealed DNA mixture, 1 µl of 0.1 M DTT, 2 µl of the diluted labeling mix, 0.5 µl of  
[α-35S]dATP and 2 µl of the diluted sequenase polymerase enzyme were added for a final 
volume of 15.5 µl. The contents were thoroughly mixed and incubated at RT for 3 min. 
The termination tubes were pre-warmed to 37°C for 2-3 min during this time. To 
terminate the reaction, 3.5 µl of the labeling reaction mixture was added to each 
termination tube (G, A, T, C), mixed well and incubated at 37°C for 5 min. The reactions 
were stopped by adding 4 µl of stop solution and placing the tubes on ice or at –20°C 
until being run on a sequencing gel. 
13-2.  DNA sequencing gel electrophoresis. 
 
 The sequencing gel was comprised of 6% acrylamide/bis, 7 M urea in 0.5X TBE 
buffer which was prepared by dissolving 25.2 g of urea in 22 ml of ddH2O with low heat, 
and then adding 3 ml of 10X TBE buffer and 9 ml of 40% acrylamide:bis (19:1). The 
volume was then adjusted to 60 ml with ddH2O. While the urea was dissolving, the 33 x 
42 cm sequencing gel plates were assembled with spacers of 0.4 mm thickness. The sides 
and bottom of the gel plates were sealed with a rubber gasket. Immediately before 
pouring the gel, 270 µl of 10% APS and 21 µl of TEMED were added to the gel. The gel 
was poured into the plate assembly held at an inclination using a 60 ml syringe without a 
needle. The flat edge of a 68-well sharktooth comb was inserted between the two plates at 
 52
the top of the assembly, which was then firmly clamped to ensure a snug fit of the comb. 
The gel was allowed to polymerize for 1-2 h with the top end of the assembly elevated at 
~15° angle during the polymerization. The comb and the gasket were removed after 
polymerization and the gel plate assembly was clamped into a vertical DNA sequencing 
electrophoresis apparatus. The upper and lower chambers were filled with a total volume 
of 2 L of 0.5X TBE buffer (50 mM Tris, 41.5 mM boric acid, 0.5 mM EDTA). The top of 
the gel was flushed with buffer, and the comb was inserted such that the teeth just 
touched the top of the gel. The gel was then pre-electrophoresed for 30 min at 1750 – 
1800 V. The samples were denatured by heating at 75°C for two min. The sample wells 
were again flushed with buffer, and the denatured samples were immediately loaded into 
the wells in 3.5 µl volumes. The four terminated reactions (G, A, T, C) of a single DNA 
template were loaded in adjacent lanes and the samples electrophoresed at 1750 – 1800 V 
for 1.5 – 2 h. One of the gel plates was removed and the gel soaked in 5% CH3COOH, 
15% CH3OH for 20 min to remove the urea. A Whatman 3MM paper cut to the exact size 
of the gel was laid on top of the gel placed in the fixing solution and any air bubbles 
rolled out with a glass rod. The gel was removed from the solution and blotted dry with 
paper towels. The gel could then be easily transferred onto the Whatman paper by peeling 
the gel off from the glass plate. The gel was then covered with saran wrap and dried in a 
vacuum gel dryer at 80°C for 1.5 h. The dried gel was then subjected to autoradiography. 
13-3.  Autoradiography. 
 
 The dried sequencing gel mounted on the Whatman paper was placed in a metal 
cassette between intensifying screens such that the gel faced upwards. In the darkroom, a 
35 x 43 cm sheet of unexposed Kodak X-Omat XAR-5 film was placed in the cassette so 
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that it was in direct contact with the gel. The cassette was closed and the film exposed to 
the gel for 24 – 48 h at RT. After exposure, the film was removed from the cassette in the 
darkroom and developed using an automatic film processor. The DNA sequences were 
then read from the exposed film. 
  
Part II-14.  Sedimentation equilibrium experiments of subtilin and synthetic peptides. 
 
 Sedimentation equilibrium technique is useful in characterizing interactions 
between proteins (39). This technique can be used to obtain the molecular weight and the 
thermodynamic parameters of associating systems (21). To determine the nature of 
interaction of subtilin with the 12-mer peptide sequences selected by subtilin from the 
phage display library, two synthetic peptides, pep16 and pep19 obtained from Research 
Genetics, Alabama were used for the interaction studies using sedimentation equilibrium.  
14-1.  Stability of subtilin at RT for 2 days in different pH buffers. 
 
 The maximum solubility of nisin at pH 8 was determined to be 0.25 mg/ml with 
higher solubility at lower pH (42). So, 25 µg of subtilin was suspended in 100 µl of 
different buffers of 50 mM sodium citrate at pH 5, 50 mM sodium phosphate at pH 6.5, 
50 mM Tris-HCl and 150 mM NaCl at pH 7.5, and 100 mM NaHCO3 at pH 8. Subtilin 
was incubated at RT for 2 days in the different pH buffers. 10 µl of subtilin in each buffer 
was electrophoresed on a Tricine-SDS-PAGE gel (see Part II-9, 9-1) and the gel was 




14-2.  Equilibrium run of subtilin. 
 
 70 µM of subtilin corresponding to an OD280 of 0.4 was suspended in 150 µl of 
TBS (50 mM Tris-HCl at pH 7.5, 150 mM NaCl), the same buffer used in the phage 
display experiment of subtilin. This buffer was also ideal for sedimentation equilibrium 
analysis due to the presence of a salt concentration between 100 mM and 200 mM and 
also because this buffer had a density (1.014 g/ml) close to that of water (1 g/ml) which 
was preferred (58).  
A 2-sector analytical ultracentrifuge cell to hold the sample and reference buffer 
was assembled together from different components. Two quartz windows were 
assembled first which was followed by sandwiching the centerpiece cell between the two 
window assemblies in a cylindrical cell housing (10). 145 µl of the subtilin sample was 
loaded into the right sector of the centerpiece cell, while 150 µl of TBS buffer to be used 
as the reference solution was loaded into the left sector. The reference sector was filled 
slightly more than the sample sector to ensure that the reference meniscus did not obscure 
the sample meniscus in the absorbance profile. The cell was placed in a four-hole rotor 
with an equally balanced counterbalance cell in the opposite hole. The Beckman XL-I 
analytical ultracentrifuge was centrifuged initially at 3k rpm and the OD280 of the sample 
was then scanned. The initial OD280 scan of the sample at 3k rpm was performed to check 
the quality of the sample. The sample was then centrifuged at 42k rpm for 24 h at 20°C. 
The absorbance as a function of radial position was scanned at 280 nm at the end of the 
run. The sample was further centrifuged for 3 h at 42k rpm and the OD280 of the sample 
was scanned again. Identical OD280 profiles obtained by overlaying the scans of both of 
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the consecutive 42k rpm runs recorded a few hours apart indicated that the sample had 
reached an equilibrium concentration distribution throughout the cell. 
14-3.  Equilibrium run of synthetic peptides pep16 and pep19. 
 
The two peptides, pep16 and pep19 synthesized to test for interaction with 
subtilin, were centrifuged individually. 70 µM of pep16 corresponding to an OD280 of 0.4 
was suspended in 150 µl of TBS, pH 7.5. 145 µl of the pep16 sample was loaded into one 
sector of the centerpiece, while 150 µl of TBS buffer was loaded into the other sector. 
The OD280 of the sample was initially scanned at 3k rpm. The sample was then 
centrifuged at 54k rpm for 20 h at 20°C, OD280 scanned, then centrifuged again at        
54k rpm for 2 h and the OD280 scanned again. This process was repeated at 56k rpm for 
the same sample. Pep19 was also subjected to the same procedure as pep16. 
14-4.  Equilibrium run of subtilin with pep16 and pep19.  
 
An equimolar mixture of subtilin and pep16 corresponding to an OD280 of 0.3 as 
determined in the uv-vis spectrophotometer was suspended in 150 µl of TBS, pH 7.5. The 
OD280 of the sample was initially scanned at 3k rpm. The sample was centrifuged at    
45k rpm for 18 h, at 45k rpm again for 1 h, at 50k rpm for 18 h, and at 50k rpm again for 
1 h. The OD280 and the OD254 of the sample were scanned at the end of each run. 
 
Part II-15.  Detection of subtilin protein targets in susceptible bacterial cells using   
monomeric avidin column. 
 
In order to isolate the biological protein targets of subtilin from susceptible 
bacterial cells, the natural affinity of biotin for avidin was availed of in this method. 
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Subtilin was biotinylated, and the biotinylated subtilin was incubated with total bacterial 
cell protein. This complex protein mixture was incubated on a monomeric avidin column, 
when biotinylated subtilin bound to bacterial proteins was affinity captured by the 
immobilized avidin. After washing the avidin column to remove non-specifically bound 
proteins, the biotinylated subtilin – protein complex was eluted from the column using a 
biotin-containing buffer followed by a low pH glycine buffer. The proteins thus isolated 
were analyzed by SDS-PAGE. 
15-1.  Incubation of biotinylated subtilin with B. cereus and B. subtilis 168 cells.  
 
500 µg of subtilin was biotinylated in a 1:1 nanomolar ratio by reacting subtilin 
with biotin disulfide N-hydroxy succinimide ester as described in Part II-8. Biotinylated 
subtilin was purified using RP-HPLC (see Part II-6) and halo assay was performed on the 
HPLC purified fractions to ensure that biotinylated subtilin retained antimicrobial 
activity. 
10 mg of B. cereus spores or B. subtilis 168 spores was heat-shocked for 2 h at 
65ºC to break the dormancy of the spores as described in Part II-16, 16-1. The heat-
shocked spores were suspended in 1 ml of sterile ddH2O. The spores were streaked onto a 
medium A plate and incubated overnight at 37°C. 50 ml of medium A solution (see Part 
II-1, 1-6) in a 250 ml flask was inoculated with a single bacterial colony picked from the 
plate and incubated at 37°C at 250 rpm until the culture reached an OD600 of ~1. The 
culture was centrifuged at 4,000 rpm for 10 min and the cell pellet suspended in 10 ml of 
50 mM Tris-HCl, pH 8. Biotinylated subtilin (500 µg) was then added to the solution and 
incubated with bacterial cells for 3 h at RT with gentle shaking. The cells were then lysed 
using a French pressure cell (56). The cell lysate was centrifuged at 4,000 rpm for 10 min 
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to pellet down the cell debris and the supernatant loaded onto the monomeric avidin 
column. A 50 ml bacterial cell culture without biotinylated subtilin was used as a control 
and was subjected to the same procedure. The supernatant from the control cell lysate 
was loaded onto another monomeric avidin column. 
15-2.  Elution of bacterial proteins bound to biotinylated subtilin from monomeric  
avidin column. 
 
Two 2 ml monomeric avidin columns were packed according to the instructions 
given in the Pierce instruction booklet for the immunopure immobilized monomeric 
avidin column. Each of the 2 ml columns was washed with 2 x 4 ml of PBS (0.1 M 
sodium phosphate, 0.15 M NaCl, pH 7.2) first and then with 3 x 2 ml of biotin blocking 
and elution buffer (2 mM biotin in PBS) to block any non-reversible biotin binding sites 
on the column. Loosely bound biotin from the reversible biotin-binding sites was 
removed by washing with 3 x 4 ml regeneration buffer (0.1 M glycine, pH 2.8) and then 
with 2 x 4 ml of PBS. The cell lysate supernatant containing biotinylated subtilin was 
added onto one of the columns dropwise, while the control cell lysate supernatant without 
biotinylated subtilin was loaded onto the other monomeric avidin column. After all of the 
sample solution had been added, 0.25 ml of PBS was added to wash the sample 
completely into the column. The sample was allowed to incubate on the column for 1 h at 
RT. The column was washed with at least 6 x 2 ml of PBS and fractions collected. The 
absorbance of the fractions was monitored at 280 nm until all unbound protein was 
washed off the column. The bound, biotinylated protein was eluted from the column with 
at least 6 x 2 ml of the biotin blocking and elution buffer and the absorbance of the 
collected fractions monitored at 280 nm. In order to elute bound, biotinylated peptide 
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completely, the column was washed with at least 6 x 2 ml of regeneration buffer and the 
OD280 monitored. The column was then washed with 5 ml of PBS and stored at 4°C. 
The samples eluted from the monomeric avidin column were dialyzed using 
snakeskin pleated dialysis tubing from Pierce (3.5k MWCO) in 5 mM Tris-HCl, pH 8 
overnight at 4°C with 2 changes of buffer. The dialyzed samples were lyophilized. After 
lyophilization, the samples were suspended in 600 µl of modified 1X gel loading buffer 
(0.05 M Tris-HCl, pH 6.8, 2% SDS, 10% glycerol). 5% 2-mercaptoethanol and 0.1% 
bromophenol blue were added to 100 µl of the sample and the sample boiled for 3 min 
before being loaded onto a 12% SDS-PAGE gel (see Part II-9, 9-2) in duplicate. At the 
end of electrophoresis, one half of the gel was transferred to a nitrocellulose membrane 
and the membrane probed with streptavidin-alkaline phosphatase conjugate (see Part     
II-11, 11-1, 11-2). The other half of the gel was silver-stained as described in Part II-10.  
 
Part II-16.  Detection of subtilin targets in B. cereus spores. 
16-1.  Incubation of biotinylated subtilin with spores. 
 
0.01 g of spores was weighed and homogenized in 20 ml of sterile ddH2O. The 
spores were heat shocked at 65°C for 2 h in a water bath. The spores were then 
centrifuged at 10,000 rpm for 10 min and the spore pellet suspended in 1 ml of sterile 
ddH2O.  
 The heat-shocked B. cereus spores (200 µg/ml) were incubated with biotinylated 
subtilin (20 µg/ml) in 1 ml of 1% tryptone-Pi, pH 7.4 for 3 h in a 37°C water bath. Two 
control spore samples, one with subtilin, and the other without any subtilin, were also 
incubated for 3 h. After incubation, the samples were observed by phase-contrast 
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microscopy to check for inhibition of germination of spores by biotinylated subtilin and 
by subtilin. Ungerminated spores were phase-bright, while germinated spores whose 
outgrowth was inhibited appeared phase-dark (42). The uninhibited spores without any 
biotinylated subtilin or subtilin were observed as elongated vegetative cells. 
16-2.  Isolation of bacterial spore targets of subtilin by spore lysis. 
 
The samples from Part II-16, 16-1 were centrifuged at 14,000 rpm for 10 min and 
the spore pellet suspended in 0.7 ml of spore lysis buffer (0.14 M NaCl, 0.3 M sucrose, 
0.1 M Tris-Pi, pH 7.4, 2 mM EDTA and 2 mM PMSF). In order to allow subtilin to react 
with any intracellular targets, 5 µg/ml of biotinylated subtilin was added to one sample, 
and 5 µg/ml of subtilin added to the other sample. Each sample was mixed with 0.7 g of 
glass beads (<0.1 mm diameter) in a capsule. The spores were lysed in a dental 
amalgamator or wig-L-bug in ten 1 min periods of shaking with 1 min intervals on ice to 
dissipate the heat produced during shaking. The lysed sample was collected and the glass 
beads rinsed with 0.7 ml of spore lysis buffer (41). The solutions were pooled and 
centrifuged at 14,000 rpm for 10 min. The supernatant was concentrated by 
lyophilization. The samples were placed at 4°C until they were electrophoresed on a  
12% Laemmli gel. 
2X gel loading buffer (0.05 M Tris-HCl, pH 6.8, 0.1% SDS, 20% glycerol, 0.01% 
bromophenol blue) was added to each sample. The samples were boiled for 3 min before 
being electrophoresed on a 12% SDS-PAGE gel. The proteins were transferred onto a 
nitrocellulose membrane and the membrane probed with streptavidin-alkaline 
phosphatase conjugate.  
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Part II-17.  Fluorescein-labeling of nisin. 
 
Highly purified, lyophilized nisin was obtained from Aplin and Barrett 
(Trowbridge, Wilts UK). A 10 mg/ml stock solution of nisin was prepared by dissolving 
1 mg of nisin in 1 ml of 0.05% TFA. Immediately before conjugation of fluorescein to 
nisin, a 10 µg/µl stock solution of NHS-Fluorescein (NHSF) was prepared by dissolving 
1 mg of the reagent in 100 µl of DMF. 7 µl of the NHSF stock corresponding to an 
equimolar concentration of nisin (149 µM) was added to 50 µl of the nisin stock (0.5 mg) 
and the volume adjusted to 2 ml with 100 mM NaHCO3, pH 8. This was incubated on ice 
for 2 hours. A control using nisin without the NHSF reagent was also performed. The 
reactions involving NHSF were performed in the dark since the reagent is light-sensitive. 
After 2 h, the unreacted nisin was separated from fluorescein-nisin (F-N) using RP-HPLC 
as described in Part II-6. The collected F-N fractions were assayed for retention of 
antimicrobial activity by halo assay (see Part II-5). The fractions exhibiting antimicrobial 
activity were lyophilized in a SpeedVac and pooled together in a 500 µl volume of  
0.05% TFA. This was stored at –20°C. The presence of the fluorescein tag was confirmed 
by electrophoresing fluorescein-nisin on a mini SDS-PAGE gel (see Part II-9, 9-2), 
followed by detection of fluorescence using a uv-transilluminator or Storm Imager 860. 
Presence of F-N was also confirmed by silver staining (see Part II-10). 
Part II-18.  Electron microscopy of B. cereus spores reacted with nisin. 
18-1.  Scanning electron microscopy (SEM) of B. cereus spores incubated with  
fluorescein-nisin. 
 
Heat-shocked B. cereus spores (200 µg/ml) were incubated with fluorescein-nisin 
(20 µg/ml) for 2 h at 37°C in 1% tryptone-Pi growth media, pH 7.4. The spores were 
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washed in 1 ml of PBS (10 mM phosphate, 150 mM NaCl), pH 7.4 thrice to remove any 
unbound fluorescein-nisin (F-N) by centrifuging at 14,000 rpm for 10 min. The sample 
was fixed by incubating in 1 ml of 2% glutaraldehyde (GA) in PBS for 1 h at RT in the 
dark. The sample could then be kept at 4°C until further processing. 
The spores were collected on a nucleopore filter (0.4 µ) held in a plastic Swinney 
filter holder. The spores were washed free of excess GA with three changes of PBS for   
5 min each. The spores were then fixed in 1 ml of 1% osmium tetraoxide in PBS for 1 h, 
and then washed with three changes of dH2O. The filter was transferred to a flat multi-
well dish for dehydration. Care was taken not to allow the sample to air dry during these 
procedures. 
The sample was then dehydrated for 10 min each in 75% ethanol and 95% ethanol 
followed by dehydration in 100% ethanol thrice. The filter with the sample was then 
dried in a Denton DCP-1 critical point dryer. The filter was fixed to a carbon tab mounted 
on a metal stub and the filter edge brushed with colloidal carbon. Next, the sample was 
placed in a Denton vacuum evaporator for a deposition of a Au-Pd coat of ~15 nm 
thickness on the specimen. The sample was stored in a desiccator until it was viewed in a 
Hitachi S4700 scanning electron microscope. Two controls were also performed, one 
control consisting of nisin incubated with spores, and the other control consisting of only 
spores without F-N or nisin. 
18-2.  SEM of immunogold labeled B. cereus spores. 
 
500 µg of nisin was biotinylated by reacting nisin with the biotinylating agent 
BDNHSE as described in Part II-8. Heat-shocked B. cereus spores (300 µg/ml) were 
incubated with biotinylated nisin (50 µg/ml) for 3 h at RT. The sample was washed thrice 
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with 1 ml of PBS buffer and then fixed in 1 ml of 1% GA in PBS for 1 h at RT with 
gentle shaking. The sample was washed thrice with 1 ml of PBS.  
Before labeling the sample with streptavidin-gold (SA-Au), the sample was 
incubated in 1 ml of 0.05 M glycine in PBS for 15 min and then washed with three 
changes of PBS buffer. The sample was next incubated in 1 ml of PBS buffer with       
5% BSA for 30 min followed by three wash steps. SA-Au (15 nm particle size) was 
added at a 1/20 dilution in 1 ml of PBS and the sample incubated for 2 h. After washing 
with PBS for 6 x 5 min, the sample was postfixed in 2% GA in 1 ml of PBS for 5 min. 
The sample was washed in 1 mL of PBS for 3 x 5 min and collected on a nucleopore 
filter (0.4 µ). The filter was removed to a flat multi-well dish for silver enhancement for 
30 min performed using Aurion R-Gent SE-EM initiator, activator and enhancer to 
increase the average gold cluster or particle size by deposition of metallic silver. The 
filter was washed thrice with distilled water for 5 min. The sample was then dehydrated, 
dried and mounted on a metal stub. A thin chromium coating of ~15 nm thickness was 
deposited on the sample which was then viewed in the Amray 1820D and the Hitachi 
S4700 scanning electron microscopes. A control consisting of spores incubated without 
biotinylated nisin was also subjected to the same procedure. 
18-3.  Transmission electron microscopy (TEM) of B. cereus spores reacted with  
nisin. 
 
Heat-shocked B. cereus spores (200 µg/ml) were incubated with biotinylated nisin 
(30 µg/ml) for 2 h at RT. Two controls were also performed, one consisting of nisin and 
spores, and the other with only spores. The sample was washed thrice with 1 ml of PBS 
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buffer and then fixed in 1 ml of 2% GA in 1X PBS for 1 h at RT with shaking. The 
sample was washed with 3 x 1 ml of PBS to remove excess GA. 
The sample was post fixed in 2% osmium tetraoxide in 1 ml of PBS for 60 min 
and washed for 3 x 10 min with dH2O. The sample was again fixed in 2% aqueous uranyl 
acetate for 60 min and then centrifuged. Dehydration was performed in 35%, 50%, 75% 
and 95% ethanol for 10 min each, with centrifugation between each dehydration step. 
This was followed by dehydration in 100% ethanol for 3 x 10 min, and in propylene 
oxide for 3 x 10 min. 
The sample was then treated with propylene oxide:Spurr’s resin mixture (1:1) for 
2 h, propylene oxide:Spurr’s resin mixture (1:2) for 2 h, propylene oxide:Spurr’s resin 
mixture (1:3) for 2 h and then with 100% Spurr’s resin for 2 h. The sample was finally 
embedded in fresh 100% Spurr’s resin and incubated (cured) at 70°C for atleast 8 h.  The 
sample was trimmed using a glass knife on a LKB-Nova ultramicrotome followed by 
manual trimming using a fresh razor. Thin sections (~ 150nm thickness) of the sample 
were collected using a freshly prepared glass knife.  
 
Part II-19.  Reacting fluorescein-nisin with B. subtilis 168 vegetative cells. 
 
10 mg of B. subtilis 168 spores was heat-shocked for 2 h at 65ºC to break the 
dormancy of the spores as described in Part II-16, 16-1. The heat-shocked spores were 
suspended in 1 ml of sterile ddH2O. Heat-shocked B. subtilis 168 spores were streaked 
onto a medium A plate and incubated overnight at 37°C. 50 ml of medium A solution in a 
250 ml flask was inoculated with a single B. subtilis colony picked from the plate and 
incubated at 37°C at 250 rpm until the culture reached an OD600 of ~0.5. The culture was 
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centrifuged at 4,000 rpm for 10 min and the cell pellet suspended in 10 ml of 10 mM 
Tris-HCl, pH 8. Nisin was labeled with fluorescein as described in Part II-17. 
Fluorescein-nisin (500 µg) was then added to the solution alongwith 0.1% glucose and 
incubated with B. subtilis cells overnight with gentle shaking. The cells were completely 
lysed using a French pressure cell (56). After cell lysis, the cell lysate was concentrated 
in YM-10 centricon tubes by centrifuging at 5,000 x g for 90 min. 2 cell cultures, one 
with the addition of 500 µg of nisin and the other without any nisin or F-N were also 
subjected to the same procedure. 
The retentate and the filtrate solutions obtained after the YM-10 concentration 
were both analyzed by SDS-PAGE. 5X gel loading buffer was added to 75 µl of the 
sample alongwith 5% 2-ME. The samples were boiled for 3 min and then run on a 12% 
Laemmli gel. Fluorescent bands were detected on the gel using a Storm 860 Imager. The 
gel was silver stained as well to detect total protein (see Part II-10). 
 
Part II-20.  Detection of fluorescein-nisin using anti-FITC antibodies. 
20-1.  Dot blot using anti-FITC antibodies. 
 
 The dot blots were performed to determine the optimum concentrations of the 
anti-FITC antibodies and the 2º Ab-alkaline phosphatase conjugate required for optimal 
detection. In the dot blots, four nitrocellulose (NC) membrane strips were wet with 
distilled water for 1 min. After the NC strips had dried, different amounts of F-N (0.5 µg, 
1 µg, 1.5 µg, 2 µg, 3 µg and 5 µg) were spotted. The NC strips were allowed to dry and 
then blocked with 3% BSA in 50 ml of TBST (10 mM Tris-HCl at pH 8, 150 mM NaCl 
and 0.05% Tween-20) for 1 h at RT with gentle agitation. Rabbit anti-FITC Ab (1º Ab) 
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was added as 1:100, 1:250, 1:500 and 1:1000 dilutions in 30 ml of TBST. Each of the 
four NC strips was incubated in one of these Ab dilutions for 1 h at RT. The strips were 
washed with 2 x 50 ml of TBST for 5 min, followed by incubation for 1 h with goat anti-
rabbit antibody-alkaline phosphatase enzyme conjugate (2º Ab-AP conjugate). The        
2º Ab-AP conjugate was added at a dilution of 1:2500 in 30 ml of TBST. The strips were 
again washed with 2 x 50 ml of TBST for 5 min. 30 ml of the 1-StepTM NBT/BCIP 
substrate solution was added to each of the four NC strips and the NC strips developed 
for 2 min. The NC strips were washed with 2 x 50 ml of ddH2O for 5 min and then dried. 
20-2.  Immuno blot detection of immobilized fluorescein-nisin. 
 
 This protocol was used to detect membrane-immobilized fluorescein-nisin bound 
to bacterial proteins. In the immuno blot, fluorescein-nisin (F-N) and bacterial proteins 
bound to F-N were transferred onto a nitrocellulose membrane overnight at 50 mA at 4ºC 
as described in Part II-10, 10-1. A 1 L solution of TBST (10 mM Tris-HCl at pH 8,     
150 mM NaCl and 0.05% Tween-20) was prepared as described in Part II-1, 1-5. The NC 
membrane with bound F-N was incubated in 50 ml of blocking buffer (3% BSA in 
TBST) for 1 h at RT with gentle agitation. The NC membrane was then incubated with 
rabbit anti-FITC Ab as a 1:500 dilution in 30 ml of TBST for 1 h with agitation. The NC 
membrane was washed with 2 x 50 ml of TBST for 5 min each, and then incubated with 
the 2º Ab-AP conjugate as a 1:2500 dilution in 30 ml of TBST for 1 h at RT. The NC 
membrane was again washed with 2 x 50 ml of TBST for 5 min, and the membrane 
developed in 30 ml of the 1-StepTM NBT/BCIP substrate solution (Pierce) for a few min. 
The NC membrane was then rinsed with 2 x 50 ml of ddH2O for 5 min, dried and 
scanned on a computer scanner to obtain a digital image of the developed protein bands. 
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Part II-21.  Size exclusion chromatography using macrosphere column. 
 
 For size exclusion chromatography, an Alltech macrosphere GPC column was 
used which was of 250 mm length and 4.6 mm internal diameter with 7 µm spherical 
particles and 100 Å pores. For every sample run on the column, the column was first 
washed with HPLC-grade water (wash buffer) for 15 min at a flow rate of 0.3 ml/min. 
The column was equilibrated with the mobile phase buffer, solvent C (0.05 M KH2PO4, 
0.1 M NaCl, pH 6.8) for 30 min at a flow rate of 0.3 ml/min (5). The sample was then 
loaded onto the column, eluted using the mobile phase buffer and 0.3 ml fractions 
collected every min for 30 min. The column was then washed with the wash buffer.  
 To test the SEC column, blue dextran (~2,000 kDa) at 2 different concentrations 
of 20 µg/150 µl and 40 µg/150 µl was loaded on the SEC column and eluted. Next, 
ethidium bromide (~394.3 Da) at 10 µg/150 µl and then at 100 µg/150 µl was eluted from 
the column and fractions collected. 2,4-dinitro phenol (~184.1 Da) was then eluted at a 
concentration of 100 µg/150 µl. 
 The lysate of B. subtilis 168 cells treated with fluorescein-nisin (F-N) and a 
negative control cell lysate sample without F-N (from Part II-19) were concentrated using 
YM-3 centricon tubes. 50 µl of the concentrated control cell lysate sample was 
centrifuged to remove cell debris. To the supernatant, 100 µl of the mobile phase buffer 
was added. The sample was eluted from the SEC column and fractions collected every 
min. The fractions were run on a gel and silver stained. Also, to another 50 µl of control 
cell lysate, 100 µl of mobile phase and 0.1% SDS were added and the sample boiled for 3 
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min. This was centrifuged to remove debris and then run on the SEC column. The same 
procedure was repeated with the F-N + cell lysate samples.  
 
Part II-22.  Affinity chromatography using immobilized protein A-antibody complex. 
22-1.  Preparation of the protein A-antibody complex column. 
 
 A 2 ml protein A column from an immunopure protein A IgG orientation kit 
(Pierce) was brought to room temperature. 50 µg – 1 mg of anti-FITC antibody (Ab) 
from Zymed Laboratories was diluted 1:1 with the antibody binding/wash buffer (50 mM 
sodium borate, pH 8.2) and added to the column. The gel was suspended by gentle 
inversion at 4°C overnight to allow binding of the anti-FITC-Ab to the protein A matrix. 
The gel was then allowed to settle and then washed with 2 x 5 ml of antibody 
binding/wash buffer. The wash fractions were collected to test for any unbound Ab. The 
Ab bound to the protein A matrix was then crosslinked by adding 13.2 mg of DMP 
(dimethyl pimelimidate) dissolved in 2 ml of the DMP crosslinking buffer (0.2 M 
triethanolamine, pH 8.2) and mixing the gel gently for 1 h at room temperature. The gel 
was allowed to settle while the remaining solution passed through, taking care not to 
allow the gel bed to run dry. The gel was then washed with 5 ml of the crosslinking 
buffer. In order to block any remaining unreacted imidate groups, 2 ml of blocking buffer 
(0.1 M ethanolamine, pH 8.2) was added and the gel mixed gently for 10 min. The gel 
was then washed with 5 ml of IgG elution buffer, pH 2.8 to elute any Ab that was not 
covalently attached to the immobilized protein A. The gel was then washed with 2 x 5 ml 
antibody binding/wash buffer and stored at 4°C in an aqueous solution containing   
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0.02% sodium azide. The same procedure was repeated with another 2 ml protein A 
column so as to use this column for the control cell lysate sample.  
22-2.  Affinity chromatography of fluorescein-nisin incubated with B. subtilis 168  
proteins. 
 
The prepared immunoaffinity column was allowed to come to room temperature. 
After the storage solution had drained, the column was equilibrated with 2 x 5 ml of 
binding buffer (10 mM Tris buffer, pH 7.5). The lysate of B. subtilis 168 cells treated 
with fluorescein-nisin (F-N + cell lysate sample) was concentrated from 10 ml to 1.5 ml 
using YM-3 centricon tubes. The sample was centrifuged to remove cell debris. The 
supernatant was diluted 1:2 with binding buffer. The sample was applied to the column 
dropwise and incubated on the column for 1 h at room temperature. After 1 h, the sample 
was allowed to flow through the column and the unbound protein collected. The column 
was then washed with 6 x 2 ml of binding buffer and fractions collected. The OD280 of 
the wash fractions was determined to check that all non-specifically bound protein was 
washed off the column. The bound protein was then eluted with at least 6 x 2 ml of 0.1 M 
glycine-HCl buffer, pH 2.8 and the elution of protein was monitored by measuring OD280. 
The pH of the eluted fractions was raised to neutral by adding 100 µl of 1 M Tris-HCl, 
pH 9.5 to each of the 2 ml fractions. The same procedure was repeated with the control 
cell lysate sample on a different 2 ml affinity column. The affinity column was 
regenerated by washing the column with 4 column volumes (8 ml) of glycine-HCl buffer. 
The column was stored at neutral pH in water containing 0.02% sodium azide. The 
fractions were concentrated using YM-3 centricon tubes by centrifuging at 7,500 x g for 
1 h. 5X gel loading buffer was added and the samples analyzed by SDS-PAGE. The gel 
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was examined on a Storm 860 Imager followed by silver staining (see Part II-10). A 
negative control cell lysate sample without F-N was also subjected to the same procedure. 
22-3.  Affinity chromatography of fluorescein-nisin. 
 
 The same procedure used for affinity chromatography of the F-N + cell lysate 
sample was followed for F-N. 25 µl of F-N corresponding to 25 µg was diluted with the 
binding buffer and incubated on the column for 1 h. The column was washed with 
binding buffer and fractions collected. F-N was eluted with glycine-HCl buffer. The 
fractions were concentrated in YM-3 tubes and run on a gel. 
 
Part II-23.  Classic immunoprecipitation using protein A column. 
 
 The Seize Classic (A) Immunoprecipitation Kit from Pierce was used for 
immunoprecipitation. An immune complex of the anti-FITC Ab and the antigen, the 
fluorescein-nisin-bacterial protein complex was prepared by incubating 100 µg of the 
anti-FITC Ab with 100 µl of the antigen in 10 mM Tris-HCl, pH 8 in a total volume of 
0.4 ml at 4°C overnight with gentle shaking. 0.4 ml of the immobilized protein A      
(50% slurry) was added into a spin cup column which was placed inside a 
microcentrifuge tube. The tube was centrifuged and the buffer discarded. The gel was 
washed twice by adding 0.4 ml of binding/wash buffer (140 mM NaCl, 8 mM sodium 
phosphate, 2 mM potassium phosphate, 10 mM KCl, pH 7.4), mixing gently for 2 min 
and centrifuging the tube. The spin cup was then placed in a new microcentrifuge tube.  
The prepared immune complex was added to the spin cup containing equilibrated 
protein A, mixed by inversion and incubated for 30 min at room temperature with gentle 
shaking. The tube was then centrifuged and the flow-through containing unbound protein 
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was collected. The gel was washed 5 times by adding 0.5 ml of wash buffer, mixing by 
inverting, and by centrifuging the tube. The wash fractions were collected for gel 
electrophoresis. The bound protein was eluted by adding 6 x 190 µl of elution buffer 
(glycine-HCl, pH 2.8), mixing by inverting at least 10 times, and then centrifuging. The 
eluate was neutralized by adding 10 µl of 1 M Tris, pH 9.5 to each fraction. All the 
collected fractions were analyzed by SDS-PAGE. The gel was regenerated by adding      
2 x 0.5 ml of wash buffer, mixing by inverting and then centrifuging the tube. 0.5 ml of 
wash buffer with 0.02% sodium azide was then added to the spin cup, which was placed 
in a microcentrifuge tube. The cap of the tube was wrapped with parafilm to prevent the 
gel from drying and the tube placed at 4ºC. The same procedure was followed with the 
control cell lysate. 
 
Part II-24.  Small-scale immunoprecipitation using immobilized protein A. 
24-1.  Preparation of the protein A-antibody complex column. 
 
Immobilized protein A from a seize X protein A immunoprecipitation kit from 
Pierce was allowed to come to room temperature. 0.4 ml of protein A (50% slurry) was 
added into a spin cup column, which was placed inside a microcentrifuge tube. The tube 
was centrifuged and the buffer discarded. The gel was washed twice by adding 0.4 ml of 
binding/wash buffer (140 mM NaCl, 8 mM sodium phosphate, 2 mM potassium 
phosphate, 10 mM KCl, pH 7.4), mixing by inverting with gentle shaking and then 
centrifuging the tube. The spin cup was then placed in a new microcentrifuge tube.      
400 µg of anti-FITC antibody prepared in binding/wash (PBS) buffer was added to the 
column and allowed to bind overnight at 4°C with shaking. After overnight incubation, 
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the column was centrifuged and the flow-through saved. The spin cup was placed in 
another microcentrifuge tube and washed with 3 x 0.5 ml of PBS buffer. 
The spin cup was transferred to a new microcentrifuge tube and 0.4 ml of PBS 
buffer was added to it. 25 µl of the cross-linker disuccinimidyl suberate (DSS) 
corresponding to 625 µg of DSS in dimethyl formamide was added to the spin cup and 
gently mixed for 1 h at room temperature. After centrifuging the tube, the antibodies that 
were not covalently bound to protein A were eluted with 5 x 0.5 ml of elution buffer at 
pH 2.8. The eluates were saved for analysis. The spin cup was placed in a new 
microcentrifuge tube and washed with 10 x 0.5 ml of PBS buffer to ensure complete 
regeneration of the bound antibody. For storage, 0.5 ml of PBS buffer was added 
alongwith 0.02% sodium azide and the gel stored at 4°C.  
24-2.  Affinity chromatography of fluorescein-nisin bound to bacterial proteins. 
 
The gel was first brought to room temperature and then washed with 10 x 0.5 ml 
of PBS buffer. 10 µg of fluorescein-nisin (F-N) was diluted with binding/wash buffer to a 
total volume of 200 µl and incubated with the bound antibody with gentle shaking at 4°C 
overnight. The tube was centrifuged and the flow-through collected. The gel was washed 
with 4 x 0.5 ml of PBS buffer and the first wash fraction saved. The antigen was eluted 
under different eluting conditions. Elution at low pH involved adding 190 µl of elution 
buffer at pH 2.8, inverting the tube several times and then centrifuging the tube. This was 
repeated 6-10 times and the eluates collected. The eluates were neutralized by the 
addition of 10 µl of 1 M Tris, pH 9.5. Other elution conditions including high salt (3.5 M 
MgCl2 in 10 mM phosphate buffer at pH 7) and denaturing conditions (8 M Guanidine-
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HCl and 1% SDS) were also used to elute F-N from the column. The eluate fractions 
were then electrophoresed on a 12% gel. The gel was visualized on a Storm 860 Imager 
and also by silver staining. The column was regenerated by washing with 10 x 0.5 ml of 
PBS buffer and stored at 4°C.  
A similar method of immunoprecipitation was performed for the F-N + cell lysate 
sample and also the control cell lysate sample (without F-N) using different amounts of 
the F-N + cell lysate and the control cell lysate samples (10 µl to 150 µl). These samples 































Results and Discussion 
Part I.  Isolation of stable subtilin from Bacillus subtilis LH45. 
Subtilin previously isolated from its natural producer Bacillus subtilis ATCC 
6633 by acetone-butanol procedure was unstable and its biological activity was lost 
during isolation and storage, with chemical instability observed in less than a day at room 
temperature (44). Although subtilin and nisin share considerable structural homology, 
subtilin had been observed to be very unstable compared to nisin, which could be stored 
for months without any detectable chemical or biological changes (42). Therefore, 
subtilin isolated from the original producer was stored at –80°C to preserve its biological 
activity (43). In this work, subtilin was isolated from Bacillus subtilis LH45, a modified 
strain of B. subtilis 168 that was engineered to produce subtilin (43).  
 
Part I-1.  Isolation of stable subtilin using hydrophobic interaction column. 
Subtilin was isolated from Bacillus subtilis LH45 using hydrophobic interaction 
chromatography (HIC) and purified using RP-HPLC. This process resulted in the 
isolation of subtilin along with succinylated subtilin which eluted after subtilin in a RP-
HPLC run. Succinylated subtilin is produced later in the bacterial growth phase than 
subtilin, and is 10-20 times less active than subtilin although succinylated subtilin retains 
antimicrobial activity (7). Isolation of subtilin from LH45 also resulted in isolation of 
sublancin, a recently discovered type A lantibiotic (57), since B. subtilis 168 is a natural 
producer of sublancin. The elution of the peptides was monitored at 254 nm and fractions 
corresponding to the peaks were collected every min to isolate sublancin, subtilin and 
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succinylated subtilin. The biological activity of subtilin in the collected fractions was 
confirmed by halo assays and the presence of subtilin in the individual fractions detected 
by MALDI-TOF. The RP-HPLC and mass spectroscopic profiles of subtilin are 
represented in Fig. 7. The predicted mass of non-succinylated subtilin is 3320 Da which 
agrees with the mass obtained from mass spectroscopic analysis. Sublancin and 
succinylated subtilin correspond to 3877 Da and 3419 Da in mass, respectively. The 
fractions containing non-succinylated subtilin were pooled and the concentration of 
subtilin determined in a uv-vis spectrophotometer at 254 nm using known concentrations 
of nisin as a standard.  
Subtilin isolated using the hydrophobic interaction column was very stable. The 
biological activity of subtilin as determined from antimicrobial (halo) assays remained 
unchanged after four months of storage at -20°C (Fig. 8). Subtilin was also stable when 
stored at room temperature for 2 days in different pH buffers (see Results, Part III). 
Isolation of subtilin from the LH45 culture using HIC also resulted in a copious quantity 
of subtilin compared to that obtained from the 6633 culture using acetone-butanol 
procedure. 2.5 – 3 mg of subtilin could be isolated from 500 ml of LH45 culture 
compared to 100 µg of subtilin purified from 500 ml of the 6633 culture (59).  
The stability of subtilin isolated from LH45 using HIC was comparable to that of 
nisin. Studies of type A lantibiotics had been performed mainly using nisin as a model 
type A lantibiotic and not subtilin, although nisin and subtilin are structurally related in 
terms of both their chemical structure and their conformation in aqueous solution (7). A 
possible reason could probably have been the instability of subtilin, which rendered 
subtilin of little practical value in spite of having a broad spectrum of action (44).  
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Figure 7. RP-HPLC and MALDI-TOF profiles of subtilin isolated using
HIC.
Subtilin isolated from LH45 using hydrophobic interaction
chromatography (HIC) was further purified by reverse phase - HPLC. The RP-
HPLC profile is depicted in the bottom figure. Fractions corresponding to the
peak were collected every min and analyzed by MALDI-TOF. Mass
spectrometric analysis of the fractions detected sublancin, subtilin and

























Subtilin isolated using HIC and purified by RP-HPLC was collected as 1.2 ml
fractions every min. In panel A, 10 µl of fractions corresponding to elution
between 14 - 22 min of the RP-HPLC run was tested for antimicrobial activity
against spores. The fractions 14 - 17 that exhibited antimicrobial
activity were stored at -20ºC. 5 µl from fractions 14 and 15, and 5 µl from
fractions 16, 17 and 18 were again tested for antimicrobial activity after four
months, as seen in panel B. From the zones of inhibition in panels A and B,
subtilin appears to be stable after four months of storage at -20ºC with little loss of
biological activity.
Figure 8. Antimicrobial (halo) assay of stable subtilin.
Bacillus cereus
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Isolation of stable subtilin has thereby enabled subtilin to be used as a model to study its 
specificity and antimicrobial mechanism of action. This has also enabled the generation 
of rabbit anti-subtilin antibodies against subtilin obtained from Research Genetics, 
Alabama.  
 
Part I-2.  Isolation of stable subtilin using non-ionic cellulose column. 
Nisin was found to bind to cellulose under mildly alkaline conditions and was 
released from non-ionic cellulose under acidic conditions (78). This work showed that 
subtilin, a structural analog of nisin, also bound to non-ionic cellulose under alkaline 
conditions and eluted from cellulose using an organic solvent. It is unusual for a 
polypeptide to bind to an inert matrix such as non-ionic cellulose. A possible biological 
significance of the interaction of nisin and subtilin with cellulose was realized due to the 
structural resemblances between cellulose and the polysaccharides present in the bacterial 
spore coats and cell membranes, both of which can bind nisin and subtilin. Binding of 
nisin to the carbohydrate moiety of lipid II present in the cell membrane is proposed to 
facilitate pore formation of nisin according to the lipid II-mediated nisin pore formation 
model (see Fig. 6). Since subtilin can be eluted from cellulose by an organic solvent, this 
suggests that binding of subtilin to cellulose occurs through hydrophobic interactions.  
This possibility may also reflect the ability of subtilin and nisin to bind to the 
mucopolysaccharide of the bacterial cell envelope. 
The ability of subtilin to bind cellulose under alkaline conditions and to dissociate 
from cellulose using an organic solvent also provided a method of isolation of subtilin 
from bacterial culture supernatant. Bacillus subtilis LH45 was grown for 27 h to allow for 
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synthesis and secretion of subtilin into the extracellular medium. The culture was 
centrifuged to obtain the culture supernatant and the pH of the supernatant adjusted to 8. 
A column packed with non-ionic cellulose powder supernatant was equilibrated with       
7 volumes of 100 mM Tris-HCl, pH 8 (wash buffer). The supernatant was also 
equilibrated with Tris-HCl (pH 8) to a final concentration of 100 mM and then loaded 
onto the cellulose column in a manner similar to loading the supernatant onto the 
hydrophobic interaction column. After washing the column with 7 volumes of wash 
buffer, peptides bound to cellulose were eluted with 2 volumes of 50% acetonitrile in 
0.05% TFA. The column eluate was analyzed for biological activity by halo assay and 
then purified using RP-HPLC. The OD254 RP-HPLC elution profile showed a peak with a 
retention time of ~16 min which is similar to the retention time of subtilin isolated from 
HIC and eluted under the same RP-HPLC conditions (Fig. 9). The fractions 
corresponding to the peak exhibited antimicrobial activity against B. cereus spores. 
MALDI-TOF analysis of RP-HPLC purified sample detected a peak corresponding to the 
molecular mass of subtilin with an added water molecule (3338 Da). 
Subtilin isolated using the cellulose column was stable for atleast a month when 
stored at 4°C. Since subtilin was the only detectable peptide present in the cellulose 
column eluate, this indicates that cellulose is highly selective for subtilin. This manner of 
isolation of stable subtilin from bacterial culture supernatant provides an alternative and 
inexpensive method to isolate hydrophobic peptides. In addition, since stable subtilin 
could be easily isolated from LH45 culture supernatant using a cellulose column, this 
method of isolation of subtilin could be utilized to provide an easy, single step procedure 







Figure 9. RP-HPLC, MALDI-TOF and halo assay of subtilin isolated from
cellulose column.
Subtilin isolated from LH45 using cellulose column was further purified
by reverse phase - HPLC. The RP-HPLC profile is depicted in the bottom figure. Fractions
corresponding to the peak were collected every min and analyzed by MALDI-TOF. Mass
spectrometric analysis of the fractions detected subtilin as seen in panel A. The mass of
3338 Da is probably due to the addition of a water molecule to subtilin which has a mass of















Part II.  Exploring functionality of subtilin using phage display and genomics. 
 
 The possibility that specificity of subtilin is conferred by interaction of subtilin 
with specific bacterial protein targets was explored using phage display, an in vitro 
selection technique that was employed to identify peptide sequences interacting with 
subtilin. Subtilin was allowed to select for specific peptide structural motifs from random 
peptide libraries displayed on the surface of M13 bacteriophage to identify potential 
peptide targets of subtilin. The phage display peptide library is based on a combinatorial 
library of random peptide sequences fused to the minor coat protein (pIII) of the M13 
bacteriophage. The displayed peptides are expressed at the N-terminus of pIII followed 
by a short spacer (G-G-G-S) and then the wild-type pIII sequence. Thus, the phage 
display technique has been used to create a linkage between the random peptide 
sequences displayed on the phage and the DNA encoding that sequence (54). 
Determination of the DNA sequence of the phage selected by subtilin therefore allowed 
for the identification of the 12-mer or the 7-mer peptide sequence binding to subtilin. The 
peptide sequences thus identified were then aligned to identify general peptide motifs. 
Since subtilin is active against Gram-positive bacteria, these motifs were used in 
homology searches against all proteins encoded by the genome of the prototypical Gram-
positive bacterium Bacillus subtilis 168 to identify the bacterial proteins containing these 
motifs. The bacterial proteins thus identified could form potential targets of subtilin, and 
identification of these bacterial targets would provide an insight into the specificity and 
also the antimicrobial mechanism of action of subtilin.  
 
 81
Part II-1. Screening of 12-mer and 7-mer peptide phage display libraries against subtilin. 
 Screening of 12-mer and 7-mer peptide phage display libraries against subtilin 
involved the use of affinity capture for biopanning. This was used as an alternative to the 
simpler biopanning procedure which involves incubating the phage-displayed peptide 
library directly with the target coated on a plate. The alternate biopanning procedure was 
chosen as it allowed for incubation of the subtilin target with phages in solution resulting 
in improved binding, followed by affinity capture of the phage-target complexes by 
immobilized streptavidin (Fig. 10). In addition, biotinylation of subtilin using biotin 
disulfide N-hydroxy succinimide ester (BDNHSE) resulted in covalent linkage of subtilin 
to the biotin moiety through a disulfide linkage. This allowed for elution of the bound 
phage by reducing the –S-S- linkage between subtilin and biotin, which disrupts both 
covalent and non-covalent interactions, so that all interactions could be detected. The 
bound phage was also eluted with low pH to identify peptides interacting non-covalently 
with subtilin.  
1-1.  Biotinylation of subtilin. 
The maximum solubility of nisin at pH 8 was determined to be 0.25 mg/ml with 
higher solubility at lower pH (42). So, 0.5 mg of subtilin was biotinylated by reacting 
with the biotinylating agent BDNHSE in pH 8 buffer in a total volume of 2 ml. Subtilin 
was incubated with BDNHSE in a 1:1 nanomolar ratio to ensure that subtilin was 
biotinylated at only one of its three lysine residues. Biotinylated subtilin was purified 
using RP-HPLC after incubation on ice for 2 h, and fractions corresponding to 
biotinylated subtilin were collected every min (Fig. 11). As seen from the halo assay, the 
RP-HPLC fractions of biotinylated subtilin retained biological activity comparable to that  
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Figure 10. Schematic representation of modified phage display using affinity
biopanning.
Biotinylated subtilin was incubated with the phage library in solution. The bound
biotinylated-subtilin phage complexes were then incubated with streptavidin immobilized
in microtiter plate wells to allow capture of the biotinylated-subtilin phage complex by
streptavidin. The unbound phages were washed away. Specifically bound phages were
eluted either by DTT or by low pH. Elution by DTT disrupts all non-covalent as well as
covalent interactions, whereas low pH disrupts all non-covalent interactions. The eluted
pool of M13 phages was amplified in . The biopanning process was repeated for two
more rounds. After three rounds of biopanning, individual phage clones were sequenced to
identify the peptide sequence interacting with subtilin.
E. coli
1. Phage library incubated with
biotinylated subtilin in solution
3. Unbound phage washed away
4. Specifically bound biotinylated subtilin-
















2. Biotinylated subtilin-phage complex
incubated with immobilized streptavidin






























4. Specifically bound biotinylated subtilin-
phage complexes eluted by low pH













Figure 11. RP-HPLC and halo assay of biotinylated subtilin.
Subtilin was incubated with
The RP-HPLC profile of biotinylated
subtilin is depicted in the bottom figure. Fractions corresponding to the
peak were collected every min and tested for antimicrobial activity as
shown in the top figure.
biotin disulfide N-hydroxy succinimide ester
(BDNHSE) in a 1:1 nanomolar ratio for 2 h on ice. Biotinylated subtilin
was purified using RP-HPLC.
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of unmodified subtilin. Concentration of biotinylated subtilin in each of the RP-HPLC 
fractions displaying antimicrobial activity (fractions #18 and #19, see Fig. 11) was 
determined in an uv-vis spectrophotometer at 254 nm using nisin dilutions to plot the 
standard curve, since subtilin and nisin each have 3 dehydro residues that absorb at 254 
nm. 
1-2.  12-mer peptide sequences selected by subtilin. 
For each round of biopanning, 5 nM of each of the two RP-HPLC biotinylated 
subtilin fractions displaying antimicrobial activity (fractions #18 and #19) with 4 X 1010 
plaque forming units (pfu) of phage from the 12-mer phage library for 1 h. The 
biotinylated subtilin bound to phage was then incubated in a streptavidin-coated 
microtiter well for 1 h to allow for binding of the biotinylated subtilin - phage complex to 
streptavidin. After washing non-bound phage, the bound phage was eluted either by DTT 
or by low pH (Gly-HCl, pH 2.2). The unamplified eluates were titered to determine the 
number of phages in each of the four eluates and then amplified. The amplified phage 
was also titered to calculate the volume of the amplified eluate corresponding to 1011 pfu 
to carry out the second and third rounds of biopanning. Each successive round of 
biopanning resulted in an increase in the phage titer of the unamplified eluate as 
determined by counting the number of blue plaques. 78 plaques were sequenced from the 
third round of biopanning, which yielded 14 dodecapeptide sequences selected by subtilin 
from the phage display screening. Sequences of the 12-mers obtained from DTT elution 
and Gly-HCl elution are represented in Table 1. As seen in Table 1, 5 of the 14 peptide 
sequences were selected from more than one experimental condition. However, only one 
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sequence, WPQMAHKTTLLM, was selected by subtilin in all four experimental 
conditions. This sequence also dominated over the other sequences, in that 29 of the 78 
phages sequenced contained the WPQMAHKTTLLM sequence. The significance of this 





12-mer sequences identified from 
DTT elution 
12-mer sequences identified from 
Gly-HCl elution 
18 WPQMAHKTTLLM (5) WPQMAHKTTLLM (8) 
19   WPQMAHKTTLLM (14) WPQMAHKTTLLM (2) 
18 SPSMLTSMWPNT (4)  
19 SPSMLTSMWPNT (5) SPSMLTSMWPNT (15) 
18 IQSDDLAAAWDL (1)            IQSDDLAAAWDL (1) 
19             IQSDDLAAAWDL (3) 
18 NFMESLPRLGMH (1)  
19 NFMESLPRLGMH (1) NFMESLPRLGMH (3) 
18 YPASHPMMTNSA (1)  
19  YPASHPMMTNSA (4) 
18  YHNMLKGDIPPG (2) 
18  SQITMAVIPGDI (1) 
18  RVILSIKLIWSA (1) 
18 TINISIKLIRSA (1)  
18 NYHMHWSTPHLP (1)  
19 FYEDPLGARGEK (1)  
19 SHIFLLIQWPLH (1)  
19 SHHIPSYQWPLH (1)  
19 SHHIPYLYVPLH (1)  
 
 
Table 1.  Sequences of 12-mer peptides selected by subtilin and eluted by DTT or 
Gly-HCl.  A 12-mer peptide phage library was biopanned against subtilin to identify 
potential peptide targets of subtilin. Two RP-HPLC fractions (#18 and # 19) of 
biotinylated subtilin were incubated with the phage-displayed peptide library in solution 
and then captured onto a streptavidin-coated target. After washing away unbound phage, 
the specifically-bound phage was eluted either by DTT or by Gly-HCl. After three such 
rounds of biopanning, 78 phages from the third round of biopanning were sequenced to 
identify 14 dodecapeptide sequences selected by subtilin from the 12-mer phage library. 
The number in parentheses next to the 12-mer sequence denotes the number of 





The 12-mer sequences selected by subtilin were examined to detect common 
motifs. The 12-mers exhibited several classes of motifs that were identified based on 
similarities in amino acid sequence within the 12-mer peptides. The 12-mer sequences 
that had amino acid sequence motifs in common were aligned according to their motifs as 
seen in Fig. 12. Analysis of these motifs is discussed in Results, Part II-2.  
            
                        RVILSIKLIWSA   
   TINISIKLIRSA                  SIKLI motif  
 
 
  IQSDDLAAAWDL 
  FYEDPLGARGEK            DXLAAXXD motif 
 
 
  SQITMAVIPGDI 
      YHNMLKGDIPPG             IXGDI motif 
 
 
  SHHIPSYQWPLH 
  SHHIPYLYVPLH              SHHIPXXXXPLH motif 
 
 
  SHHIPSYQWPLH 
   SHIFLLIQWPLH              QWPLH motif 
 
 
  WPQMAHKTTLLM  →  KTTLL motif 
 
Fig. 12:  Alignment of 12-mer peptide sequences selected by subtilin from phage 
display screening.  The 12-mer peptide sequences selected by subtilin were identified 
after the third round of biopanning. Some of the sequences have been aligned based on 
similarities in the amino acid sequence of the peptides to identify six motifs. 
 
1-3.  7-mer peptide sequences selected by subtilin. 
 
Phage display screening using a 12-mer peptide library was employed to detect 
potential peptide targets of subtilin. The 12-mer library screening against subtilin 
identified several 12-mer peptide sequences selected by subtilin. However, the 
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disadvantage in using a 12-mer phage library is that it contains so many variant 12-mers 
that it is possible to screen only a small subset (approximately 1.9 x 109) of the entire 
population (2012 possible sequences) for subtilin binding (80). A 7-mer phage library 
would theoretically permit screening of all possible random sequences (1.28 x 109) for 
subtilin binding. Therefore, a 7-mer peptide phage library was screened against subtilin 
with the expectation that the peptides selected by subtilin from the 7-mer library would 
be identical or similar to those obtained from the 12-mer library screening.  
In the 7-mer phage display screening against subtilin, the 7-mers bound to subtilin 
were also eluted both by DTT and by Gly-HCl, in a manner similar to the procedure used 
in the 12-mer phage elution. Three rounds of biopanning were performed, and the phages 
obtained from the third round of biopanning were sequenced. The 7-mer sequences 
obtained from sequencing 61 phages are represented in Fig. 13. The 7-mer peptide 
sequences when compared to the 12-mer sequences did not show much similarity to the 
12-mer sequences, except for the presence of short HLP and RSA motifs seen in both the 
12-mer and the 7-mer sequences. This could have occurred if subtilin requires a peptide 
surface larger than that of a 7-mer for efficient binding. Analysis of each of the 7-mer 
sequences involving homology searches against the B. subtilis 168 proteome did not 
result in any proteins being identified when zero mismatch was allowed. However, when 
the sequence LLDQPPA was used as a query pattern allowing 2 mismatches, the search 
identified CydC, an ABC transporter and YfmO, a protein with function similar to a 
multidrug-efflux transporter. YfmO contains the pattern NQKTGLLSQPKAVWAVA. 
CydC is an ABC transporter required for expression of cytochrome bd (ATP-binding 
protein) with the sequence pattern NRPILLLDEPTAHLDIE. 
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MATTSPT (2)                  
              PTFQITH (5)                            
          SLPTENM (1) 
MAHHLPQ (2) 
            PPHQEIT (11) 
           LMHSELT (4) 
    RNHPEHA (9) 
  LLDQPPA (9) 
          YYPLVFS (6) 
   RNWKPIF (1) 
   RSASMTI (8) 
    AWQQTRS (2) 
  AFITTQT (1) 
 
Figure 13.  Sequences of 7-mer peptides selected by subtilin and eluted by DTT or 
Gly-HCl.  A 7-mer peptide phage library was biopanned against subtilin to identify 
potential peptide targets of subtilin. After three rounds of biopanning, 61 phages from the 
third round of biopanning were sequenced to identify thirteen 7-mer sequences selected 
by subtilin from the 7-mer phage library. The number in parentheses next to the 7-mer 
sequence denotes the number of occurrence of each sequence. 
 
Part II-2.  Analysis of 12-mer sequences using genomics. 
 
 The 12-mer sequences selected by subtilin from the phage display screening were 
further analyzed using genomics as a tool to decipher their biological relevance to the 
specificity and the antimicrobial mechanism of action of subtilin. Subtilin exhibits 
antimicrobial activity against a broad spectrum of Gram-positive bacteria. This indicates 
that any bacterial protein target of subtilin should be present in all susceptible Gram-
positive bacteria. Since the entire genome of the prototypical Gram–positive bacterium 
Bacillus subtilis 168 has been sequenced (36), the motifs selected by subtilin from the 
phage display screening were used in homology searches against all possible translated 
proteins encoded by the B. subtilis 168 genome. These searches were performed using the 
Search Pattern tool available on the SubtiList World-Wide Web Server at 
http://genolist.pasteur.fr/SubtiList/. 
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2-1.  Analysis of KTTLL motif. 
 
As seen in Table 1, the WPQMAHKTTLLM sequence was selected by subtilin 
the most number of times, occurring at a frequency of more than 37% of all selected 
sequences. In addition, this sequence was selected by subtilin under four different 
experimental conditions, including elution by DTT and also by Gly-HCl. This indicates 
that the WPQMAHKTTLLM sequence selected by subtilin is a strong contender for 
being a bacterial peptide target of subtilin. Analysis of the most commonly occurring 
sequence WPQMAHKTTLLM showed that it contains a motif KTTLL that is 
characteristic of ATP binding cassette (ABC) transporters. This KTTLL pattern is 
conserved among ABC transporters and forms part of the ATP binding cassette domain 
in the cytoplasmic Walker A region (12). The sequence WPQMAHKTTLLM, when 
input as a search pattern with zero mismatch against all proteins encoded by the Bacillus 
subtilis 168 genome, resulted in no identifiable B. subtilis proteins. However, when the 
KTTLL motif was used as the query pattern, 13 proteins with zero mismatch to the 
KTTLL motif were extracted and these are represented in Table 2. The proteins thus 
identified mainly comprised of ABC transporters, some of which were similar to 
glutamine, anion transport and iron transport ABC transporters. These ABC transporters 
are mainly located on the cell membrane and could form potential protein targets of 
subtilin. In addition, initiation factor IF-2 (InfB) was also identified as a potential subtilin 
target from these results. Initiation factor IF-2 (~78 kDa in B. subtilis 168) is involved in 




                
            gene: Description 
 
       
      Pattern sequence 
 
infB: initiation factor IF-2 
 
 HVDHGKTTLLDSIRK
expZ: ATP-binding transport protein 
 
 PNGSGKTTLLNIILG
yckI: unknown; similar to glutamine ABC 
transporter (ATP-binding protein) 
 
 PSGSGKTTLLRCLNA
ytlC: unknown; similar to anion transport ABC 
transporter (ATP-binding protein) 
 
 PSGCGKTTLLSIIAG
yvrA: unknown; similar to iron transport system 
 
 PNGSGKTTLLHLLTG












yvcR: unknown; similar to ABC transporter 
(ATP-binding protein) 
 PSGSGKTTLLNLLAT
   
yciC: unknown; similar to unknown proteins 
 
 YLGAGKTTLLNSILQ




spoIIIAA: mutants block sporulation after 
engulfment 
 








Table 2.  Bacillus subtilis 168 proteins containing the KTTLL motif.  The KTTLL 
motif found in the 12-mer WPQMAHKTTLLM sequence selected by subtilin was used 
as a search pattern against all proteins in the B. subtilis 168 genome. This resulted in the 
identification of 13 proteins with zero mismatch to the KTTLL motif. The first column 
lists the gene name in italics, followed by a brief description of the protein encoded by 
the gene. The second column indicates the segments of the B. subtilis proteins that 
contain the KTTLL motif.  
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Another interesting result was obtained when the KTTLL motif was used as a 
search pattern by allowing one mismatch for the KTTLL motif. Of several proteins 
identified, elongation factor Tu (TufA) was of particular interest. Elongation factor Tu is 
also involved in protein synthesis like the initiation factor IF-2 identified in Table 3. 
TufA (~43 kDa) is involved in the elongation of the peptide chain during protein 
synthesis, and is also an aminoacyl tRNA and a GTP binding protein like IF-2. Other 
proteins identified by allowing one mismatch for the KTTLL motif included penicillin-
binding protein DacB and several proteins with functions similar to multidrug resistance 
proteins as seen in Table 3. 
 
                
            gene: Description 
 
       
      Pattern sequence 
 
tufA: elongation factor Tu 
 
 HVDHGKTTLTAAITT 
dacB: penicillin-binding protein 5 
 
yqjV: unknown; similar to multidrug resistance 
protein 
 
ycnB: unknown; similar to multidrug resistance 
protein 
 














Table 3.  Bacillus subtilis 168 proteins containing the KTTLL motif with one 
allowed mismatch.  The KTTLL motif found in the 12-mer WPQMAHKTTLLM 
sequence selected by subtilin was used as a search pattern against all proteins in the B. 
subtilis 168 genome. This resulted in the identification of several proteins when one 
mismatch for the KTTLL motif was allowed. The first column lists the gene name in 
italics, followed by a brief description of the protein encoded by the gene. The second 
column indicates the segments of the B. subtilis proteins that contain the KTTLL motif 
with one mismatch.  
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2-2.  Analysis of other motifs seen in the 12-mer peptide sequences. 
 
The motif SIKLI seen in the 12-mers RVILSIKLIWSA and TINISIKLIRSA 
identified several proteins when one mismatch was allowed, with proteins having 
functions similar to multidrug resistance proteins being identified. The motif IXGDI seen 
in Fig. 12 identified another elongation factor FusA with zero mismatch to the motif. 
FusA or elongation factor G with the pattern sequence YMGDIMGDITSRRG is also 
involved in protein synthesis. Another motif, DXLAAXXD also identified FusA with the 
pattern sequence LDAVLDYLPAPTDVAAIK when one mismatch was allowed.  
The results obtained from the homology searches appear to indicate that subtilin 
could potentially act as an inhibitor of protein synthesis, either at the initiation stage or at 
the elongation stage. This would then suggest an alternative mechanism of action of 
subtilin, in addition to pore formation. Further, the identification of ABC transporters as 
potential protein targets of subtilin appears to indicate that the ABC transporters within 
the cell membrane could facilitate binding of subtilin to the cell membrane, which is then 
followed by insertion of subtilin into the cell membrane leading to pore formation. This 
would contribute to the specificity of antimicrobial action of subtilin. 
 
Part III.  Sedimentation equilibrium analysis of subtilin, pep16 and pep19. 
 Sedimentation equilibrium experiments are useful in studying a variety of 
interactions, including the self-association of macromolecules and the binding of 
heterogeneous macromolecular interactions (58). To determine the nature of interaction 
of subtilin with the 12-mer sequences selected by subtilin from the phage display 
screening, two synthetic peptides were obtained from Research Genetics, Alabama. The 
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sequence of one of the synthetic peptides, pep16, corresponded to the 12-mer peptide 
sequence with the KTTLL motif that was selected the most number of times by subtilin. 
The sequence of the other synthetic peptide (pep19) was part of the protein encoded by 
the gene yxdL in B. subtilis 168 (see Table 2). This protein also has the KTTLL motif and 
is thought to have a function similar to an ABC transporter. The sequences of pep16 and 
pep19 were WPQMAHKTTLLMGGGC-[CONH2] and PSGSGKTTLLNIISTGGGC-
[CONH2], respectively. The sequence of the synthetic peptides was designed taking into 
consideration two factors. The 12-mer phage library had been constructed to include a 
peptide spacer fused to the pIII coat protein, and therefore, a G-G-G-C spacer was 
included at the C-terminus of the selected 12-mer sequence to design the synthetic 
peptide. Also, the C-terminus of the 12-mer displayed on the M13 phage was fused to its 
pIII coat protein, while the N-terminus was free during biopanning. This ensured that the 
C-terminus of the 12-mer did not contain a free negatively charged carboxylate during 
panning. The C-terminal carboxylate of the synthetic peptide was therefore amidated to 
block the negative charge to ensure that this charge did not interfere with binding of the 
synthetic peptide to subtilin. 
Sedimentation equilibrium experiments were performed to examine the 
interaction between subtilin and the synthetic peptides, pep16 and pep19. The 
sedimentation equilibrium experiments were designed to centrifuge the macromolecules 
at low speeds over a period of 2 days so as to obtain an equilibrium distribution 
concentration of the macromolecules throughout the centrifuge cell (21). Subtilin isolated 
previously from B. subtilis 6633 by the method of acetone-butanol procedure was 
unstable at RT with loss of chemical integrity seen in less than a day (44). Also, nisin was 
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observed to form multimers at high pH (42). If subtilin were also participating in 
multimer formation, then self-association of subtilin resulting in the formation of 
aggregates would have led to complications in the analysis of the interactions between 
subtilin and the synthetic peptide due to the presence of multiple species. In addition, 
multimer formation of subtilin might affect subtilin binding to pep16 or pep19. Subtilin 
was therefore tested for stability at RT for 2 days, since the equilibrium runs were of 1-2 
days duration. Subtilin was incubated at RT for 2 days in different pH buffers of 5, 6.5, 
7.5 and 8 to determine the best pH buffer for the existence of monomeric subtilin. Each 
sample was then run on a Tricine-SDS-PAGE gel and silver stained. The silver-stained 
gel showed that subtilin was stable when incubated at RT for 2 days (Fig. 14) with no 
multimers seen at pH 5, 6.5, 7.5 or at pH 8. The different pH buffers containing subtilin 
were also desalted by RP-HPLC and analyzed by MALDI-TOF when monomeric subtilin 
was detected in each buffer.  
The amount of subtilin, pep16 and pep19 for the sedimentation equilibrium 
experiments was chosen such that the amount corresponded to an OD280 < 0.5 based on 
the range of the spectrophotometer used in the Beckman XL-I analytical ultracentrifuge. 
This OD corresponded to micromolar concentrations of subtilin, pep16 and pep19 used in 
the sedimentation equilibrium experiments. The amount of subtilin and pep16 was 
calculated using the molar extinction coefficient of Trp (5690 M-1 cm-1) and Beer’s law 
(20). Pep19 did not have any Trp residue, but since the molecular weight of pep19 (1762 
Da) is approximately that of pep16 (1730 Da), the amount of pep19 used was the same as 
pep16. Subtilin, pep16 and pep19 were centrifuged individually at first in order to detect  
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Figure 14. Stability of subtilin incubated in different pH buffers for 2d
at RT.
Subtilin was incubated at RT for 2 days in different pH buffers of 5, 6.5, 7.5
and 8 to determine the best pH buffer for the existence of monomeric
subtilin. Each sample was then run on a Tricine-SDS-PAGE gel and silver
stained. The silver-stained gel showed that subtilin was stable when
incubated at RT for 2 days with no multimers seen at pH 5, 6.5, 7.5 or at pH
8 (bottom figure). The different pH buffers containing subtilin were
desalted by RP-HPLC and analyzed by MALDI-TOF when monomeric
subtilin was detected in each buffer (top four figures).
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the formation of aggregates if any of the macromolecules were participating in self-
associations. Equimolar amounts of subtilin and pep16 were then centrifuged together to   
detect the association of subtilin with pep16. 
The molecular mass, M, of the macromolecule can be determined from the 
equation (21) 
σ = M (1 - ν⎯ρ) ω2 / 2RT  
 
where σ = reduced molecular mass 
           ν⎯ = partial specific volume of the solute 
           ρ = density of the solvent  
           ω = angular velocity 
           R = gas constant 
           T = absolute temperature 
 
 The partial specific volume of a protein is the ratio between its volume and 
molecular weight (http://www.basic.nwu.edu/biotools/ProteinCalc.html). The partial 
specific volume of subtilin, pep16 and pep19 was calculated from a weight average of the 
partial specific volumes of the component amino acid residues (15). The accurate ν⎯ of 
subtilin could not be calculated because the ν⎯ of the dehydro residues is not known. 
Therefore, the partial specific volume of subtilin was calculated to be 0.7198 using 
estimated values for the dehydro residues, with the partial specific volume of serine and 
threonine being substituted for dehydroalanine (Dha) and dehydrobutyrine (Dhb), 
respectively, since Dha and Dhb are formed as a result of the dehydration of Ser and Thr, 
respectively. The calculated value of 0.7198 for subtilin falls within the 0.70 - 0.75 range 
of partial specific volumes for proteins, with an average value of 0.73 for most proteins 
(58). 
 The reduced molecular mass, σ was determined from the NONLIN least squares 
analysis values by analyzing the absorbance gradient as one ideal species. The density of 
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TBS was calculated to be 1.014 g/ml. The molecular weight of subtilin was then 
computed from the reduced molecular mass (buoyant molecular weight) using estimated 
values for the partial specific volume of subtilin. The molecular mass of pep19 could not 
be determined because pep19 precipitated when centrifuged at very high speeds. The 
molecular masses of subtilin, pep16 and subtilin + pep16 samples as calculated from the 














subtilin 0.7198 0.79 3320 Da 3663 Da 
pep16 0.7094 0.738 1730 Da 2001 Da 
subtilin + pep16 0.7146 0.798 5050 Da 3177 Da 
 
Table 4: Comparison of theoretical and calculated molecular masses obtained from 
sedimentation equilibrium experiments.  Interaction between subtilin and the synthetic 
peptide, pep16 was analyzed by sedimentation equilibrium. Subtilin and pep16 were 
analyzed individually at first, followed by analyzing an equimolar concentration of 
subtilin and pep16. The reduced molecular mass, σ was determined from a nonlinear 
least squares analysis and this was used to calculate the molecular mass of subtilin and 
pep16. The calculated molecular mass of subtilin and pep16 was then compared with the 




The data obtained from the individual sedimentation equilibrium runs of subtilin 
and pep16 indicated that subtilin and pep16 formed monomeric species and did not 
participate in self-associations, as the resulting absorbance gradient at 280 nm could be fit 
to a single ideal species. So, for the sedimentation equilibrium run of subtilin with pep16, 
1-3 species were expected to be seen depending on the Kd of the association between 
subtilin and pep16. Tight binding of subtilin to pep16 would result in the formation of a 
single species of the subtilin-pep16 complex. However, a high Kd would result in three 
species – free subtilin, free pep16 and the subtilin-pep16 complex. The calculated 
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molecular mass M of the subtilin and pep16 mixture was less than that expected for a 
subtilin-pep16 complex. This indicated that subtilin and pep16 were not associating 
tightly enough to form a single species, since this value of 3177 Da is the average 
weighted molecular mass of subtilin and pep16.  
The observation that the 12-mer peptide sequence selected from the phage library 
by subtilin bound to the target (subtilin) when presented on the intact phage, but could 
not bind as a synthetic peptide may be explained if the selected 12-mer sequence required 
additional elements from adjacent sequence on pIII protein for efficient binding to 
subtilin (http://www.neb.com/nebecomm/tech_reference/drug_discovery/phdFaq.asp). 
Also, if the Kd of binding of the synthetic peptide to subtilin is high and possibly in the 
millimolar range, then the interaction between subtilin and the peptide would not have 
been detected since micromolar concentrations of subtilin and synthetic peptide were 
used in the sedimentation equilibrium experiments. The sedimentation results therefore 
do not conclusively determine that the 12-mer sequence with the KTTLL motif selected 
by subtilin from the phage library was an artifact, especially in view of the fact that this 
12-mer sequence was selected by subtilin in four different experimental conditions of 
phage display screening (see Table 1). 
 
Part IV.  Isolation of subtilin-binding proteins from susceptible bacterial cells using  
monomeric avidin column. 
 
Identification of subtilin-binding 12-mer peptide sequences in vitro from the 
phage display screening followed by comparison of the selected 12-mers to the B. subtilis 
168 proteome resulted in detection of ABC transporters and initiation factor IF-2 as 
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potential bacterial protein targets of subtilin (see Results, Part II). To confirm that the 
selected 12-mer with the KTTLL motif in ABC transporters was actually involved in 
interaction with subtilin and was responsible for its specificity, in vivo studies were 
performed to isolate subtilin-binding proteins from intact bacterial cells. Isolation of 
bacterial proteins binding to subtilin followed by identification of these subtilin-binding 
bacterial proteins would then provide an insight into the specificity and antimicrobial 
mechanism of action of subtilin.  
To isolate subtilin-binding bacterial proteins, the same strategy of using 
biotinylated subtilin as was used in phage display screening to identify subtilin-binding       
12-mer peptide sequences was employed. Biotinylated subtilin used in this method 
provided a means for the isolation of subtilin-binding bacterial proteins from a lysate of 
susceptible bacterial cells. The advantage of using biotinylated subtilin in this method 
was that the lysate of bacterial cell proteins incubated with biotinylated subtilin could be 
further incubated with immobilized monomeric avidin to allow binding of the 
biotinylated subtilin-bacterial protein complex to avidin, followed by elution of bound 
proteins by biotin or low pH. The monomeric avidin column provided a support with 
lower biotin-binding affinity than native tetrameric avidin, and this enabled recovery of 
biotinylated complexes using biotin or low pH. Biotinylated subtilin was initially 
incubated with B. cereus cells to isolate subtilin-binding bacterial proteins, since            
B. cereus was generally used as the test organism for subtilin activity. However, the 
availability of the complete genome of B. subtilis 168 could facilitate the identification of 
subtilin-binding bacterial proteins by enabling sequencing of tryptic digests of the 
isolated protein by tandem mass spectrometry (27) followed by comparison of the peptide 
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sequences thus obtained with protein sequences in the B. subtilis 168 protein database 
using the SEQUEST program (40). Therefore, subtilin was tested for antimicrobial 
activity against B. subtilis 168 spores when subtilin was found to be biologically active 
against B. subtilis 168 spores (Fig. 15). Biotinylated subtilin was then incubated with     
B. subtilis 168 cells to isolate subtilin-binding bacterial proteins.  
Part IV-1.  Isolation of subtilin-binding proteins from B. cereus cells. 
 
 Subtilin was biotinylated and purified using RP-HPLC as described in Materials 
and Methods, Part II-8. Biotinylated subtilin retained antimicrobial activity against both 
B. cereus and B. subtilis 168 spores as seen from the halo assays (Fig. 16). 1 or 2 ml 
monomeric avidin columns were prepared for purification of biotinylated complexes by 
first blocking the high affinity biotin-binding sites on the avidin columns with a biotin-
containing buffer and then eluting loosely bound biotin from the columns with a low pH 
(Gly-HCl, pH 2.8) solution to reveal the reversible biotin-binding sites. The columns 
were now ready for purification of biotinylated complexes. 
To test the efficacy of the column, 250 µg of biotinylated subtilin was applied to a 
1 ml monomeric avidin column as a positive control. After washing with PBS, bound 
biotinylated subtilin was eluted with a biotin-containing buffer. The column was then 
regenerated by washing with Gly-HCl buffer. Samples were collected during the PBS 
wash, and also during the biotin buffer elution and the Gly-HCl wash. The samples were 
dialyzed and then analyzed by SDS-PAGE and Western blotting. The Western blot 
showed a ~20 kDa band in the PBS wash and eluted fractions, but no other band was seen 
(Fig. 17). The same band appeared when some biotinylated subtilin (25 µg) was also run 








Different amounts of subtilin varying from 5 g to 25 g were tested
for antimicrobial activity against and
168 spores by halo assay. In panel A, different amounts of subtilin
were spotted on a medium A plate. After allowing the different
amounts to dry, t
From the zones of inhibition seen in panelsAand B, subtilin appears to
be biologically active against both and 168 spores.
µ µ
Bacillus cereus Bacillus subtilis
B. cereus B. subtilis
B. subtilis 168 spores.
he plate was sprayed with spores and
incubated at 37 C overnight. In panel B, different amounts of subtilin








Subtilin was biotinylated by reacting with
ractions
corresponding to biotinylated subtilin were collected every min and tested
for antimicrobial activity. In panel A, 10 µl of each RP-HPLC fraction of
biotinylated subtilin was tested against spores whereas in panel









Figure 17. SDS-PAGE analysis of biotinylated subtilin eluted from
monomeric avidin column.
Biotinylated subtilin was applied to a monomeric avidin column to test for
isolation of biotinylated subtilin from the monomeric avidin column.After
washing any non-specifically bound protein from the column using PBS,
the bound biotinylated subtilin was eluted with biotin followed by a
glycine-HCl wash. After dialysis, the PBS wash and elution fractions were
analyzed by SDS-PAGE and Western blot. A small amount of biotinylated





























































































































To isolate subtilin-binding bacterial proteins, B. cereus cells were incubated with 
500 µg of biotinylated subtilin for 3 h. The cells appeared to be completely lysed after a  
3 h incubation with biotinylated subtilin as seen from loss of solution turbidity. The cells 
were then passed through a French pressure cell to ensure complete cell lysis. The lysate 
of bacterial proteins containing biotinylated subtilin-bacterial protein complexes was 
loaded onto a 2 ml monomeric avidin column for purification. Unbound protein was 
washed off the column using PBS and wash samples collected. Bound, biotinylated 
proteins were eluted using a biotin-containing buffer, and proteins eluting off the column 
were collected. The column was then washed with Gly-HCl buffer to regenerate the 
column. Samples from Gly-HCl elution were also collected for further analysis. After 
dialysis, the PBS wash samples, biotin-eluted samples and Gly-HCl eluted samples were 
analyzed by SDS-PAGE in duplicates and detected both by silver staining and also by 
Western blotting. A bacterial cell sample without biotinylated subtilin was also subjected 
to the same procedure as a negative control.  
As seen in Fig. 18, more bands were visible in the silver-stained gel than on the 
Western blot, indicating that many B. cereus proteins interact non-covalently with 
subtilin while subtilin bound covalently only to some specific proteins. Also, more 
proteins were eluted by Gly-HCl buffer than by biotin elution buffer indicating that the 
monomeric avidin column was binding biotinylated complexes tighter than those that 
could be eluted off the column using the biotin elution buffer. A few bands were also 
seen in the wash fraction of the negative control sample in the Western blot. A band of 
~99 kDa size appeared in both the wash fraction of the negative control and also the Gly-
HCl eluted fraction of the experimental sample (biotinylated subtilin-bacterial protein  
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Figure 18.
B. cereus cells were incubated with biotinylated subtilin (B-S) and the cells lysed after
incubation. The B-S + bacterial cell lysate was applied to a monomeric avidin column
to isolate subtilin-binding bacterial proteins. Non-specifically bound protein was
washed off the column with a PBS wash. The bound protein was eluted first with biotin
followed by glycine-HCl elution. A bacterial cell sample without any biotinylated
subtilin used as a negative control was also subjected to the same procedure. After
dialysis, the PBS wash and elution fractions were analyzed by SDS-PAGE. Bacterial
proteins covalently attached to subtilin are seen in the Western blot of the SDS-PAGE
gel in panel A. The silver stained gel in panel B shows all noncovalent and covalent
interactions of the bacterial proteins with subtilin.
Isolation of subtilin-binding bacterial proteins from cells








































































































































































































































































































sample), while a band of ~12 kDa appeared only in the wash fraction of the negative 
control. The presence of bands in the wash fraction of the negative control in the Western 
blot suggests that some naturally occurring biotin-containing proteins/peptides present in 
bacterial cells loosely bound to the monomeric avidin column (26), and were washed off 
by PBS. No proteins from the negative control sample were eluted from the monomeric 
avidin column either by biotin buffer or Gly-HCl buffer, as seen in the Western blot. 
The Gly-HCl eluted fraction of the experimental sample showed bands of ~130 
kDa, ~115 kDa, ~108 kDa, ~78 kDa, ~60 kDa, ~50 kDa, ~45 kDa, ~43 kDa and ~40 kDa 
in the Western blot. The ~78 kDa and the ~43 kDa proteins are of particular interest, 
since the phage display results identified initiation factor IF-2 (~78 kDa) and elongation 
factor Tu (~43 kDa) as possible bacterial protein targets of subtilin (see Results, Part     
II-2). Further, the bands seen in the Western blot represent bacterial proteins bound 
covalently to biotinylated subtilin, since the biotinylated subtilin-bacterial protein 
complexes eluted from the monomeric avidin column were probed using a streptavidin-
alkaline phosphatase conjugate in the Western blot. This detection method therefore 
detected only those bacterial proteins that were covalently attached to biotinylated 
subtilin. Covalent attachment of subtilin to bacterial proteins indicates that the 
electrophilic dehydro residues of subtilin could be interacting with specific nucleophilic 
groups in bacterial protein targets. The significance of covalent attachment of subtilin to 
bacterial protein targets and the possible mechanism of covalent attachment is discussed 




Part IV-2.  Isolation of subtilin-binding proteins from B. subtilis 168 cells. 
 
To identify bacterial proteins interacting with subtilin, B. subtilis 168 cells were 
also subjected to the same protocol of incubation with biotinylated subtilin as the           
B. cereus cells. After incubation and cell lysis, the B. subtilis 168 cell lysate with 
biotinylated subtilin was affinity purified using a monomeric avidin column to isolate 
subtilin-binding bacterial proteins. The samples eluted from the column were analyzed by 
SDS-PAGE and visualized by silver stain and Western blot. As seen with the B. cereus 
cellular proteins, more B. subtilis 168 proteins were visible in the silver-stained gel than 
in the Western blot (Fig. 19), further confirming that subtilin was interacting covalently 
with only some specific bacterial proteins. Some of the higher molecular weight bands 
(~130 kDa, ~110 kDa, etc.) were seen in both the B. subtilis and the B. cereus samples 
eluted by glycine-HCl buffer, suggesting that these proteins could be evolutionarily 
conserved in both species. The advantage of performing these experiments with             
B. subtilis 168 cells is that bacterial proteins isolated using the monomeric avidin column 
could now be identified by comparing these proteins with all proteins encoded by the     
B. subtilis 168 genome. 
 
Part V.  Isolation of bacterial protein targets of nisin from B. subtilis 168 cells. 
 
The monomeric avidin column used in the purification of subtilin-binding 
proteins was successful in isolating specific bacterial proteins binding covalently to 
subtilin. However, this method of isolation also resulted in the isolation of a large number 
of bacterial proteins interacting noncovalently with subtilin, as seen in Fig. 18. Attempts 
to identify any bacterial protein covalently attached to subtilin by in-gel tryptic digestion  
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Figure 19.
B. subtilis 168 cells were incubated with biotinylated subtilin (B-S) and the cells lysed
after incubation. The B-S + bacterial cell lysate was applied to a monomeric avidin
column to isolate subtilin-binding bacterial proteins. Non-specifically bound protein
was washed off the column with a PBS wash. The bound protein was eluted first with
biotin followed by glycine-HCl elution. A bacterial cell sample without any
biotinylated subtilin used as a negative control was also subjected to the same
procedure. After dialysis, the PBS wash and elution fractions were analyzed by SDS-
PAGE. The silver stained gel shown in panel A depicts all noncovalent and covalent
interactions of the bacterial proteins with subtilin. The Western blot shown in panel B
depicts bacterial proteins attached covalently to subtilin.
Isolation of subtilin-binding bacterial proteins from 168










































































































































































































































































































of the protein band excised from the gel might have resulted in problems with 
contamination from other closely migrating, noncovalently interacting bacterial proteins. 
In addition, several similar bands were seen in both the wash fraction, and the fractions 
eluted by biotin buffer and Gly-HCl buffer in Fig. 18, suggesting the possibility that the 
capacity of a 2 ml monomeric avidin column to bind biotinylated subtilin was less than 
that of 500 µg of biotinylated subtilin that was incubated with the bacterial cells. The 
capacity of 1 ml of monomeric avidin gel to bind biotinylated protein is theoretically    
1.2 mg (http://www.piercenet.com/files/0340as4.pdf). Since the monomeric avidin 
column had been originally used to isolate biotin-containing bacterial enzymes (26), it is 
possible that some of the proteins eluted by biotin buffer and Gly-HCl buffer were biotin-
containing proteins, thereby resulting in the isolation of unexpectedly large number of 
proteins as seen in the silver stained gel (Fig. 18).  
 To overcome these problems, a more direct method of isolation of bacterial 
protein targets was employed. This method involved labeling nisin with a fluorescent tag 
so that any bacterial proteins covalently attached to nisin could be directly detected on 
account of the fluorescent tag on nisin. Bacterial proteins interacting with nisin could 
then be isolated using affinity chromatography. Therefore, nisin was labeled with 
fluorescein by reacting with N-hydroxysuccinimide-fluorescein (NHSF). After testing 
fluorescein-nisin (F-N) for antimicrobial activity, F-N was incubated with Bacillus 
subtilis 168 cells. Nisin-binding bacterial proteins were then isolated by applying the 
bacterial cell lysate containing F-N to an anti-FITC column and eluting the bound 
proteins with low pH. 
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Part V-1.  Fluorescein-labeling of nisin. 
 
Since the maximum solubility of nisin at pH 8 was determined to be 0.25 mg/ml 
(42), 0.5 mg of nisin was reacted with N-hydroxysuccinimide-fluorescein (NHSF) at    
pH 8 in a total volume of 2 ml. Similar to the biotinylation reaction of subtilin (see Part 
II-1, 1-1), nisin was reacted with the fluorescent reagent, NHSF in a 1:1 equimolar 
(nanomolar) ratio to ensure that nisin would be fluorescently labeled at only one of its 
three lysine residues. After a 2 h incubation on ice, fluorescein-nisin (F-N) was purified 
using RP-HPLC and fractions collected every min. Halo assay of RP-HPLC fractions of 
F-N showed that F-N retained antimicrobial activity, as seen in Fig. 20.  
In order to determine the mimimum amount of F-N that could be visualized by 
fluorescence, and also to test the stability of the fluorescein label on nisin with regard to 
whether the fluorescence would be quenched on a SDS-PAGE gel, varying amounts of  
F-N ranging from 1 µg to 15 µg were run on a mini SDS-PAGE gel and visualized on a 
uv transilluminator and also by silver staining the gel (Fig. 21). All amounts of F-N were 
visible on the gel, indicating that the fluorescein label was stable and that upto 1 µg of   
F-N could be detected on the UV transilluminator. The fluorescence imager, Storm 860 
Imager later used to detect fluorescence was capable of detecting upto 0.1 µg of F-N. 
 
Part V-2.  Reacting fluorescein-nisin with B. subtilis 168 cells. 
 
500 µg of F-N was initially incubated with B. cereus cells at an OD600 of 1 for 3 h 
to detect nisin-binding bacterial proteins since B. cereus is generally used as the test 
organism for the antimicrobial activity of nisin. B. cereus cells were also incubated with 
500 µg of nisin for 3 h to compare the antimicrobial activity of F-N against B. cereus  
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Figure 20. RP-HPLC and halo assay of fluorescein-nisin.
Nisin was incubated with
The RP-HPLC profile of fluorescein-nisin is depicted in the
bottom figure. Fractions corresponding to the peak were collected every
min and tested for antimicrobial activity as shown in the top figure.
N-hydroxysuccinimide-fluorescein (NHSF) in a
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Figure 21. SDS-PAGE analysis of fluorescein-nisin.
RP-HPLC purified fractions of fluorescein-nisin (F-N) exhibiting antimicrobial
activity were pooled together. Various concentration of F-N ranging from 1 µg to
15 µg were run on a mini SDS-PAGE gel. The gel was visualized on a uv
transilluminator to detect fluorescent-nisin (panel A) when all concentrations of
F-N could be detected ( . The gel was also silver stained as seen in panel B.1 - 15 µg)



























































































































































































cells with nisin. When B. cereus cells had been treated in a similar manner with 
biotinylated subtilin to isolate subtilin-binding bacterial proteins, the cells had shown 
evidence of cell lysis within 3 h as seen by loss of solution turbidity compared to control 
cells without biotinylated subtilin. However, the cells treated with F-N and nisin did not 
show any evidence of cell lysis after 3 h. Therefore, several changes were made, 
including incubating F-N with B. cereus cells at an OD600 of 0.5 (instead of 1), adding 
0.1% glucose to encourage cells to actively metabolize while treating with F-N, and 
incubating B. cereus cells with F-N and nisin overnight. These modifications then 
resulted in complete cell lysis, suggesting that subtilin is more effective at inhibiting      
B. cereus cells than nisin. The implications of these observations are discussed in the 
Discussion chapter. 
Since the complete genome of B. subtilis 168 has been sequenced, fluorescein-
nisin was then incubated with B. subtilis 168 cells to isolate and identify nisin-binding   
B. subtilis 168 proteins. Overnight incubation of F-N with B. subtilis 168 cells resulted in 
cell lysis, while the B. subtilis 168 cells incubated overnight without any F-N as a 
negative control showed no cell lysis. The cells in both samples were then completely 
lysed using a French pressure cell (56). The cell lysates were concentrated using YM-10 
centricon centrifugal filter devices, which also decreased the amount of free, unbound F-
N in the sample containing F-N. Since the YM-10 device has a nominal molecular weight 
cutoff of 10 kDa, some of the unbound F-N (3.8 kDa) passed through into the filtrate. 
The samples were boiled for 3 min and then analyzed on a SDS-PAGE gel. Fluorescent 
bands in the gel were detected using a Storm 860 Imager. Several high molecular weight 
fluorescent bands were detected in the cell lysate sample containing F-N, while no 
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fluorescent bands were seen in the control cell lysate sample, as expected (Fig. 22). 
Detection of high molecular weight fluorescent bands in the cell lysate sample containing 
F-N indicated that nisin was binding covalently to B. subtilis 168 proteins. Covalent 
attachment of nisin and subtilin to their bacterial protein targets indicates that the 
electrophilic dehydro residues of nisin and subtilin could be interacting with specific 
nucleophilic groups in their bacterial protein targets. This result confirmed that the type A 
lantibiotics nisin and subtilin are both capable of participating in covalent interactions 
with their bacterial protein targets. 
Silver staining of the gel resulted in detection of numerous bands that represent 
the complex mixture of total cellular protein (Fig. 22). Of the bacterial proteins 
interacting both covalently and noncovalently with nisin, bacterial proteins covalently 
attached to nisin were of greater interest. Identification of these covalently attached 
proteins would probably decipher the role of the dehydro residues of nisin in covalent 
binding with its target proteins. To isolate these covalent bands, an immunoaffinity 
column with anti-FITC antibodies could be used. However, the presence of free, unbound 
F-N in the cell lysate + F-N sample might result in swamping of the antibody binding 
sites leading to inefficient elution of the required proteins. Therefore, size exclusion 
chromatography (SEC) was employed to eliminate free unbound, F-N from the cell lysate 
+ F-N sample before isolating the covalently bound bacterial targets of nisin using 
affinity chromatography. The SEC column used had a pore size of 100 Å with an 
exclusion limit of 350 kDa and an inclusion limit of 2.5 kDa. However, this column was 
not very useful in separating the complex mixture of total bacterial protein (data not 
shown). For samples with a range of molecular weights such as the complex bacterial  
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Figure 22. SDS-PAGE analysis of 168 cells treated with fluorescein-nisin.B. subtilis
B. subtilis 168 cells were incubated overnight with fluorescein-nisin (F-N) and nisin and the
cells lysed after incubation. The cell lysate was concentrated using YM-10 centricon tubes.
The retentate and filtrate samples obtained from YM-10 concentration were boiled for 3 min
and then run on a SDS-PAGE gel. Fluorescent bands were detected on the gel using a Storm
Imager (panel A). High molecular weight fluorescent bands represent bacterial proteins
covalently attached to F-N. Control cell lysate sample without any F-N or nisin was used as a















































































































































































































































































































protein mixture, two or more columns with different pore sizes joined in series are 
recommended.  
Part V-3.  Affinity chromatography using anti-FITC antibodies. 
 
Since SEC could not be successfully employed in separating excess unbound F-N 
from the F-N bound to the bacterial proteins, the protocol for incubation of F-N with 
bacterial cells was modified. Bacillus subtilis 168 cells were first incubated with 500 µg 
of nisin and 0.1% of glucose for 1 h and then centrifuged before cell lysis was seen. This 
ensured that excess unbound nisin was removed. The cell pellet was resuspended in       
10 ml of 10 mM Tris-HCl, pH 8 with 0.1% glucose and incubated for 4 h when there was 
a slight decrease in solution turbidity indicating cell lysis. Incubation was continued 
overnight when complete cell lysis was observed. The same procedure was then followed 
for incubation of F-N with B. subtilis 168 cells except that cells were incubated for        
90 min before being centrifuged to remove excess unbound F-N, since F-N appears to be 
slightly less biologically active than nisin as observed from the halo assay.  
After French pressure cell lysis, the 10 ml samples were concentrated using YM-3 
tubes to ~2 ml. The samples were analyzed by SDS-PAGE, and visualized using the 
Storm Imager and also by silver staining (Fig. 23). Although this procedural modification 
did not entirely remove all of the free, unbound F-N, Fig. 23 shows a huge decrease in the 
amount of free, unbound F-N as compared to Fig. 22. The sample was then loaded onto 







Figure 23. SDS-PAGE analysis of bacterial proteins bound to fluorescein-nisin.
B. subtilis 168 cells were incubated with fluorescein-nisin (F-N). The cells were centrifuged
to remove free, unbound F-N after 1 hour and incubation continued overnight. The cell lysate
was concentrated using YM-3 centricon tubes. The retentate and filtrate samples obtained
from the YM-3 concentration were run on a gel and the gel visualized
. Some of the retentate samples were centrifuged to remove cell debris before
loading on the gel (lanes 4 and 7). Control cell sample without any F-N was used as a negative
control. The gel was
using a Storm Imager
(panel A)
































































































































































































































































































3-1.  Immuno blot using anti-FITC antibodies. 
 
To check the efficacy of the anti-FITC Ab, a dot blot was first performed to 
determine the effective concentrations of the anti-FITC Ab and fluorescein-nisin. All 
dilutions of the anti-FITC Ab used (1:100, 1:250, 1:500 and 1:1000) worked well in 
detecting all concentrations of F-N used (0.5, 1, 1.5, 2, 3 and 5 µg). This indicated that 
the anti-FITC Ab was functional in binding to F-N. This was further tested by an immuno 
blot using a 1:500 dilution of the anti-FITC Ab. F-N + cell lysate samples obtained after 
incubating F-N with B. subtilis 168 cells were run on a gel along with a negative control 
(bacterial cell lysate without any F-N), transferred onto a nitrocellulose membrane and 
probed with anti-FITC Ab followed by the 2º Ab-alkaline phosphatase conjugate. The   
F-N + cell lysate samples showed several bands while the control lanes had none as seen 
from the immuno blot. The bands seen on the Western blot represent bacterial proteins 
covalently attached to F-N. The gel was silver stained as well when all proteins were 
detected (Fig. 24). 
3-2.  Affinity chromatography using immobilized protein A-antibody complex. 
 
 The lysate of B. subtilis 168 cells treated with F-N (F-N + cell lysate) was applied 
to two different columns, one with 50 µg of anti-FITC Ab covalently linked to a 2 ml of 
protein A, and another with 1 mg of anti-FITC Ab covalently linked to 2 ml of 
immobilized protein A. Several fractions were collected from the immunoaffinity 
columns, including flow-throughs, wash and elution fractions. The fractions were 
analyzed by SDS-PAGE and visualized using a Storm Imager. No fluorescent bands were 
seen in any of the elution fractions, although some fluorescent bands were noticed in the  
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Figure 24. Detection of bacterial proteins covalently attached to fluorescein-nisin
by immunoblotting.
B. subtilis 168 cells were incubated with fluorescein-nisin (F-N).
lysates were run on a gel. Some of the cell lysates were
centrifuged to remove cell debris before loading on the gel (lanes 5 and 7). The gel was
immunoblotted using anti-FITC antibodies to detect bacterial proteins covalently
attached to F-N (panelA). The gel was silver stained as well (panel B).
The cells were
centrifuged to remove free, unbound F-N after 1 hour and incubation continued
overnight. A control cell sample without any F-N was used as a negative control. After







































































































































































wash lanes (data not shown). Similar results were seen with the silver stained gel, 
indicating that the amount of the F-N + cell lysate sample applied to the column was too 
large for efficient binding to either of the two columns with 50 µg and 1 mg of anti-FITC 
Ab. In order to test the efficiency of the immunoaffinity column, 25 µg of F-N was 
incubated on the immunoaffinity column containing 1 mg of bound anti-FITC Ab and 
eluted. The wash and elution fractions were run on a gel. No fluorescent band 
corresponding to F-N was seen in either the wash or the elution fractions (data not 
shown). As seen in Fig. 24, the immuno blot showed that the anti-FITC Ab was 
functional in binding to the F-N + bacterial protein. So, a probable reason for the absence 
of F-N + bacterial protein in the fractions obtained from the immunoaffinity procedure is 
that insufficient amount of anti-FITC Ab was crosslinked to the protein A column. The 
binding capacity of the 2 ml protein A column from Pierce is 10 mg/ml for rabbit IgG, 
and a loading of about 50% of the total protein A binding capacity for the Ab was 
recommended. However, in the above immunoaffinity experiments, a maximum 
concentration of 1 mg/ml (10%) of the rabbit anti-FITC Ab was used. Therefore, 
purification of the F-N bound protein was attempted on a much smaller scale by classic 
immunoprecipitation using the Sieze Classic (A) Immunoprecipitation kit from Pierce.  
3-3.  Classic immunoprecipitation using protein A column. 
 
In this method, the anti-FITC antibody was incubated with the antigen, 
fluorescein-nisin-bacterial protein complex in solution. The immune complex was then 
applied to immobilized protein A, washed to remove unbound protein and then eluted by 
low pH. All the wash fractions and the elution fractions from the immunoprecipitation of 
the F-N + cell lysate sample were run on 2 identical gels. One of the gels was probed by 
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immunoblotting while the other gel was silver stained. 2 bands corresponding to ~50 kDa 
and ~25 kDa were seen in the first elution fraction in the silver stained gel (data not 
shown). The immunoblot showed a major band corresponding to ~50 kDa in addition to a 
few faint bands. The ~50 kDa and the ~25 kDa bands in the silver stained gel probably 
correspond to the heavy and light chains of the anti-FITC Ab. No other bands 
corresponding to fluorescein-nisin-bacterial protein complex were visible. 
3-4.  Small scale immunoprecipitation using immobilized protein A. 
 
 To avoid contamination of anti-FITC Ab in the antigen eluate, the Seize X Protein 
A Immunoprecipitation kit from Pierce was used. 400 µg of anti-FITC antibody was 
incubated overnight with 0.4 ml of immobilized protein A in a spin cup column placed 
inside a microcentrifuge tube. After overnight incubation, the bound Ab was cross-linked 
to immobilized protein A. Anti-FITC Ab not covalently linked to protein A was eluted by 
low pH several times and the elution fractions collected. To verify that sufficient anti-
FITC antibody was cross-linked to the immobilized protein A, the elution fractions were 
run on a gel. Most of the antibody appeared to be cross-linked to protein A, since the 
fractions collected after incubation and cross-linking had little to no amount of antibody, 
as seen from the silver stained gel (Fig. 25).  
To test the efficacy of the prepared immunoaffinity column, 10 µg of fluorescein-
nisin (F-N) was applied to the immunoaffinity column, eluted by Gly-HCl (pH 2.8) in 6 
fractions, and the collected samples analyzed by SDS-PAGE. As seen in the silver 
stained gel in Fig. 26, F-N eluted off the column in elution fractions # 3-6, although F-N 
was expected to be eluted in the first three fractions. To check whether F-N was eluting 
off in fractions later than elution fraction # 6, F-N was again incubated and eluted by  
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Figure 25. Analysis of cross-linking of anti-FITC Ab to immobilized protein A.
400 µg of anti-FITC antibody was incubated overnight with 0.4 ml of protein A gel in a
spin cup column placed inside a microcentrifuge tube. Two such columns were prepared.
After overnight incubation, the column was centrifuged to collect the unbound Ab flow-
through. The gel was washed and the bound Ab cross-linked to protein A. The Ab not
covalently linked to protein A was eluted by low pH several times. The elutions were
collected after centrifuging the column and analyzed by SDS-PAGE. Most of the anti-
FITCAb appeared to be cross-linked to proteinA, since noAb was eluted by low pH from
















































































































































































































































































































































































Figure 26. SDS-PAGE analysis of fluorescein-nisin eluted by low pH from
immunoaffinity column.
10 µg of fluorescein-nisin (F-N) was incubated with anti-FITC Ab cross-linked to
protein A in a spin cup column placed inside a microcentrifuge tube. After
incubation, the column was centrifuged to collect the unbound F-N flow-through.
The gel was washed and the bound F-N was eluted by Gly-HCl (pH 2.8) several
times. The elutions were collected and analyzed by SDS-PAGE. A
, F-N was eluted by low pH in elution fractions # 3 - # 6.



































































































































low pH ten times. When the elution fractions were analyzed on a gel, F-N was seen to be 
eluting in fractions as late as # 9 and # 10. F-N therefore appeared to be leaching slowly 
from the column rather than being eluted off the column in a few fractions. 
 Since the fluorescein-nisin sample appeared to be leaching from the column rather 
than eluting, different elution conditions were applied to optimize the elution of F-N from 
the column. F-N was eluted using high salt instead of low pH. 200 µl of 3.5 M 
magnesium chloride in 10 mM phosphate buffer, pH 7.0 was added to the F-N sample 
bound to immobilized anti-FITC Ab, incubated for 5 min with shaking and the eluate 
collected after centrifugation. This was repeated another 9 times to collect 10 fractions. 
The high salt in the eluates was removed by desalting using microcon YM-3 tubes and 
the desalted samples run on a gel. No band corresponding to F-N was seen in any of the 
eluates, as seen in the silver stained gel in Fig. 27. Therefore, to thoroughly disrupt the 
antigen-antibody binding interaction, denaturing conditions using Guanidine-HCl      
(Gu-HCl) and SDS were used to elute the antigen. F-N was incubated with bound 
antibody at 4°C overnight. F-N was first eluted with 8 M Gu-HCl in 0.1 M phosphate 
buffer, pH 7. The sample was incubated with 5 x 200 µl of 8 M Gu-HCl for 5 min each 
and then centrifuged to collect the eluate. To determine whether 8 M Gu-HCl had eluted 
the F-N sample completely from the column, the same sample was further eluted with 5 x 
200 µl of 1% SDS by inverting the column gently 20 times and then centrifuging. The 
fractions eluted with 8 M Gu-HCl were desalted using microcon YM-3 tubes and all 
fractions run on a gel. No silver stained bands corresponding to F-N were seen in any of 
the fractions eluted using 8 M Gu-HCl (Fig. 27). However, a band corresponding to F-N  










Figure 27. SDS-PAGE analysis of fluorescein-nisin eluted by high salt,
Guanidine-HCl and SDS from immunoaffinity column.
10 µg of fluorescein-nisin (F-N) was incubated with anti-FITC Ab cross-linked to
protein A in a spin cup column placed inside a microcentrifuge tube. After incubation,
the column was centrifuged to collect the unbound F-N flow-through. The gel was
washed and the bound F-N was eluted by high salt (
everal times. The elutions were collected and analyzed by SDS-PAGE. A
, F-N was not eluted by high salt. 10 F-N was
again incubated with immobilized anti-FITC Ab and eluted with 8 M Guanidine-HCl
(Gu-HCl) and 1% SDS. As seen from the silver stained gel in panel B, F-N was eluted
by SDS (SDS elution # 3) but not by Gu-HCl.
s seen from
the silver stained gel in panel A µg of
3.5 M magnesium chloride)
s
































































































































































































































































































































































































































 Although SDS could elute F-N from immobilized anti-FITC Ab, the total amount 
of F-N eluted was less than the amount of F-N loaded onto the column. Low pH appeared 
to elute F-N better than the other eluting agents. Therefore, the B. subtilis 168 cell lysate 
with bacterial proteins bound to F-N was applied to the immunoaffinity column and 
eluted with low pH to isolate nisin-binding bacterial proteins. Different amounts of F-N + 
cell lysate sample were applied to the anti-FITC column and the bound proteins eluted 
with low pH. Elution of a 10 µl of F-N + cell lysate sample amount applied to the column 
resulted in the successful isolation of a ~70 kDa protein (Fig. 28). This protein band was 
not seen in the eluates of the control cell lysate sample (Fig. 29). Several more attempts 
to isolate more of the ~70 kDa protein from the F-N + cell lysate using anti-FITC column 
were not very successful. Isolation of a larger amount of the ~70 kDa protein would have 
enabled the identification of this B. subtilis 168 protein by tryptic digestion followed by 
sequencing of the tryptic peptides and comparison of the peptide sequences with the      
B. subtilis 168 proteome. This would have probably provided an insight into the 
specificity and also the antimicrobial mechanism of action of nisin. 
Part VI.  Detection of bacterial spore targets of subtilin and nisin in B. cereus spores. 
 
Detection of covalent attachment of subtilin and nisin to bacterial proteins from 
vegetative bacterial cells led to experiments performed to detect, isolate and identify 
covalently bound subtilin and nisin targets from B. cereus spores. Morris et al. had shown 
that specific B. cereus spore membrane components of 13 kDa, 28 kDa and 29 kDa 
molecular weights that were covalently modified at their sulfhydryl groups caused 
inhibition of spore outgrowth. Nisin was shown to act as an inactivator of membrane 
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Figure 28. Isolation of 168 proteins bound to nisin using affinity
chromatography.
B. subtilis
10 µl of 168 cell lysate with bacterial proteins bound to fluorescein-nisin
(F-N) was incubated with anti-FITC Ab cross-linked to protein A in a spin cup
column placed inside a microcentrifuge tube. After incubation, the column was
centrifuged to collect the unbound F-N + cell lysate flow-through. The gel was
washed and bacterial proteins bound to F-N were eluted by Gly-HCl (pH 2.8) several
times. The elutions were collected and analyzed by SDS-PAGE. A
, a ~70 kDa bacterial protein was eluted by low pH in elution
fractions # 3, # 7 and # 9.
B. subtilis






























































































































































































































Figure 29. SDS-PAGE analysis of 168 proteins eluted from anti-
FITC column.
B. subtilis
B. subtilis 168 cell lysate without fluorescein-nisin (F-N) was used as a negative
control for
was incubated with anti-FITC Ab cross-linked to protein A in a spin cup
column placed inside a microcentrifuge tube. After incubation, the column was
centrifuged to collect unbound proteins as the cell lysate flow-through. The gel was
washed and any bound bacterial proteins were eluted by Gly-HCl (pH 2.8) several
times. The elutions were collected and analyzed by SDS-PAGE. A
, no bacterial proteins were eluted from the anti-FITC column, as
expected.
B. subtilis 168 cell lysate incubated with F-N. 15 µl of the control cell
lysate


















































































































































































































































































suggesting that these membrane sulfhydryl groups are the natural targets of nisin. To 
visualize the targets of nisin in bacterial spores, electron microscopy experiments were 
performed on B. cereus spores treated with nisin (81). The targets of nisin action in 
bacterial spores could then be isolated by disrupting the spores incubated with nisin and 
subjecting the spore lysate to SDS-PAGE analysis.  
Scanning electron microscopy of B. cereus spores treated with fluorescein-nisin 
and immunogold labeled nisin showed the presence of nisin targets in B. cereus spores. 
Heat-shocked B. cereus spores were incubated with fluorescein-nisin (F-N) for 2 h in a 
water bath at 37°C in 1% tryptone-Pi growth media, pH 7.4. After the 2 h incubation, the 
spores were observed by phase-contrast microscopy to detect spores inhibited at different 
stages of germination and outgrowth. A control spore sample without any F-N was also 
incubated in growth media for 2 h. The control sample when observed by phase-contrast 
microscopy showed the presence of uninhibited, elongated vegetative cells. The untreated 
spores and the spores treated with F-N were then prepared for scanning electron 
microscopy as described in Materials and Methods, Part II-18. Fig. 30 shows the 
scanning electron micrographs of untreated spores and spores with fluorescein-nisin 
bound to the spore surface. Fluorescein-nisin bound to spores was detected due to extra 
deposition of Au-Pd metal coating on F-N resulting in clusters. Untreated spores 
appeared as elongated cells due to lack of inhibition of spore outgrowth. 
Nisin bound to the targets on the spore surface was then visualized by 
immunogold labeling. Heat-shocked B. cereus spores were incubated with biotinylated 
nisin for 3 h at room temperature. Untreated spores without biotinylated nisin were also 
incubated for 3 h. The samples were labeled with streptavidin-gold and collected on a  
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Figure 30. SEM of spores treated with fluorescein-nisin.B. cereus
B. cereus spores were incubated with fluorescein-nisin in growth media. The
sample was collected on a nucleopore filter, fixed on the filter, dehyrated and then
dried. A thin Au-Pd coating was done and the sample was viewed in a scanning
electron microscope (SEM). Spores with bound fluorescein-nisin showed extra
deposition of coating seen as clusters SEM pictures of control
spores without fluorescein-nisin are seen in panels C and D. The untreated spores
appear as elongated cells due to lack of inhibition of spore outgrowth by
fluorescein-nisin.





filter (3). After silver enhancement, the samples were dehydrated, dried and coated with a 
thin layer of chromium. Scanning electron micrographs of the spore sample treated with 
biotinylated nisin showed that the spores were immunogold labeled in discrete locations, 
indicating that nisin was binding to specific targets on the spore surface (Fig. 31). 
Untreated spores were not labeled with immunogold, as expected. 
The scanning electron micrographs detected nisin binding sites on the spore 
surface. To ascertain whether nisin bound to intracellular spore targets in addition to 
surface targets, transmission electron microscopy (TEM) of B. cereus spores treated with 
nisin was performed. Bacillus cereus spores were incubated with biotinylated nisin for    
2 h. A control spore sample without biotinylated nisin was also incubated for 2 h. The 
samples were fixed in various reagents as described in Materials and Methods, Part II-18. 
The samples were dehydrated and finally embedded in resin. The samples embedded in 
resin were sectioned using a glass knife. Upto ~150 nm thin sections of samples were 
obtained. For TEM, ~60 nm thin sections were required which would then be stained 
with 2% uranyl acetate followed by 0.1% lead citrate before viewing in a Zeiss EM10CA 
transmission electron microscope. 
SEM of spores treated with nisin helped visualize the spore targets of nisin. To 
isolate the bacterial spore targets, heat-shocked B. cereus spores were treated with 
subtilin labeled with an affinity tag such as biotin. After incubation with biotinylated 
subtilin, the spores were observed by phase-contrast microscopy to check for inhibition 
of spore outgrowth. The spores were observed to be phase-dark, indicating inhibition of  
spore outgrowth by biotinylated subtilin. The spores were then lysed using glass beads as 
described in Materials and Methods, Part II-16. The lysed sample was analyzed by     
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Figure 31. SEM of spores reacted with biotinylated nisin and
labeled with streptavidin-gold.
B. cereus
B. cereus spores were incubated with biotinylated nisin. The sample was labeled
with streptavidin-gold and collected on a nucleopore filter. A thin chromium
coating was done and the sample was viewed in a scanning electron microscope
(SEM). Nisin targets in bacterial spores were labeled with immunogold
SEM pictures of control spores incubated without biotinylated nisin
and treated with streptavidin-gold are seen in panels C and D. Immunogold labeling







SDS-PAGE and Western blot. Detection of discernible bands on the Western blot was 
difficult, probably because of the low concentrations of biotinylated subtilin and spores 




















Summary and Conclusions 
 
Lantibiotics are antimicrobial peptides that contain unusual dehydro and 
lanthionine residues as a result of posttranslational modifications. These unusual residues 
enhance the physical, chemical and biological properties of lantibiotics. Lanthionine rings 
confer extreme thermal stability on lantibiotics. Dehydro residues are electrophilic which 
make them capable of reacting with a nucleophilic group. Study of the reactivity and 
specificity of the electrophilic dehydro residues toward different nucleophilic groups can 
be utilized to explore the range of biological targets that lantibiotics are effective against. 
This study could also open a new window into understanding the mechanism of the 
antimicrobial effect of lantibiotics. This knowledge could help in designing analogs that 
exhibit enhanced antimicrobial properties in addition to acting on a wider spectrum of 
targets.  
Subtilin and nisin are type A lantibiotics that exhibit bactericidal effects against 
Gram-positive bacterial cells in addition to inhibiting bacterial spore outgrowth by 
different mechanisms (45). Previous studies on the mechanism of the antimicrobial action 
of lantibiotics have indicated that they act by forming pores in the cell membrane of 
susceptible Gram-positive bacteria. Formation of pores was proposed as being facilitated 
by the binding of nisin to lipid II, a cell membrane component that acts as a precursor to 
peptidoglycan (4). The explanation that nisin causes pore formation in sensitive Gram-
positive bacteria by interacting with a peptidoglycan precursor does not satisfactorily 
explain its specificity, as peptidoglycan is a component of the bacterial cell wall of both 
Gram-positive and Gram-negative bacteria. In addition, nisin experiments performed  
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with artificial liposomes showed that nisin was unable to permeabilize liposomes 
composed of the anionic phosphatidylglycerol whereas nisin was capable of 
permeabilizing proteoliposomes prepared from phosphatidylglycerol and beef heart 
cytochrome c oxidase (14). Since protein-protein interactions are highly specific, this 
work examined the possibility that the specificity of lantibiotics subtilin and nisin is due 
to their binding to specific protein targets in the bacterial cell membrane, similar to the 
mechanism of penicillin interacting with the penicillin binding protein in the cell 
membrane of susceptible bacteria.  
The in vitro selection technique of phage display was proposed for initial 
screening of peptide sequences interacting with subtilin to identify bacterial proteins 
interacting with subtilin that could be responsible for subtilin specificity. However, 
subtilin isolated previously from Bacillus subtilis 6633 by acetone-butanol precipitation 
had resulted in the isolation of subtilin that was very unstable, with loss of chemical 
activity observed in less than a day at room temperature. In this work, subtilin was 
isolated from B. subtilis LH45 using hydrophobic interaction chromatography, that 
resulted in subtilin that was stable even after being placed at room temperature for 2 d. 
Subtilin thus isolated also retained biological activity after four months of storage at        
–20°C. The stability of subtilin could be attributed to different factors. It is possible that 
using the acetone-butanol precipitation for subtilin isolation also resulted in precipitation 
of certain proteases that degraded subtilin. Another possibility is that the strain B. subtilis 
LH45 engineered to produce subtilin did not produce subtilin-degrading proteases. Using 
the hydrophobic interaction chromatographic method for subtilin isolation in addition to 
using the modified strain B. subtilis LH45 to produce subtilin probably enabled the 
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isolation of subtilin without proteases which would account for the increased stability of 
subtilin.  The isolation of stable subtilin now facilitated several experiments involving 
subtilin that could then be compared with nisin, since subtilin and nisin are thought to 
possess similar mechanisms of action on account of being structural analogs. For 
instance, subtilin appears to be more effective at inhibiting B. cereus cells than nisin, as 
shown in Results, Part V, V-2. Since B. cereus and B. anthracis are genetically very 
closely related, and Coughlin et al. showed that formulations containing nisin, chelator, 
detergent, and alcohol inhibited growth of spores and vegetative cells of a test strain of  
B. anthracis (11), the above observations indicate that subtilin, like nisin, could 
potentially be used to combat B. anthracis as well. The isolation of stable subtilin 
demonstrated in this work enables the testing of this possibility. Stable subtilin was also 
isolated in this work from a cellulose column by eluting using hydrophobic conditions. 
This method of isolation of stable subtilin from a cellulose column points towards a new 
and easy method of large-scale isolation of subtilin from bacterial cultures.  
 Phage display experiments were then performed with subtilin to identify peptide 
targets of subtilin. Phage display is a powerful technique used to identify peptide ligands 
for a variety of target molecules such as enzymes, antibodies, cell receptors, etc. (70), 
(18). Phage display experiments of subtilin identified a 12-mer peptide sequence with a 
KTTLL motif that is characteristic of ATP binding cassette (ABC) proteins, including the 
initiation factor IF-2 (~78 kDa) that is involved in protein synthesis at the initiation stage. 
Another protein that was identified with one mismatch to the KTTLL motif was the 
elongation factor Tu (~43 kDa) involved in protein synthesis at the elongation stage. The 
identification of these two factors as possible subtilin-binding proteins is interesting in 
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that the elongation factor Tu was also identified as the protein target of sublancin (78). 
Sublancin with one dehydro residue, is another type A lantibiotic like subtilin which has 
three dehydro residues. Interestingly, other antibiotics containing dehydro residues such 
as thiostrepton and micrococcin, also inhibit protein synthesis by interfering with the 
function of elongation factor G (EF-G) and initiation factor IF-2 (6). This points to the 
possibility that inhibition of protein synthesis by type A lantibiotics such as subtilin, nisin 
and sublancin might be another mechanism of their antimicrobial effect, in addition to 
pore formation. Inhibition of protein synthesis by subtilin could perhaps be a secondary 
mechanism of antimicrobial action in vegetative cells, while the primary mechanism of 
action is pore formation in cell membranes leading to cell lysis. 
Analysis of the KTTLL motif also resulted in the identification of ABC 
transporters similar to glutamine, anion transport and iron transport ABC transporters. 
The KTTLL motif is conserved among ABC transporters and forms part of the ATP 
binding cassette domain in ABC transporters (12). This suggests that subtilin could be 
binding to the ATP binding region and inhibiting ABC transporters present in the cell 
membrane. Binding of subtilin to ABC transporters is a likely possibility since nisin 
naturally binds to NisT, an ABC transporter that facilitates transport of nisin into the 
extracellular medium as part of nisin biosynthesis and secretion (see Fig. 4) (68). Nisin, 
subtilin and epidermin also bind to other membrane-bound ABC transporters (NisGEF, 
SpaIFG and EpiFEG, respectively) that are involved in providing immunity to the 
producer organism against the secreted lantibiotic (55). Binding of subtilin to specific 
ABC transporters in the cell membrane of susceptible bacteria would thus contribute to 
the specificity of antimicrobial action of subtilin. 
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Phage display studies were then followed by in vivo studies performed to isolate 
and identify subtilin-binding and nisin-binding proteins from intact bacterial cells to 
confirm the phage display results. Isolation of bacterial proteins binding to subtilin or 
nisin followed by identification of these subtilin-binding and nisin-binding bacterial 
proteins would then provide an insight into the specificity and antimicrobial mechanism 
of action of subtilin and nisin. Subtilin-binding bacterial proteins were isolated by 
applying the cell lysate of B. cereus and B. subtilis 168 cells reacted with biotinylated 
subtilin onto a monomeric avidin column. Bacterial proteins interacting both covalently 
and non-covalently with subtilin were isolated from both the B. cereus and B. subtilis 
samples. Of the bacterial proteins interacting covalently with subtilin, proteins 
corresponding to ~78 kDa and ~43 kDa were of particular interest, since the phage 
display results identified initiation factor IF-2 (~78 kDa) and elongation factor Tu           
(~ 43 kDa) as possible bacterial protein targets of subtilin. 
To detect bacterial proteins that nisin interacts with, nisin was fluorescently 
labeled with fluorescein and reacted with B. subtilis 168 cells. Nisin, like subtilin, also 
bound both covalently and noncovalently to bacterial proteins. Several bacterial proteins 
covalently bound to fluorescein-nisin (F-N) were detected using a Storm Imager and also 
by immuno blotting. Both subtilin and nisin were shown to interact covalently with 
bacterial proteins. This indicated that the dehydro residues of subtilin and nisin were 
probably involved in the covalent interaction of subtilin and nisin with target proteins. 
The electrophilic dehydro residues of subtilin and nisin are capable of reacting with free 
nucleophilic groups in bacterial protein targets, probably a –SH group in a Cys residue, or 
a –OH group in Ser or Thr.  
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Addition of subtilin or nisin to a –SH group appears to be a more likely 
possibility. Morris et al. reported that nisin inhibited the reactivity of bacterial membrane 
sulfhydryl groups toward sulfhydryl agents, suggesting that the membrane sulfhydryl 
groups might be the biological target of nisin in its antimicrobial activity (51). Also, Rose 
et al. reported that when glutathione, a tripeptide with a free –SH group, is reacted with 
nisin, the number of glutathione molecules that can add on to nisin or nisin variant is 
dependent on the number of dehydro residues in nisin (60). This indicated that the 
dehydro residues of nisin are the sites of addition of glutathione to nisin. Further, 
experiments performed where nisin was reacted with Cys and monitored by NMR 
showed a decrease in the peak intensity of the dehydro residues (1). Another good reason 
in favor of the possibility of addition of nisin to a –SH group is that this occurs naturally 
during the formation of lanthionine or β-methyl-lanthionine residues in lantibiotics, when 
the dehydroalanine or dehydrobutyrine residue reacts with neighboring Cys residues to 
form lanthionine or β-methyl-lanthionine residues (24).  
Covalent attachment of antibiotic to its target protein is seen in only a few other 
antibiotics such as fosfomycin (46) and thiostrepton (9). Thiostrepton, a peptide antibiotic 
with three dehydro alanines and one dehydrobutyrine, binds covalently to the Cys residue 
of its target protein TipAS through its dehydro alanine residue (9). In view of these 
observations, it is reasonable to propose that subtilin and nisin bind covalently to the –SH 
group of Cys residues in target proteins through their dehydro residues. A possible 
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Figure 32.  Possible mechanism of covalent attachment of subtilin to bacterial 
proteins.  The electrophilic dehydro alanine residue (Dha5) in subtilin is shown to react 
with a free nucleophilic group present in a bacterial protein. The carboxyl group of Glu4 
in subtilin is capable of behaving as a general base to remove a proton from a potential 
nucleophile such as a free -SH group in the Cys residue of a bacterial protein. The 
nucleophile can then attack the methylene group of Dha5 in a Michael-type addition 
reaction resulting in covalent attachment of subtilin to the bacterial protein. 
 
 
To isolate and identify bacterial proteins interacting with nisin, affinity 
chromatography was employed. Several different immunoaffinity columns with anti-
FITC antibodies were then used to isolate bacterial proteins bound to fluorescein-nisin 
(F-N). However, when F-N was applied to the immunoaffinity column and eluted using 
low pH, it was difficult to elute the F-N sample completely from the immunoaffinity 
column. Other elution conditions including high salt and denaturing conditions (8 M 
Guanidine-HCl and 1% SDS) were also used, but the high salt and the 8 M Gu-HCl failed 
to elute any F-N from the column, although the 1% SDS eluted a small amount of F-N 
from the column. When bacterial proteins bound to F-N were applied to the 
immunoaffinity column and eluted using low pH, this resulted in the elution of a very low  
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amount of a protein of ~70 kDa size. Attempts were made to elute a sufficiently large 
amount of the ~70 kDa protein from the anti-FITC column so as to enable identification 
of the nisin-binding bacterial protein using trypsin digestion in conjunction with tandem 
mass spectrometry. However, it was difficult to elute the bound protein sample from the 
column completely. A similar problem was observed with sublancin, another type A 
antibiotic, when immunoaffinity chromatography was employed to isolate sublancin-
binding bacterial proteins. A control experiment performed to elute 35S-sublancin from an 
anti-sublancin antibody column using low pH failed to elute 35S-sublancin completely 
from the column (59). It is possible that nisin and sublancin bind very tightly to 
components of the immunoaffinity column which results in low elution of nisin or 
sublancin from the column.  
Future experiments can attempt to perform 2-D gel analysis of the bacterial 
proteins interacting with fluorescein-nisin to facilitate the isolation and identification of 
nisin-binding bacterial proteins using tandem mass spectrometry. This would help in 
understanding the specificity and antimicrobial mechanism of action of nisin and subtilin, 
since nisin and subtilin are structural analogs and possess a similar mechanism of action. 
This knowledge should prove useful in the design of structural variants of gene-encoded 
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